Hospital electronic prescribing and medicines administration system implementation into a district general hospital: a mixed method evaluation of discharge communication. by Mills, Pamela Ruth
  
 
AUTHOR: 
 
 
TITLE:  
 
 
YEAR:  
 
 
OpenAIR citation: 
 
 
 
 
 
 
 
 
 
 
 
 
OpenAIR takedown statement: 
 
 This work is made freely 
available under open 
access. 
 
 
 
 
This ƚŚĞƐŝƐ is distributed under a CC ____________ license. 
____________________________________________________ 
 
Section 6 of the “Repository policy for OpenAIR @ RGU” (available from http://www.rgu.ac.uk/staff-and-current-
students/library/library-policies/repository-policies) provides guidance on the criteria under which RGU will 
consider withdrawing material from OpenAIR. If you believe that this item is subject to any of these criteria, or for 
any other reason should not be held on OpenAIR, then please contact openair-help@rgu.ac.uk with the details of 
the item and the nature of your complaint. 
This work was submitted to- and approved by Robert Gordon University in partial fulfilment of the following degree: 
_______________________________________________________________________________________________ 
i 
 
Hospital electronic prescribing and 
medicines administration system 
implementation into a District General 
Hospital: a mixed method evaluation of 
discharge communication 
Pamela Ruth Mills 
A thesis submitted in partial fulfillment of the requirements of 
the Robert Gordon University for the degree of Doctorate of 
Professional Practice 
This research programme was carried out in collaboration with 
NHS Ayrshire & Arran 
 
January 2016 
 
 
 
 
ii 
 
ABSTRACT 
Hospital electronic prescribing and medicines administration (HEPMA) system 
implementation is advocated by national e-health strategies to produce patient 
safety benefits. No previous study has evaluated HEPMA implementation 
impacting discharge information communication or assessed discharge 
prescribing errors. 
The aims were to assess HEPMA system implementation impact on medicines 
related discharge communication and prescribing errors, and to gain the 
perspective of hospital staff involved in the communication process. 
Following a narrative literature review, a convergent parallel mixed methods 
was selected, consisting of interpretative phenomenology and experimental 
before and after study design. Face-to-face semi-structured interviews of a 
purposive sample of hospital staff involved in discharge information 
communication were undertaken using the Theoretical Domains Framework 
(TDF) as a theoretical lens. In addition a quasi experimental retrospective case 
notes review, both before and after implementation was completed. 
Pre-implementation, staff described patient safety concerns with traditional 
discharge communication processes. They cited frequent prescribing errors, 
and associated adverse events and hospital readmissions. HEPMA 
implementation was anticipated to improve patient safety and create more 
efficient discharge communication. 
Post-implementation staff articulated improved information quality highlighting 
fewer omitted medicines and improved patient safety. TDF findings of 
behaviour change highlighted behavioural alteration including adaption of 
processes to improve discharge quality. 
Quantitative data collection (n=159 before and after) confirmed qualitative 
findings; increased compliance with discharge documentation, for example 
staff grade recorded increased from 40% to 100% (p<0.001). Prescribing 
error quantity and severity were reduced; errors reduced from 99% to 23% of 
patients (p<0.001); only 22% of identified errors likely to cause harm. 
Omitted medicines decreased from 42% to 11% of patients (p<0.001). 
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The findings contribute original knowledge concerning HEPMA implementation 
impacting discharge information communication and prescribing errors. The 
study demonstrated reduced prescribing errors and improved patient safety 
which potentially impacted health and wellbeing. Qualitative findings and 
quantitative results are transferable and applicable to other NHS organisations 
or similar healthcare settings. 
KEY WORDS 
HEPMA, discharge communication, prescribing errors, patient safety, 
theoretical domains framework, behavioural change 
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FOREWORD 
My current role is as Principal Pharmacist – Redesign in NHS Ayrshire and 
Arran, which is an area post with innovation and service development as key 
components. 
My current role includes the following: 
· Developing and implementing procedures for new ways of working to 
ensure efficient practice, patient safety and improvements in patient 
journeys. 
· Undertaking research and complex audits to evaluate service change.  
· Providing leadership to multi-disciplinary healthcare staff. 
I am an experienced clinical pharmacist and have worked in multiple 
specialities, especially medical wards. I maintain my clinical competency by 
participating in two clinical sessions per week in the Emergency Department. 
Working as a clinical pharmacist in a hospital setting I have completed formal 
both clinical pharmacy qualifications and also undertaken quality improvement 
and audit work. 
As a fellow of the Scottish Patient Safety Programme I received intensive 
coaching in improvement methodology and leadership and I am the lead 
pharmacist for Safer Medicines work within the hospital. 
My reason for selecting this particular course rather than the traditional PhD 
was because as an experienced practitioner of clinical pharmacy, service 
redesign and quality improvement, I was keen to undertake more formal 
research. I wanted to ensure that my selected research would be relevant to 
my job as a hospital pharmacist and would impact on my local organisation as 
well as being relevant to national and international audiences. 
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CHAPTER 1 GENERAL INTRODUCTION 
CHAPTER INTRODUCTION 
This chapter provides the introduction to the thesis, with specific focus on the 
communication of medicines information to general practitioners (GPs) 
following an in-patient stay.  
The chapter commences with a description of the legal policies for prescribing 
of medicines in hospitals, with particular emphasis on the legislation relating 
to discharge information communication and medicine prescribing at the point 
of patients’ hospital discharge following an inpatient stay. 
Patient safety issues including medication and prescribing errors are described 
with consideration to discharge communication. 
There is coverage of the local setting and context including the background to 
hospital electronic prescribing and medicines administration (HEPMA) systems 
implementation.  
This is followed by evolution of prescribing systems over time to provide 
context to the implementation of HEPMA systems, and the political drivers and 
associated policy documentation relating to these systems. 
A narrative, critical appraisal is provided of the limited literature available 
relating to HEPMA implementation and specifically discharges information 
communication. 
The aims of the research are then stated. 
PRESCRIBING IN NATIONAL HEALTH SERVICE (NHS) HOSPITALS 
Prescribing of medicines in hospitals is legislated by the Medicines Act 1968 
and associated statutes and regulations (The Medicines Act 1968). 
The requirements for a prescription are detailed in the Prescribing Section of 
the Code of Practice for Medicines Governance of NHS Ayrshire and Arran 
(NHS Ayrshire and Arran). This code was developed under the auspices of a 
subgroup of the Area Drug and Therapeutics Committee (The Medicines Risk 
Protection Group) (NHS Ayrshire and Arran). 
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Prescribing is defined in the Code of Practice for Medicines Governance as “a 
written direction for the preparation, compounding and administration of a 
medicine”. 
The prescribing of medicines in hospital must be undertaken by suitably 
qualified prescribers. These include doctors, pharmacist independent and 
supplementary prescribers, nurse independent or supplementary prescribers 
and also allied health professionals who have completed an approved 
prescribing qualification. A patient specific direction (PSD) may be used for 
hospital inpatient prescribing as ”directions to administer” as outlined in 
guidance produced by the Royal Pharmaceutical Society in Medicines and 
Ethics (Royal Pharmaceutical Society of Great Britain  2014).  A PSD must 
refer to a specific named patient but does not need to comply with the 
specifications required for a prescription. The information on a PSD may be 
transcribed to create an order for discharge. 
Transcribing of medicines is also defined in the Prescribing Section of Code of 
Practice for Medicine Governance. Transcribing is the “transfer of information 
from one direction to supply or administer to another form of direction to 
supply or administer. This includes transcribing medicines to discharge letters, 
writing transfer letters, copying illegible patient administration charts onto new 
charts, whether handwritten or computer generated.” 
Documentation for Hospital Inpatient Stay 
The documentation used to record the prescribing and administration of 
medicines is an inpatient prescription chart.  Local policies have been 
produced to provide clear advice for practitioners working within the Health 
Board area and documented in the Code of Practice for Medicines Governance 
(NHS Ayrshire and Arran). A copy of the traditional NHS Ayrshire and Arran 
inpatient prescription chart is included in Appendix 1.1, with a HEPMA version 
in Appendix 1.2. 
Documentation at Hospital Discharge 
A specific document is used to communicate discharge information to the 
patient’s GP when discharged from hospital to home or onward place of care. 
This document is traditionally termed an Immediate Discharge Letter (IDL), 
which serves as both prescription and communication of information about the 
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inpatient stay to the GP. A copy of the traditional IDL is included in Appendix 
1.3, with a HEPMA version in Appendix 1.4. This documentation should be sent 
to the patient’s GP on the day of the discharge from hospital. 
MEDICATION ERRORS AND PRESCRIBING ERRORS 
This section provides an overview of medication errors, with emphasis on 
prescribing errors. These are described within the context of the patient 
journey during stay and specifically in relation to discharge.  
Medicine related errors may occur during the process of prescribing medicines, 
dispensing of medicines or administration of medicines (MERP  2001). There is 
often a lack of clarity in the published studies on the array of terms around 
medicine related errors.  
Reasons’ model of accident causation for human error, which is the most 
widely used model to describe human error in complex organisations, 
describes several error causality factors (Reason  1990). Execution errors are 
slips or lapses which tend to occur during everyday tasks and may be detected 
by self-checking. Planning failures are actually mistakes which may either be 
rules based or knowledge based mistakes and are rarely detected by self-
checking as the individual considers their actions to be correct. 
Medication related error definitions 
The National Co-ordinating Council for Medication Error Reporting and 
Preventing (NCCMERP) is an American independent body comprised of 27 
American health care organisations with a vision that “no patient will be 
harmed by a medication error and a mission to maximise the safe use of 
medicines and to increase awareness of medicine errors” (The National Co-
ordinating Council for Medication Error Reporting and Preventing 2014). The 
NCCMERP recommends the term, medication error, defined as ”any 
preventable event that may cause or lead to inappropriate medicine use or 
patient harm while the medicine is in the control of the health care 
professional, patient, or consumer. Such events may be related to professional 
practice, health care products, procedures, and systems, including prescribing; 
order communication; product labelling, packaging, and nomenclature; 
compounding; dispensing; distribution; administration; education; monitoring; 
and use."  
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Ferner et al define a medication error as “a failure in the treatment process 
that leads to, or has the potential to lead to, harm to the patient” (Ferner and 
Aronson 2006). They further describe a classification based on Reason’s 
classification of errors (Reason  1990). “Errors can be classified according to 
whether they are mistakes, slips or lapses. Mistakes are errors in the planning 
of the action. They can be knowledge based or rule based. Slips and lapses are 
errors in carrying out an action- a slip through an erroneous performance and 
a lapse through an erroneous memory.” The distinction between different error 
types is important in influencing prevention efforts. Their medication error 
definition includes all stages in the process of medicines use and encompasses 
prescribing, transcribing, preparation, dispensing and administration of 
medicines as well as therapy monitoring. 
Definition of medicine and medication 
The Medicines and Healthcare Products Regulatory Agency (MHRA) is 
responsible for regulating medicines in the UK (Medicines and Healthcare 
Products Regulatory Agency 2014). The MHRA defines a medicine as 
“something used in disease, whether it is used to prevent, treat or diagnose it, 
in anaesthesia, investigating conditions or interfering with the normal 
operation of the body. It does not include such things as contact lens fluids, 
food supplements and cosmetics”. The MHRA does not provide a definition for 
medication but frequently the terms medicine and medication are used 
interchangeably. The Oxford dictionary defines a medicine as “a drug or other 
preparation for the treatment or prevention of disease” (Oxford University 
Press 2014a). Whilst the definition of a medication is defined by the same 
publication as either “a drug or other form of medicine that is used to treat or 
prevent disease” or “treatment using drugs” (Oxford University Press 2014b). 
Prescribing error definition 
A definition of a prescribing error is provided by Dean et al, derived from a 
formal consensus approach as “a prescribing error occurs, when as a result of 
a prescribing decision or prescription writing process, there is an unintentional 
reduction in the probability of treatment being timely and effective or increase 
in the risk of harm” (Dean, Barber and Schachter 2000). This highlights two 
separate phases: the decision making about the prescription and the act of 
writing a prescription.  
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Whilst this doctoral research is focussed on discharge prescribing errors 
consideration must be given to inpatient prescribing errors as these errors 
may be transcribed onto discharge prescriptions, perpetuating the errors.  
Inpatient prescribing errors 
Review of the published literature for inpatient prescribing errors shows 
variation in error prevalence rates.  There are two UK systematic reviews 
which demonstrate the scale of the issue and the breadth of the literature 
base.  A systematic review published by Lewis PJ et al in 2009, conducted as 
part of the EQUIP study critically reviewed 63 studies and identified an error 
rate which ranged from 7.4% to 18.7% of prescriptions (Lewis et al. 2009). 
They identified that there was “no consistent pattern in the number or types of 
errors, or medicines associated with them.”  Furthermore they highlighted 
variation in study design and outcome measures, which may have contributed 
to the range of prevalence rates. Of note, they excluded papers of electronic 
prescribing systems and also discharge prescriptions.  
A systematic review, published by Ross et al in 2009, assessed the prevalence 
of prescribing errors committed by junior doctors (Ross et al. 2009). They 
critically reviewed 24 papers, identifying an error prevalence rate in the 
studied countries (Europe, USA, Australia and New Zealand) which ranged 
from 2 to 514 per 1000 prescribed items or 4.2 to 82% of patients or reviewed 
charts. They also highlighted inconsistencies in error definition and 
methodologies in the reviewed papers.  
Two large studies on prescribing errors in the hospital setting in the UK merit 
further consideration: the EQUIP and PROTECT studies. 
EQUIP study 
EQUIP is an acronym for Errors- Questioning Undergraduate Impact on 
Prescribing, commissioned by the UK General Medical Council (GMC). It was 
an ” in depth investigation into causes of prescribing errors by foundation 
trainees in relation to their medical education”, limited to two regions in 
England (Dornan et al. 2009). The study report was published in 2009 and 
comprises three components: systematic reviews, prevalence study and 
qualitative research.   
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The prevalence component studied the prescribing errors of junior doctors in 
the first year of practice, assessed in relation to their actual environment and 
education provision. Errors were detected in 4190 out of total 50,016 
prescribed medicines with a mean error prevalence of 8.4%. 
Greater than 50% of errors (using Dean’s definition) were “errors due to the 
correct execution of an incorrect plan” and noted the need to differentiate 
between execution errors and planning errors. Qualitative interviews with a 
sample (n=30) identified that they were acutely aware of knowledge gaps at 
the point of prescribing and associated errors with busy workloads and 
tiredness.  
A further article from the EQUIP study published in 2015, reported the 
prevalence of prescribing errors at hospital discharge as 6.3% per 100 
prescribed items (Ashcroft et al. 2015). They also reported a reduction in 
prescribing error incidence with electronic systems (12% less likely) although 
described no association between prescribing system used and error severity 
(Ashcroft et al. 2015). 
PROTECT study  
PROTECT, Prevalence and Causes of Prescribing Errors: The PRescribing 
Outcomes for Trainee Doctors Engaged in Clinical Training Study consists of 
three phases conducted in eight different Scottish hospitals (Ryan et al. 2014). 
Phase one determined the prescribing error prevalence rates for junior 
doctors, phase two assessed their awareness of prescribing errors and 
experience of errors, whilst phase three assessed their perceived ability to 
prescribe accurately. 
More errors were found at hospital admission (56.7%; n=1907) than at 
discharge (14.5%; n=489), although a much smaller sample size was used at 
discharge compared to admission. Results indicated that 60% of observed 
errors reached patients but with less than 1% of these errors resulting in 
patient harm (Ryan et al. 2014). 
Specific issues relating to the creation of discharge communication by junior 
doctors due to pressures on hospital flow were identified as contributing to 
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prescribing errors (Ross et al. 2013). Junior doctors identified feeling the need 
to create discharge prescriptions under duress and at high speed.  
Junior doctors were self-aware of their prescribing error rate but were 
unworried about potential or actual patient harm as a result of these errors 
and in fact were self-assured about their prescribing aptitude (Ryan et al. 
2013).  
Thus to reduce prescribing errors will need multiple solutions due to the 
complexity of the causative factors. 
PATIENT SAFETY 
The NHS in Scotland was the first country worldwide to introduce a national 
programme to improve patient safety. 
Scottish Patient Safety Programme 
The Scottish Patient Safety Programme (SPSP) was established by the Scottish 
Government in conjunction with Healthcare Improvement Scotland(HIS) in 
January 2008.The primary aim of the programme was “to reduce mortality by 
15% and adverse events by 30% in acute hospitals by end of 2012”. The SPSP 
programme was extended by the Scottish Government in June 2012 “with a 
more ambitious target of reducing hospital standardised mortality by 20% by 
end of 2015 “(Healthcare Improvement Scotland 2014b).The SPSP is 
described as “a unique national initiative that aims to improve the safety and 
reliability of healthcare and reduce avoidable harm.” The initial work 
concentrated on acute hospitals with separate work streams targeting different 
components for example, medicines management, general ward, intensive 
care and peri-operative work. The medicine management work stream 
consists of specific improvement activities related to medicine safety to be 
undertaken in each acute hospital in Scotland. Recommended improvement 
areas included “accuracy of medicines at the interface” and “communication 
with primary care”. The former is responsible for medicine reconciliation work 
whilst the latter includes the need “to develop a communication process with 
primary care”. Improvements to the existing discharge information 
communication system and reduction of prescribing errors would therefore be 
important work to contribute to the SPSP medication safety effort. 
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NHS England Patient Safety Alert 
NHS England published a patient safety alert in 2014, aimed at all NHS 
organisations, other providers of NHS care and social care sectors highlighting 
problems with essential information communication at patients’ hospital 
discharge (NHS England 2014). They are currently collating information of 
possible solutions before publishing a resource to enable discharge information 
communication improvement. 
STRATEGIES TO OVERCOME PRESCRIBING ERRORS 
Various solutions have been proposed to reduce the incidence and patient 
harm associated with prescribing errors. These include alteration to the 
training of medical and non-medical prescribers, standardisation of prescribing 
documentation, and the use of IT systems including HEPMA (Dornan et al. 
2009). 
Training of medical and non-medical prescribers is beyond the scope of this 
DPP research. Consideration will be given to the other proposed solutions. 
Standardisation of inpatient prescription chart 
Studies reviewing inpatient prescribing errors have recommended 
standardisation of the inpatient chart as a strategy to reduce errors. 
Dornan el al considered the design of hospital inpatient charts to have 
contributed to medication errors in the EQUIP study (Dornan et al. 2009). In 
the hope of overcoming some of these errors, a national paper inpatient chart 
has been prepared in Wales (Routledge  2012) but to date there is no 
published evidence on the impact of standardisation on prescribing error rates. 
The NHS in England has produced a guidance document stating the 
requirements for a safe inpatient prescription chart (Academy of Medical Royal 
Colleges 2008). In Scotland, a group led by the Royal College of Physicians of 
Edinburgh is devising an inpatient SPARS (Scottish Prescription and 
Administration Record) chart, which is in draft format and only applies to 
inpatient paper charts. HIS produced a Scottish good practice guide for HEPMA 
implementation which states that a standardised paper inpatient prescription 
chart may be used as a template for the HEPMA inpatient chart (Healthcare 
Improvement Scotland 2014a). 
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Tallentire et al in 2013 reviewed inpatient chart design in Scotland, noting that 
it may be hypothesised that knowledge of chart layout and design would 
reduce prescribing errors. Their study identified that faster prescribing speed 
was associated with increased error rates (Tallentire et al. 2013). A limitation 
of their study was that the design involved trainee doctors prescribing using 
different styles of inpatient charts, some of which were unfamiliar, which may 
have impacted their prescribing time and hence the study findings. 
e-Prescribing impact on prescribing errors 
Electronic prescribing (e-prescribing) is defined by NHS Connecting for Health 
in 2007 as “the utilisation of electronic systems to facilitate and enhance 
communication of a prescription or medicine order, aiding the choice, 
administration and supply of medicine through knowledge and decision 
support and providing a robust audit trail for the entire medicine use process” 
(NHS Connecting for Health 2007). 
Two UK papers demonstrate the impact of e-prescribing on prescribing errors. 
Data from Donyai et al highlighted a reduction in prescribing error frequency 
for inpatients following e-prescribing implementation (Donyai et al. 2008). 
They reviewed prescribing errors four weeks prior to and four weeks following 
e-prescribing implementation, with a reduction in clinical pharmacist 
interventions on one surgical ward (28 beds) from 3% of all prescribed items 
to 1.9% and prescribing errors reduced from 3.8% of prescribed items to 2%. 
The system implemented did not include an electronic discharge component. 
The second study by Redwood et al explored the implementation of e-
prescribing solutions on the nature of prescribing errors (Redwood et al. 
2011). They analysed medicine related incident reports over a five month 
period in one UK hospital that had implemented an e-prescribing system. The 
study aimed primarily to detect if new error types, termed sociotechnical 
errors “occurring at the point where the system and the professional 
intersected and would not have occurred in the absence of the system” 
occurred. While they attributed 15% (n=73) of reported incidents as being 
sociotechnical, with almost half related to the failure to record electronic 
signatures. They acknowledged that a major limitation of their study was the 
known underreporting of medicine incidents.  
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The Health Foundation is an independent UK charity with the aim of improving 
the quality of healthcare to make lasting improvements. The two main 
priorities are patient safety and person centred-care. The Health Foundation 
produced an evidence scan in 2012 which focused on the reduction of 
prescribing errors (The Health Foundation 2012). While hospital electronic 
prescribing was identified as a key tool for reducing prescribing errors, they 
highlighted that change implementation may cause an initial drop in 
performance. Of note, incomplete communication of medicine information 
between care settings was identified as the highest cause of errors. They 
concluded that the implementation of e-prescribing systems with decision 
support could realise a 50% reduction in prescribing errors. One limitation of 
the evidence scan is that the majority of studies reviewed were based in the 
United States of America (USA) and hence not necessarily generalisable to UK 
systems and situations. Furthermore, no studies in this scan focused on 
discharge communication. 
GOVERNMENT DIRECTION- STRATEGY AND E-STRATEGY  
Both National Health Service (NHS) England and NHS Scotland have 
developed policies committing to HEPMA as a future e-health model in all 
secondary healthcare settings. In 2013, the Department of Health produced a 
£260 million investment plan to aim for the NHS in England to be paperless by 
2018 (Department of Health 2013). The Scottish e-health strategy (2011 to 
2017) produced by the Scottish Government and revised in 2012 recommends 
all Scottish health boards implement HEPMA (The Scottish Government 2012). 
They also recommend HEPMA connects to other IT clinical systems  as outlined 
in Payne’s SPICe Briefing in 2013(Payne and The National Health Service in 
Scotland. 2013). SPICe briefings are written by research specialists in the 
Scottish Parliament Information Centre (SPICe) and are used by Members of 
the Scottish Parliament to support parliamentary business. The e-health 
strategy for Scotland aims include “to maximise efficient working practices and 
to improve the safety of people taking medicines...”  It states “the Scottish 
Parliament and Audit Scotland have urged the Scottish Government to roll out 
a HEPMA system across Scotland. HEPMA supports the prescribing, ordering, 
administration, reconciliation and supply of medicines, as well as supporting a 
robust audit trail.” 
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TOOLKITS AND GOOD PRACTICE GUIDES 
E-prescribing toolkit 
The NHS in England produced an e-prescribing toolkit in 2013 (NIHR 
Programme Grant for Applied Research 2013). The toolkit was created by a 
National Institute for Health Research (NIHR) funded e-prescribing research 
programme entitled” Investigating the implementation, adoption and 
effectiveness of e-prescribing systems in English hospitals: a mixed methods 
national evaluation”. The study is “a multidisciplinary collaboration between 
the Universities of Edinburgh, Birmingham and Nottingham.”  The NIHR is 
funded through the Department of Health in England to ”improve the health 
and wealth of the nation through research”. The e-prescribing toolkit was 
“designed to support NHS hospitals in the planning implementation and use of 
e-prescribing and medicines administration systems, the toolkit offers you 
tools, resources and information to help you every step of the way”. The 
toolkit consists of the following sections: planner; case study showcases; 
tools; interact; quick references; and news and documents.  
The toolkit states that e-prescribing systems “can eliminate or reduce certain 
types of prescribing errors, and alerts users to potential dangers but they 
cannot replace sound clinical judgement. There is a need to understand that 
these systems can lead to the introduction of new errors...”   
The research programme consists of four separate phases 
1. Qualitative case studies of implementation and adoption 
2. Quantitative assessment of prescribing safety before and after 
implementation 
3. Health economic analyses of the implementation 
4. Best practice recommendations and a toolkit for the NHS 
This toolkit provides information about planning, system choice, business case 
creation and implementation advice but includes limited evaluation tools for 
organisations to use when undertaking system evaluation.  
The e-prescribing toolkit website provides information in the form of 
PowerPoint presentations and published papers on error measurement, with a 
strong focus on safety culture. A document, prepared by NHS England, 
12 
 
outlines the assessment of benefits of system implementation in terms of 
quality/effectiveness, financial or efficiency with each benefit potentially fitting 
into more than one category (Slee 2014).  
In relation to patient hospital discharge prescribing, benefits are stated as:  
1. Reduction in prescribing errors due to removal of transcription process 
from inpatient to discharge prescription 
2. Improvement in legibility and completeness 
3. Improvement in process completion 
4. Improvements in timeliness and accuracy of information communication 
to GPs 
5. Improved communication as “integrate admission medication history 
into discharge summary” 
Proposed measures to demonstrate these benefits are respectively: 
1. Audit of transcription prescribing errors or near misses before and after 
implementation 
2. Before and after audit of prescriptions 
3. Number of complaints and compliance with Royal Pharmaceutical 
Society (RPS) standards (Picton and Wright2012) 
4. Number of complaints/incidents before and after and compliance with 
RPS standards  
5. Before and after user survey and compliance with RPS standards 
A key limitation is the minimal attention placed on discharge. 
HEPMA implementation good practice guide 
Healthcare Improvement Scotland (HIS) published a good practice guide for 
HEPMA implementation in April 2014 (Healthcare Improvement Scotland 
2014a).  HIS is a national body which supports Scottish healthcare 
professionals obtain and use the best advances in medicines, technology and 
medical practice to improve the quality of healthcare. HIS works to support 
Scottish Government priorities and produces advice, guidance and standards. 
This Scottish good practice guide was commissioned by the Scottish 
Government to overcome identified inhibitors for HEPMA implementation 
including “clinical risks due to inadequate system or poor implementation”. 
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The aim is “to support safe and consistent implementation and provide 
information and tools for implementation”. It focuses on three specific areas: 
governance and risk management, leadership and organisational change and 
technology. This document articulates that HEPMA systems need to be at least 
as safe as the traditional paper systems and provides certain safety 
requirements with the goal of improving patient safety relating to medicine 
prescribing and administration. 
This publication does not provide explicit evaluation guidance for assessing the 
impact of HEPMA implementation on discharge information communication. 
DISCHARGE INFORMATION GUIDANCE 
Guidance on hospital discharge documentation requirements are provided by 
two UK bodies which are applicable to the NHS in Scotland. 
Royal Pharmaceutical Society Guidance 
RPS published recommendations in June 2012 focusing on the accuracy of 
medicine information when patients move between different care settings 
(Picton and Wright 2012). These recommendations highlight the frequency of 
changes made to patients’ medicines during hospital admissions. Data from 
the National Patient Safety Association are cited, with 30 to 70% of patients 
experiencing an error on hospital admission during the initial medicine 
reconciliation process (National Institute for Health and Clinical Excellence and 
National Patient Safety Association 2007). The RPS guidance proposes core 
content for medicine information communication on hospital discharge, which 
includes a mandatory requirement for information about any medicine changes 
during hospital inpatient stays to be recorded in electronic discharge 
communication. 
SIGN Guideline 128 
The Scottish Intercollegiate Guideline Network (SIGN) produced national 
guidance to define the ideal content of hospital discharge documentation 
(Scottish Intercollegiate Guidelines Network (SIGN) 2012).  The current 
version is the third iteration of guidance relating to hospital discharge 
documentation. It provides additional recommendations to improve the quality 
of timely discharge information communication, taking into consideration 
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changes to electronic production and transmission of discharge letters and 
medicine reconciliation requirements. 
The guidance applies to patients discharged from hospital after an inpatient 
stay of greater than 24 hours, excluding patients in mental health wards. It 
states the minimum requirements for essential information and, while it is 
intended primarily for healthcare professionals, a copy may be provided to 
patients and carers. 
It also specifies a core discharge document (CDD) to replace the IDL which is 
mandatorily produced for every patient on their discharge day. The CDD alone 
will suffice for patients with straightforward hospital stays. More complicated 
patients will require an additional extended discharge document (EDD) which 
should ideally be communicated within seven days of patient’s discharge and 
no later than 14 days post-discharge. The CDD and EDD should be produced 
by the multidisciplinary team, including pharmacy input. Where the CDD is the 
only discharge communication, the letter should be countersigned by the 
patient’s hospital consultant or a locally designated senior doctor at time of 
discharge. In circumstances where senior doctors are not available at 
discharge point, a countersigned letter must be sent within seven days of 
patient’s discharge. 
The guidance provides a template with 29 required sections with notes 
provided to aid completion of the CDD. 
A summary of the key points from SIGN 128 is included in Appendix 1.5. 
Medicine reconciliation 
A review of hospital discharge information communication would be incomplete 
without mention of medicine reconciliation. 
Medicine reconciliation (MR) is a crucial component of the hospital discharge 
process. Medicine reconciliation is defined in NHS Scotland as “the process 
that the healthcare team undertakes to ensure that the list of medication, both 
prescribed and over-the-counter, that I am taking is exactly the same as the 
list that I or my carers, GP, community pharmacist and hospital team have. 
This is achieved in partnership with me through obtaining an up-to-date and 
accurate medication list that has been compared with the most recently 
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available information and has documented any discrepancies, changes, 
deletions or additions resulting in a complete list of medicines accurately 
communicated” (The Scottish Government  2013). Failure to complete MR on 
discharge may result in errors.  
HEPMA implementation may facilitate the MR discharge process. If a medicine 
is discontinued during the inpatient stay the prescriber will be forced to 
document the reason for the discontinuation. This is achieved by mandatory 
completion of a dropdown box pre-populated with a list of discontinue choices. 
This information will be transferred onto the discharge letter and there is 
scope to add additional “free text” information if required. Appendices 1.6 and 
1.7 provide screenshots to demonstrate the MR functionality provided by 
HEPMA for discharge communication. 
Analysis of discharge MR is beyond the scope of the proposed DPP research. 
HEPMA BACKGROUND 
A report commissioned by NHS Connecting for Health in England states that 
“e-prescribing systems will change how people work” and indicates that some 
tasks are more rigid requiring complete compliance and limiting options 
(Cornford et al. 2009). They predict that HEPMA implementation will permit 
simple and direct discharge prescription production.  It should be noted that 
they suggest that hospital staff will develop ”work-rounds” to get work done 
quickly and simply which may be helpful or may actually compromise safety.  
While there is a clear need for a multi-perspective research evaluation of 
HEPMA implementation, there is a lack of published formal evaluation which 
relates to UK hospitals. 
A review of systematic reviews of all e-health solution implementations 
published between 1997 and 2010 was undertaken by Black et al (Black et al. 
2011). They included 108 systematic reviews in total with 28 papers focusing 
on e-prescribing assessment.  They highlighted that the available literature is 
of low quality in relation to methodology and outcomes and that often these 
systems are heralded as solutions with minimal or no data to support these 
claims. Whilst e-prescribing solutions are reviewed, they did not differentiate 
between systems in primary and secondary care or between systems in adult 
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or paediatric populations. Neither a fully integrated HEPMA system nor 
discharge communication was reviewed in any of the studies. The review 
highlighted system design as being crucial. The system should be easy to use 
with adequate training provided for users or unsafe workarounds and an 
increase in prescribing errors will result. They highlighted a concern that the 
amount of published evidence is low and expressed disquiet at the thought 
that negative findings may not be published due to the cost of implementing 
such systems. 
A later systematic review by Motamedi et al, published in 2011 into the 
effectiveness of computer generated discharge summaries compared to 
handwritten letters advocated the need for further research of IT 
communication systems versus traditional systems. They advised that 
organisations implementing such systems should undertake formal evaluations 
of these systems (Motamedi et al. 2011). 
HEPMA IMPLEMENTATION SURVEY OF NHS ENGLAND 
McLeod et al conducted a postal questionnaire survey in 2011 to review 
progress with HEPMA implementation in all NHS Hospitals in England (McLeod 
et al. 2014). Results highlighted HEPMA implementation as being sporadic, 
with only 13% (n=100) of replying hospitals (response rate 61%) having 
completed HEPMA implementation in ‘most’ inpatient wards. These results are 
confirmed by 2012 survey by with results demonstrating low implementation 
rates, as only 7% (n=168) of replying English hospitals (response rate 79%) 
had implemented any e-prescribing solution (Cresswell et al. 2013). At 
publication time there were a further 20% (n=168) of hospitals completing 
some stage of implementation with a further 55% (n=168) in the planning or 
procuring process. Many hospitals were either implementing or considering 
implementation of systems falling short of full HEPMA implementation for 
example a separate discharge module which may be integrated into a full 
HEPMA system at a later stage. 
Mozaffar et al in 2013 noted a marked variation in types of HEPMA systems in 
use in English NHS hospitals (Mozaffar et al. 2014). They highlighted the 
number (17) of available options for e-prescribing systems ranging from 
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commercially available to bespoke systems, and acknowledged low 
implementation in English Hospitals. 
LOCAL SETTING AND CONTEXT 
Ayrshire and Arran Health Board serves a population of 367,000 (7.3% of the 
Scottish population) and consists of two District General Hospitals (DGH), 
University Hospital Ayr (UHA) and University Hospital Crosshouse (UHC), with 
318 General Practitioners (GPs) working in 57 different practices.  
University Hospital Ayr is a 350 bedded DGH which has had a HEPMA system 
implemented gradually since 1995.  
The doctoral research was conducted at University Hospital Crosshouse (UHC), 
a 560 bedded DGH (NHS Ayrshire and Arran). Services provided from UHC 
include general medicine, general surgery, orthopaedics, gynaecology, ear, 
nose and throat, oncology, mental health, maternity and paediatric inpatient 
wards. The initial implementation of HEPMA at UHC commenced in October 
2013 into the Intensive Therapy Unit. The planned progression of 
implementation into surgical wards in November 2013 was delayed due to a 
significant information technology (IT) incident at NHS Greater Glasgow and 
Clyde in early October 2013.The local Stop Press information notice is 
provided in Appendix 1.8 (NHS Ayrshire and Arran 2013). The NHS Ayrshire 
and Arran Corporate Management Team decided to delay any planned 
implementation of IT systems until the cause of these problems was 
determined and resolved. The implementation resumed in March 2014, in 
surgical wards followed by medical wards being completed in September 2014.  
HEPMA Implementation in NHS Ayrshire and Arran 
The driver for HEPMA implementation in NHS Ayrshire and Arran (and indeed 
globally) is to improve patient safety.  
The initial clinical sponsor for the HEPMA project was the then South Ayrshire 
NHS Trust Drug & Therapeutics Committee.  Clinical ownership was considered 
an essential component of this project.  The Clinical Champion was the Chief 
Pharmacist. 
The main drivers for the implementation were: 
 To achieve compliance with the standards for prescription writing. 
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(Repeated unpublished audits having highlighted a range of issues 
associated with poor prescription writing). 
 To reduce prescribing non conformances and opportunity for 
misadventure 
 To reduce administration non conformances and opportunity for 
misadventure 
 To link prescribing and administration to dispensing and supply 
 To provide a typed, legible and validated immediate discharge letter 
 To support further clinical audit 
 
Reducing prescribing errors was of key significance especially errors related to 
poor handwriting and cluttered and untidy prescription charts. Concerns had 
been raised by GPs about the quality, content, information accuracy and 
timeliness of receipt of discharge information. 
The initial implementation of HEPMA into UHA offered the following 
functionalities: 
 paperless electronic prescribing  
 prescribing protocol management 
 paperless nurse administration with full charting 
 pre admission module 
 generation of an immediate discharge letter compliant with the 
mandatory requirements and some desirable requirements of 
national guidelines 
 automatic linkage to pharmacy dispensing and procurement 
 clinical decision support (not switched on due to system immaturity) 
 
The HEPMA system chosen for implementation into UHC is the same 
commercially available standalone system that has been refined since the 
initial implementation in UHA. The system consists of both inpatient and 
discharge e-prescribing documentation.  
Notably, HEPMA includes allergy information with limited decision support 
(allergy information, drug-drug interactions and therapeutic duplications). 
There is still a requirement for paper prescribing charts for infusions and 
complex medicines, for example insulin. 
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The doctoral research focuses on HEPMA implementation in relation to aspects 
of the hospital discharge process. Prior to HEPMA implementation, there was a 
clear need to improve the quality of prescribing of medicines generally and 
specifically in relation to discharge. A recent audit conducted at UHC in 
September 2012 (unpublished data) reviewed one week of immediate 
discharge letters completed by Foundation Year 1 (FY1) junior doctors. The 
FY1 doctors had completed letters for 77 patients, prescribed 372 items with 
1,134 identified errors by the investigating team of pharmacists and hospital 
consultants. 
Pre HEPMA Implementation 
The IDL traditionally used in Ayrshire and Arran prior to HEPMA 
implementation is included in Appendix 1.3. 
This document consists of designated sections for diagnosis, investigations and 
medicines, providing both communication and a prescription. Frequently 
amendments are made to the IDL by pharmacists to allow for legal and 
dispensing requirements. The traditional IDL consists of multiple carbon copies 
therefore any changes made in pharmacy applies to all copies. Although an 
audit trail of change exists on the IDL, it may be difficult to identify individual 
practitioners due to poor documentation of prescribing or dispensing 
information. A copy of the IDL is held in pharmacy, the patient’s notes and 
passed to the patient’s  GP, either via the patient or by post. This traditional 
version is not fully compliant with the SIGN guidelines standards (Scottish 
Intercollegiate Guidelines Network (SIGN) 2012). 
HEPMA version 
The HEPMA version of the discharge document is included in Appendix 1.4. To 
create the discharge document, the medicine information is pre-populated 
with each medicine currently prescribed on the inpatient chart. Thereafter, 
each medicine must be selected individually by the prescriber to ensure that 
the medicine is appropriate to be continued on discharge. The prescriber may 
alter the required duration of each medicine and must indicate if each 
individual medicine should be continued by the patient’ GP after hospital 
discharge.  Additional medicines may be also added at this stage.  
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PROCESSES FOR DISCHARGE COMMUNICATION 
Local traditional process 
The traditional method of discharge communication (which is not compliant 
with most recent SIGN guidelines) consists of two documents: the Immediate 
Discharge Letter (IDL) and the Final Typed Letter (FL).  
In NHS Ayrshire and Arran, pre-HEPMA implementation, the IDL is completed 
by a junior doctor who is completing postgraduate training (Foundation Year 1 
or Foundation Year 2), without any input from senior colleagues. The IDL is a 
handwritten document as outlined in the template included in Appendix 1.3. 
The only exception to handwritten completion is for the patient demographic 
information which may be completed by adding a pre-printed label.  
The IDL is followed by a more complete typed communication, the typed FL 
which provides detailed information about the patient’s hospital stay and 
ideally should be sent within a week of the patient’s discharge date (Scottish 
Intercollegiate Guidelines Network (SIGN) 2012).  A more senior doctor i.e. 
completing specialist training (ST) grade or above (rarely hospital consultants) 
is usually responsible for completing the FL.  
The process involves the doctor dictating the letter, being typed by 
administration staff, signing by the doctor, return to administration staff, 
countersigning by the consultant (or ‘per procurationem’ by administration 
staff), and then posted to the GP. It should be noted the local process for 
posting letters is not by Royal Mail delivery but by use of routine laboratory 
van deliveries. There may be delays at any or all parts of this process. Thus 
there may be time delays of several weeks or months for the FL to reach the 
patient’s GP.  
Local data (unpublished) for one clinical area gives median time from patient 
discharge to FL being posted of 11 days (range 2 to 41). 
Figure 1.1 depicts the traditional discharge letter communication in NHS 
Ayrshire and Arran  
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Decision to discharge 
patient by Consultant
IDL handwritten by 
junior doctor-
medicines 
transcribed from 
inpatient 
prescription
IDL delivered to 
pharmacy
Errors detected by 
pharmacist 
rectified
No errors detected
Copy of IDL for 
GP
Medicines 
dispensed 
and IDL 
returned to 
ward by 
porter
Patient hand 
delivers
Ward clerk posts
ST doctor dictates 
FL
Admin staff types 
FL
No errors detected 
by ST doctor
Errors detected by 
ST doctor - admin 
staff retype
FL signed by ST 
doctor
FL counter signed 
by consultant
FL not 
countersigned by 
consultant
Admin staff posts 
to GP
 
Blue- Immediate Discharge Letter   Orange- Final Letter   
Figure 1.1 Traditional (paper based handwritten) Local Process Map 
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Interim solutions 
Advances in IT have permitted changes to this traditional method. Prescribing 
systems have evolved nationally and globally over time. Due to the complexity 
of implementing a fully integrated HEPMA system, some NHS organisations 
and international healthcare systems have made changes to both the inpatient 
and discharge prescription documentation. They have implemented various 
interim processes, harnessing electronic solutions that fall short of full HEPMA 
implementation. Several countries, including the UK, have produced electronic 
immediate discharge letters which still require information transcription from 
inpatient prescription charts. These electronic letters may be sent to GP by 
different methods including fax and e-mail as well as by the traditional 
methods of patient delivery or post (Chen, Brennan and Magrabi 2010, 
Scullard et al.  2007). 
Other interim solutions have concentrated on electronic implementation of 
documentation on hospital admission for example medicine reconciliation 
documentation. This information is not used as part of the inpatient 
prescription chart but may be used to pre-populate the medicine component of 
the discharge letter. Figure 1.2 depicts interim electronic solutions. 
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Decision to discharge 
patient by Consultant
IDL typed by junior 
doctor-medicines 
transcribed from 
inpatient 
prescription
IDL delivered to 
pharmacy
Errors detected by 
pharmacist 
rectified
No errors detected
Copy of IDL for 
GP
Medicines 
dispensed 
and IDL 
returned to 
ward by 
porter
Patient hand 
delivers
Ward clerk faxes
ST doctor dictates 
FL
Admin staff types 
FL
No errors detected 
by ST doctor
Errors detected by 
ST doctor - admin 
staff retype
FL signed by ST 
doctor
FL counter signed 
by consultant
FL not 
countersigned by 
consultant
Admin staff posts 
to GP
IDL sent 
electronically to 
pharmacy
Ward clerk posts
E-mail
 
White- Traditional; Purple – Electronic; Blue FL (may become redundant with some interim systems) 
Figure 1.2 Process map of national and international interim solutions  
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Proposed HEPMA plus electronic transmission solution 
The implementation of HEPMA ensures electronic generation of IDLs, which 
may be electronically transmitted to GP surgeries by use of facsimile or secure 
e-mail. The IDL may be compiled throughout the patient’s hospital stay, with 
the possibility of senior medical input during this process. The HEPMA system 
negates the need for medicine transcription from the inpatient prescription 
sheet to the IDL, a recognised cause of prescribing errors.  The creation of the 
discharge document throughout the patient stay facilitates the change from 
the IDL followed by FL, to the CDD and negates the need for a further typed 
discharge letter, especially for patients with short hospital stays.   
The HEPMA process is provided in Figure 1.3. 
Other changes in healthcare systems have occurred simultaneously. This is 
especially related to changed roles for healthcare professionals as a result of 
changes due to modernising medical careers (Scottish Executive and 
Department of Health 2004). Whilst the consultant remains accountable for 
the care of their allocated patients, changes to the way doctors and other 
healthcare professionals are trained in the UK, has resulted in other members 
of the healthcare team assuming responsibility for tasks that would 
traditionally be associated with junior doctors for example non-medical 
prescribing.  
Thus the change to the discharge process provided in Figure 1.3 also depicts 
the evolution in roles of the hospital multidisciplinary team as well as HEPMA 
implementation. 
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Decision to discharge 
patient using consultant 
agreed criteria
CDD prepared 
throughout stay by 
multidisciplinary 
team. Medicines 
to be continued 
selected from 
inpatient 
prescription by 
junior doctor, 
advanced nurse 
practitioner or 
pharmacist
Errors detected by 
pharmacist 
rectified
No errors detected
Copy of CDD for 
GP
Medicines 
dispensed 
and CDD 
returned to 
ward by 
porter
CDD sent 
electronically to 
pharmacy
Automatic E-mail
 
The purple box denotes use of HEPMA and IT 
Figure 1.3 Process Map for full HEPMA system (NHS Ayrshire and Arran) 
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NARRATIVE LITERATURE REVIEW 
A narrative review was undertaken of the literature on the communication of 
discharge information to GPs.  
The search was conducted using the Knowledge Network of NHS Scotland 
electronic database which incorporates MEDLINE, EMBASE, Cumulative Index 
to Nursing and Allied Health Literature (CINAHL) and Applied Social Sciences 
Index and Abstracts (ASSIA) databases. These provided coverage of: medical 
and healthcare topics; nursing midwifery and allied healthcare topics; and 
health and social sciences respectively. The search was supplemented by RPS 
and International Pharmacy Abstracts databases to encompass relevant 
pharmaceutical literature.  The search terms used were: hospital discharge 
information communication; electronic hospital discharge letters; hospital 
electronic prescribing information communication; electronic discharge 
medicine information; integrated care information communication to GPs; 
seamless care information communication to GPs; and e-prescribing discharge 
information. Papers were included if they were published in the English 
language, from 2000 onwards, and reporting data from the UK, or countries 
with similar healthcare systems.  
Results of literature review 
There is a lack of a published systematic review of the prevalence and causes 
of prescribing errors at the point of patient discharge from hospital. Kripalani 
et al completed a systematic review, published in 2007, which assessed 
communication gaps on any type of discharge information communication 
including handwritten and typed letters and/or summaries (Kripalani et al. 
2007). They reviewed 213 articles in total, with 83 included for data 
extraction. The review mainly involved studies in American settings and did 
not focus on prescribing errors. They identified missing information including 
medicine information as problematic. 
This section therefore describes primary studies of published literature. 
Fifteen papers were identified and reviewed, none of which reported post-
HEPMA implementation. Table 1.1 provides details of study, setting, aim 
design and key findings.   
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Table 1.1 Descriptions of studies 
Authors 
Publication 
Year 
Country Setting Aim Design 
(Study type) 
Outcome Measures Sample size  Key Findings Key Limitations 
Sexton J,  
Ho YJ,  
Green CF, and 
Caldwell NA. 
2000 
UK UK survey To assess hospital 
pharmacy service 
provision for hospital 
discharge  
Postal survey 
of 
UK Chief 
Pharmacists 
Grade of staff preparing 
IDLs; 
communication method; 
format of 
communication 
153/222 
(73.4%) 
Junior doctors prepared 
nearly all IDLs. 
Only 10% of hospitals 
electronically prepared 
IDLs. 
Only 9% of respondents 
communicated medicine 
changes on discharge. 
 
Survey conducted in 1999 so 
information quite dated. 
 
Wilson S, 
Ruscoe W, 
Chapman M, 
and Miller R. 
2001 
Australia Medical, 
surgical, 
elderly, 
gynaecology 
and 
paediatric 
from one 
hospital 
To assess information 
accuracy and GP receipt 
time of hospital IDLs, 
and GP opinion of the 
process  
 
Retrospective 
audit; 
semi- 
structured GP 
interviews 
Receipt time; 
information content; 
accuracy of medicine 
information; 
GP opinions 
569 (5% 
sample) of 
patients 
 
20 GPs 
27% GPs received IDLs; 
IDLS assessed as 64% 
accurate; 
medicine information 
errors in 17.5% of IDLs 
included incorrect 
medicine, omitted 
medicines and 
inaccuracy of dose or 
frequency; 
GPs preferred faxed 
communication method 
 
Includes paediatric patients who are 
prescribed fewer medicines than 
adults. 
Transcription errors not considered. 
Breakdown of medicine error types 
not reported. 
Patients mainly delivered IDLs which 
is not consistent with other studies.  
Small number of IDLs received by 
GPs which limits usefulness of GP 
opinion data Use of extrapolated 
data to determine percentage 
receipt by GP which may be 
inaccurate. 
Foster DS, 
Paterson C 
and  
Fairfield G. 
2002 
 
Scotland 
Patients 
discharged 
from 
hospital to 4 
GP practices 
(35000 
patients) 
To assess information 
content of IDLs and 
receipt time of IDLs by 
GP surgeries 
Retrospective 
audit SIGN 5 
(Sign 5 
superseded by 
SIGN 128) 
Receipt time; 
information content 
244 IDLs  
(28 days) 
Basic information 
missing in 30% of 
letters. 
93% contained medicine 
information. 
60% received within 5 
days of patients’ hospital 
discharge. 
 
SIGN criteria now superseded. 
Validity of all information not 
assessed; if data were present it 
was deemed sufficient. 
Neither accuracy assessment of 
medicine information nor 
consideration of transcription errors.  
Pillai A, 
Thomas SS 
and Garg M. 
2004 
 
UK 
GPs in one 
Scottish 
Health Board 
area 
To assess GP opinion 
about quality and 
accuracy of electronic 
IDLs 
Postal survey 
GPs 
Information content; 
number of 
communications; 
GP opinions 
28/40 (70%) 
receiving 
electronic 
version; 
67/96 (70%) 
will receive 
electronic 
version in 
future 
Accuracy and 
completeness of 
information was 
perceived most 
important to GPs(n=28). 
GPs tended not to rely 
solely on electronic 
immediate version and 
wanted final version too. 
One health board area. 
Restricted to GPs using electronic 
systems- different survey for those 
not receiving electronic version. 
No evaluation of transcription errors 
as cause of errors on the electronic 
IDLs. 
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Author 
Publication 
Year 
Country Setting Aim Design 
(Study type) 
Outcome Measures Sample size Key Findings Key Limitations 
McMillan TE, 
Allan W and 
Black PN 
2006 
New 
Zealand 
Medical, 
surgical 
patients 
from one 
hospital 
To assess medicine error 
frequency and type on 
IDLs 
 
Retrospective 
audit 
Accuracy of medicine 
information;  
potential patient harm 
100 medical 
100 surgical 
0.81 errors per surgical 
IDL and 1.42 errors per 
medical IDL. 
50% of errors were 
classified as minor with 
13% classified as either 
potentially serious or 
likely to cause 
readmission. 
 
 
Only assessed handwritten inpatient 
and discharge documentation. 
Small number of patients so lack of 
generalisability. 
Validated severity scoring tool not 
used. 
 
 
 
Alderton M 
and Callen J. 
2007 
Australia General 
medical, 
elderly 
wards, 
75 bed 
hospital 
To assess GP opinion 
regarding information 
quality and receipt time 
of electronic IDLs 
GP survey  Receipt time; 
Information content; 
GP opinion 
54/85 (64%) 93% preferred electronic  
to handwritten version.  
83% of IDLs received 
within 2 weeks.  
76% very satisfied with 
medicine information. 
Future preference for 
electronic 
communication. 
 
 
Small hospital. 
Individual doctor variation in  
completing IDLs. 
Acknowledgment of transcription of 
medicine information but not 
assessed as potential error source. 
Electronic IDL not sent electronically 
but by post. 
Scullard P, 
Iqbal N,  
White L, 
Olla E and 
Thomson GA. 
2007 
UK Hospital 
type not 
stated  
To assess information 
content of traditional 
handwritten IDLs and 
typed FLs with an 
electronic summary 
alone using SIGN 
guideline criteria 
 
Retrospective 
audit; 
GP survey 
Information content and 
accuracy; 
GP opinions 
30 patients The electronic summary 
met 82% of criteria 
versus 62% for 
traditional method. 
83% of GPs preferred 
electronic version. 
Small sample size of 30 patients 
selected randomly but no 
randomisation information provided 
so potential lack of generalisability. 
Transcription errors not considered. 
Accuracy of medicine information 
not assessed. 
Process for version control of IDLs 
not considered. 
 
 
Callen JL, 
Alderton M 
McIntosh J. 
2008 
Australia Unknown To compare handwritten  
and electronic  IDLs for 
information content and 
accuracy  
Retrospective 
audit 
Information content; 
Accuracy of medicine 
information 
Control  
94 (38%) 
Intervention 
151(62%) 
Electronic IDLs 
contained more errors or 
omissions than 
handwritten ones  
87.4% of electronic IDLs 
were assessed as having 
accurate medicine 
information versus 
93.6% of handwritten 
ones 
 
 
 
Incorrect information discounted if 
documented in incorrect section. 
Completeness and accuracy of 
information only assessed for 
medicine information. 
Not calculation of sample size. 
No information about patient 
demographics or number of 
medicines. 
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Authors 
Publication 
Year 
Country Setting Aim Design 
(Study type) 
Outcome Measures Sample size  Key Findings Key Limitations 
Grimes T, 
Delaney T, 
Duggan C, 
Kelly JG, 
Graham IM 
2008 
Ireland Cardiology 
patients in 
four medical 
wards in a 
teaching 
hospital 
To assess the accuracy 
of medicine information 
on discharge documents 
and to correlate 
discrepancies with 
patient harm 
Retrospective 
audit 
Accuracy medicine 
information;  
potential patient harm 
139 patients 65.5% of patients had at 
least one identified error 
on discharge documents. 
Errors in 10.8% 
prescribed items. 
Medicine omission most 
common error (21% of 
patients). 
No errors assessed with 
potential for severe 
patient harm; 53% 
moderate and 47% none 
or minor harm. 
 
Only assessed handwritten inpatient 
and discharge documentation. 
Have a separate discharge 
prescription document and discharge 
summary document in Ireland. 
Small number of patients so lack of 
generalisability. 
 
Witherington 
EMA,  
Pirzada OM, 
and Avery AJ. 
2008 
UK Elderly 
patients, 
one district 
general 
hospital 
To assess discharge 
information availability 
and content for patients 
readmitted to hospital 
within 28 days, and if 
lack of information or 
content contributed to 
readmission 
Retrospective 
audit 
Information content and 
availability; 
accuracy of medicine 
information; preventable 
readmissions 
 
141 patients 96% of patient had IDLs 
available but 62% of 
patients were 
readmitted without FL 
being completed. 
38% of readmissions 
were medicine related of 
which 61% were 
preventable. 
18% of IDLs omitted 
medicines and only 71% 
had information about 
medicine changes. 
 
Study only in patients aged 75 and 
over who were readmitted to 
hospital therefore potential  lack of 
generalisability 
Accuracy of admission medicine 
information unknown and GP 
processes for IDL unknown. 
Multiple causes for hospital 
readmissions. 
 
Abdel-Qader 
DH, Harper L, 
Cantrill JA, 
and Tully MP. 
2010 
UK Medical and 
elderly care 
patients, 
one teaching 
hospital 
(904 beds) 
To assess the number of 
prescribing errors on e-
prescribing discharge 
prescriptions detected 
by pharmacists during 
usual validation practice 
and to determine error 
severity. 
Retrospective 
observational 
interrupted 
time sequence  
Number and type of 
pharmacist identified 
prescribing errors; 
error severity 
assessment 
1038 patients 
7290 
prescribed 
items 
Error rate 8.4% per 
prescribed item. 
Errors were medicine 
omission 31%; medicine 
choice 29.4%; dose 
error 18.1%. 
Error severity 
assessment: serious 
2.9%; significant 76.3% 
and minor 20.8%. 
Sociotechnical errors 
44.3% but lower error 
severity than non 
sociotechnical errors. 
Four prescribing errors 
occurred per hour. 
High risk medicines  
33% of errors. 
 
Short time duration (4 weeks). 
Error severity assessment by 
pharmacist alone and not 
multidisciplinary. 
Pharmacists aware of study so 
potential Hawthorne effect. 
Only medical and elderly care so a 
lack of generalisability to other 
populations. 
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Authors 
Publication 
Year 
Country Setting Aim Design 
(Study type) 
Outcome Measures Sample size  Key Findings Key Limitations 
Callen J, 
McIntosh J, 
and Li J. 
2010 
Australia Elderly 
ward,  
78 bed 
hospital 
To compare transcription 
errors on handwritten 
and electronic IDLs and 
assess medicine 
information in relation to 
grade of staff preparing 
document 
 
Retrospective 
audit 
Accuracy of medicine 
information;  
potential patient harm 
966 
Handwritten 
842 Electronic 
Transcription errors 
common 
Medicine omissions most 
common error 12% 
handwritten and 11% 
electronic 
No statically significant  
error difference between 
doctor grade and errors 
Only elderly patients who tend to be 
on more medicines than average 
population. 
Lack of generalisabiliy of study data 
to other populations and countries. 
No assessment of errors on patient 
outcome i.e. actual or potential 
patient harm. 
Chen Y, 
Brennan N, 
and Magrabi 
F. 
2010 
Australia Elderly 
ward, 
300 bed 
teaching 
hospital 
To assess effectiveness 
of IDL communication by 
different delivery 
methods 
 
Blinded 
randomised 
controlled 
trial; 
GP survey 
Receipt by GP practice 
within 7 days following 
hospital discharge; 
GP opinions 
Control 63 
RCT 168: 
email 40, 
fax 48,  
post 40, 
patient 40; 
GP n=52 
Electronic delivery 
methods [fax (69.4%) 
or email( 73.9%)] 
proved more effective 
than post  
(43.8%) or patient 
delivery (24.2%) 
GPs preferred fax  
Small study in one ward in Australia 
so potential lack of generalisability. 
Study restricted to elderly patients 
so not directly comparable to 
general population. 
Not all GP surgeries had IT 
equipment available to receive 
secure e-mail communication. 
Hammad EA 
Wright DJ 
Nunney I and 
Battacharya  
2014 
UK Patients 
discharged 
from 
hospital to 
one English 
primary care 
area 
(91 GP 
practices) 
To assess information 
content of IDLs against 
a recommended 
minimum dataset and 
assess compliance with 
medicine information 
Retrospective 
review of IDLs 
Full data set compliance; 
medicine information 
compliance; 
medicine change 
compliance; 
legibility 
3444  IDLs 
from 12 
hospitals 
audited by 84 
GP practices 
Total data set 
compliance: electronic 
73.7%  versus 
handwritten 67%  
Medicine information: 
electronic 67.2% 
compliant versus 
handwritten 54.8% 
Medicines changes: 
electronic 50.9% 
compliant versus 
handwritten 40.2%  
 
47% handwritten 
legible. 
Dataset applies to England so 
potential lack of generalisability. 
Assessment in primary care so 
would not have access to inpatient 
prescriptions. 
Accuracy of medicine information 
recorded as pass or fail so detail not 
assessed. 
 
Yemm R, 
Bhattacharya 
D, 
Wright D, and 
Poland F. 
2014 
UK 600 bed 
district 
general 
hospital 
43 GP 
practices 
(325,000 
patients) 
To assess opinion of 
hospital junior doctors 
and GPs in relation to 
discharge letter content 
Survey Ideal receipt time of 
IDLs; 
content accuracy 
assessed by GPs; 
importance of content 
and features of IDLs 
36 junior 
doctors, 
42 GPs 
GPs wanted IDLs within 
24 hours of patients 
discharge but 59% 
would wait longer for 
improved accuracy.  
15% IDLs contained 
inaccuracies needing GP 
rectification.  
Information accuracy 
was top priority with 
both GPs (72%) and 
junior doctors (88%). 
 
Small sample size 
GPs receive only electronic letters so 
results may not be applicable to 
handwritten or HEPMA systems. 
One area of UK so potential lack of 
generalisability. 
31 
 
Analysis of results 
HEPMA systems were not being used in any of these studies.  
Key findings and results are described under the following three headings: 
1. Studies investigating the traditional paper handwritten system 
2. Studies comparing electronic interim solutions to traditional paper 
handwritten system 
3. Studies investigating solely electronic interim solutions 
Traditional handwritten systems  
Six studies investigated traditional communication methods (Sexton et al.  
2000, Wilson et al. 2001, Foster, Paterson and Fairfield 2002, McMillan, Allan 
and Black 2006, Grimes et al. 2008, Witherington, Pirzada and Avery 2008). 
The majority were retrospective audits (Wilson et al. 2001, Foster, Paterson 
and Fairfield 2002, McMillan, Allan and Black 2006, Grimes et al. 2008, 
Witherington, Pirzada and Avery 2008), one survey(Sexton et al.  2000) and 
one using a qualitative approach of semi-structured interviews (Wilson et al. 
2001). Details of key findings are provided in Table 1.2, clearly demonstrating 
the high prevalence of errors (medicine information assessed as 64-66% 
inaccurate) combined with delays in receipt of communication (60% received 
within 5 days and 66% assessed received in time for effective patient care). 
Furthermore, it is evident that few studies fully researched all aspects of 
communication with limited assessment of potential patient harm.  
The following key findings and results were obtained from the studies: 
Information Content and Accuracy 
Information accuracy and completeness was not researched in all studies. 
Different methods and outcome measures related to the assessment of 
content and accuracy were adopted. Inadequate information (in terms of both 
content and accuracy) was found in all sections of both IDLs and FLs with an 
accuracy rate of 63.6% (Wilson et al. 2001).  
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Medicine Information Accuracy 
Errors were common and included inaccurate medicines information with 
10.8% errors per prescribed item or 66% of patients (Grimes et al. 2008), 
with omitted medicines (18-21%) (Wilson et al. 2001, Grimes et al. 2008, 
Witherington, Pirzada and Avery 2008) accounting for the most prevalent error 
type. The majority of patients (up to 86%) had medicine changes during 
inpatient stays (Witherington, Pirzada and Avery 2008), but these were not 
always communicated on hospital discharge (McMillan, Allan and Black 2006). 
More medicines changes occurred during medical than surgical stays (1.7 
changes in medical patients and 0.59 changes in surgical patients), which may 
account for higher error rates detected (McMillan, Allan and Black 2006). 
Legibility 
There was high variability in the extent of communication deemed to be legible 
with up to 77% deemed as “mostly legible” (Wilson et al. 2001), with some 
authors noting that the measurement of legibility to be highly subjective. 
Time to Receipt 
Approaches to measurement varied from those subjective e.g. “timely as 
regards to effective patient management” with 66% success (Wilson et al. 
2001) to more objective approaches e.g. being compared against a standard 
of five days for IDL (60%) and 28 days for FL (51%) (Foster, Paterson and 
Fairfield 2002). Results demonstrated inter-country differences, including 
differences in communication methods; in Australia delivery was mainly reliant 
on the patient whereas in the UK there was a combination of postal and 
patient delivery. 
Patient Harm 
Hospital readmissions due to medicine related problems were detected in 38% 
of patients but with uncertainty regarding the association between inaccurate 
communication and the potential to cause readmission (Witherington, Pirzada 
and Avery 2008). The population studied consisted of elderly patients who are 
more likely to be re-admitted due to significant co-morbidity, terminal 
illnesses and complex social problems irrespective of poor communication.
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Table 1.2 Results of Studies of Traditional IDLs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NA- not assessed;    - communication error alone not responsible for patient harm
Author 
Year 
Country 
Population 
Information 
content + 
accuracy 
Medicine 
Information 
Accuracy 
Receipt  Time to 
receipt 
GP  
satisfaction 
Number of 
Communications 
Potential 
Patient 
 Harm 
Legibility Communication 
Method 
Grade 
of 
Staff 
Sexton J,  
Ho YJ,  
Green CF, and 
Caldwell NA. 
2000 
UK NA NA NA NA NA NA NA NA Only 9.9% 
electronic means, 
19 different 
combinations 
Junior 
doctors  
Wilson S, 
Ruscoe W, 
Chapman M, 
and Miller R. 
2001 
Australia 
General 
Errors all 
parts of 
document- 
63.6% 
accuracy 
36.4% med 
accuracy 
21% no med 
info recorded 
27.1% 66% for 
effective 
patient 
care 
GP prefer 
fax 
NA NA 77% 
mostly 
legible or 
legible 
NA NA 
Foster DS, 
Paterson C and  
Fairfield G. 
2002 
UK 
Unknown 
20% no 
admission or 
discharge 
dates, 13% 
no diagnosis 
NA NA 60%IDL 
5 days 
51% FL 
4 days 
NA NA NA 39% 
legible 
signature 
NA NA 
McMillan TE, 
Allan W and 
Black PN 
2006 
New 
Zealand 
Medical/ 
surgical 
NA More errors 
med(1.42) 
than surg 
(0.81) more 
changes  
NA NA NA NA 88% errors 
minor or 
potentially 
troublesome 
1.8% may 
result 
readmission 
NA NA NA 
Grimes T, 
Delaney T, 
Duggan C, 
Kelly JG, 
Graham IM 
2008 
Ireland 
Cardiology 
NA Errors in 
65.5% patients 
or in 10.8% 
per prescribed 
item 
NA NA NA NA 53% 
moderate 
harm;  
47% none 
or minor 
harm. 
NA NA NA 
Witherington 
EMA,  
Pirzada OM, and 
Avery AJ. 
2008 
UK 
elderly 
62% no FL 
on re-
admission 
Baseline 
66% 
incomplete 
NA NA NA NA  NA NA NA 
34 
 
Comparison of traditional and interim electronic solutions 
Four studies compared handwritten traditional methods with electronically 
prepared IDLs (Scullard et al.  2007, Callen J, McIntosh J and Li J  2010, 
Callen, Alderton and McIntosh 2008, Hammad et al. 2014). All involved 
retrospective audits with one study including a survey of GPs (Scullard et al.  
2007). Details of key findings and results are provided inTable1.3, which 
demonstrates variability in results among the studies especially in relation to 
errors and medicine information accuracy. Scullard et al and Hammad et al 
demonstrated an improvement in information accuracy using electronic 
systems with up to 82% completed accurately with electronic versus 62% with 
paper (Scullard et al.  2007, Hammad et al. 2014); whereas Callen, McIntosh 
et al showed no significance difference with an error rate of 12.1% with paper 
versus 13.3% for electronic although both systems required transcription 
(Callen J, McIntosh J and Li J  2010); and Callen, Alderton et al reported more 
errors with the electronic system with (13% versus 6% errors) with a free-
format section being particularly problematic for errors (Callen, Alderton and 
McIntosh 2008). 
The following key findings and results were obtained: 
Information Content and Accuracy 
Improved information content and accuracy was found when changing to a 
first and final electronic discharge letter (FFL) (Scullard et al.  2007, Hammad 
et al. 2014). On initial implementation a higher error rate was detected in the 
electronic version for all audited components which resolved with system 
integration (Callen, Alderton and McIntosh 2008). Scullard et al and Hammad 
et al demonstrated improved compliance of up to 82% with a minimum 
dataset when using electronic template (Scullard et al.  2007, Hammad et al. 
2014). 
Medicines Information Accuracy 
There are inconsistent findings in relation to medicine accuracy. Studies found 
deterioration in accuracy from 6.4% handwritten prescribing errors to 12.6% 
with electronic version (Callen, Alderton and McIntosh 2008), no change in 
accuracy (13.3 % electronic medication errors versus 12.1% handwritten 
(Callen J, McIntosh J and Li J  2010) or improvement in accuracy from 54.8% 
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to 67.2% compliance (Scullard et al.  2007). Medicines omission was the 
commonest detected error type with an average error rate of 1.5 with paper 
versus 1.4 with electronic discharge letters with errors (Callen J, McIntosh J 
and Li J  2010).   
GP Satisfaction 
GPs preferred electronic versions of communication with standardised format 
and improved legibility cited as the main reasons (Callen, Alderton and 
McIntosh 2008, Hammad et al. 2014). 
Number of Communications 
Replacing the traditional documents (IDL followed by FL) with a FFL was 
acceptable and improved communication. This single communication was 
assessed as having sufficient information (Hammad et al. 2014). 
Legibility  
Changing to electronic discharge letters resulted in complete legibility 
(Hammad et al. 2014). 
Grade of Staff  
No significant difference was found in prescribing error rates for discharge 
letters being created by different grade of doctors although data not provided 
in the study to corroborate this claim (Hammad et al. 2014).
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Table 1.3 Results of studies comparing handwritten and electronic IDLs 
 
 
 
 
 
NA- not assessed +- significantly improved   - -significantly worse - no significance between groups
Author 
Year 
Country 
Population 
Information 
content + 
accuracy 
Medicine 
Information 
Accuracy 
Receipt  Time 
to 
receipt 
GP  
satisfaction 
Number of 
Communications 
Potential 
Patient 
 Harm 
Legibility Communication 
Method 
Grade 
of 
Staff 
Scullard P, 
Iqbal N,  
White L et al. 
2007 
UK 
unknown 
electronic 
+ 
NA NA NA electronic 
+ 
FFL alone 
+ 
NA electronic 
+ 
NA NA 
Callen JL, 
Alderton M, 
McIntosh J. 
2008 
Australia 
unknown 
electronic 
- 
electronic 
- 
NA NA electronic 
+ 
NA NA electronic 
+ 
NA NA 
Callen J, 
McIntosh J, 
and Li J. 
2010 
Australia 
Elderly 
NA  NA NA NA NA NA NA NA  
Hammad EA 
Wright DJ 
Nunney I and 
Battacharya  
2014 
UK 
General 
electronic 
+ 
electronic 
+ 
NA NA NA NA NA electronic 
+ 
NA NA 
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Results of studies of electronic immediate discharge letters 
Five studies evaluated electronic immediate discharge letters, with the 
majority assessing delivery methods (Chen, Brennan and Magrabi 2010, Pillai, 
Thomas and Garg 2004, Alderton and Callen  2007, Abdel-Qader et al. 2010, 
Yemm et al. 2014). Four used survey approaches to gauge opinions (Chen, 
Brennan and Magrabi 2010, Pillai, Thomas and Garg 2004, Alderton and Callen  
2007, Yemm et al. 2014), with one retrospective observational interrupted 
time sequence (Abdel-Qader et al. 2010); and one blinded randomised control 
trial (Chen, Brennan and Magrabi 2010). One study surveyed the 
requirements for IDLs from the perspectives of both GPs and hospital junior 
doctors (Yemm et al. 2014). 
 Details of key findings and results are provided in Table 1.4.   
Information content and accuracy 
Pillai et al found information accuracy and content to be at least as good as 
the previous system (Pillai, Thomas and Garg 2004); whilst Alderton et al 
identified that 93% of GPs surveyed noted enhancement with the electronic 
version (Alderton and Callen  2007). Accurate information was stated to be 
most important category on discharge communication for surveyed GPs (72%) 
and junior doctors (88%) (Yemm et al. 2014). This rated higher than 
comprehensiveness, timely receipt and grammatical accuracy. 
Medication information 
Prescribing errors were found to still occur with electronic systems, at an error 
rate of 8.4% per prescribed item. Errors categorised as sociotechnical errors 
(defined as an error unlikely to occur with handwritten charts) were associated 
with lower patient harm with 68% considered significant or serious versus 
85% of non-sociotechnical errors (Abdel-Qader et al. 2010). Error severity was 
assessed using a five point scale as: potentially lethal; serious; significant; 
minor; or no error. 
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Receipt  
Patient delivery, mail or electronic delivery methods failed to reach a target of 
95% reliability for receipt within 1 week of hospital discharge. The slowest 
method was patient delivery with only 24% received within seven days (Chen, 
Brennan and Magrabi 2010). 
Time to receipt  
Electronic communication methods resulted in improvement in receipt times 
with 74% of emailed and 69% of faxed letters arriving within 7 days (Chen, 
Brennan and Magrabi 2010) and 80% of surveyed GPs stating that e-mailed 
letters had quicker receipt time (Pillai, Thomas and Garg 2004). GPs wanted 
IDLs within 24 hours of discharge but 59% would wait longer for improved 
accuracy (Yemm et al. 2014). 
GP satisfaction 
Electronic documentation resulted in improved satisfaction of GPs, with 93% 
reporting enhanced satisfaction compared to handwritten version (Alderton 
and Callen  2007). 
Number of communications 
Less than half (42%) of responding GPs agreed that an electronic FFL could 
replace the traditional process of the IDL followed by a typed FL (Pillai, 
Thomas and Garg 2004).  
Communication methods  
Almost all (83%) of responding GPs favoured electronic communication of IDLs 
rather than faxed receipt (Chen, Brennan and Magrabi 2010). 
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Table 1.4 Results of studies of electronic IDL 
 
 
 
 
NA- not assessed +- significantly improved   - -significantly worse   - no significance between groups 
# 58% actually receiving GPs disagreed with 78% potentially receiving agreeing      
  
* status quo favoured by actually receiving GPs whilst potentially receiving favoured electronic version 
Author 
Year 
Country 
Population 
Information 
content + 
accuracy 
Medicine 
Information 
Accuracy 
Receipt  Time to 
receipt 
GP  
satisfaction 
Number of 
Communications 
Potential 
Patient 
 Harm 
Legibility Communication 
Method 
Grade 
of Staff 
Pillai A, 
Thomas SS 
and Garg M. 
2004 
UK 
General 
 NA NA electronic 
      + 
electronic 
      + 
electronic 
      -/+ # 
NA NA electronic 
     +/- * 
NA 
Alderton M 
and Callen J. 
2007 
Australia 
General 
medical, 
elderly 
electronic 
      + 
NA NA electronic 
      + 
electronic 
      + 
NA NA NA NA NA 
Abdel-Qader 
DH, Harper L, 
Cantrill JA, 
and Tully MP. 
2010 
UK 
Medical, 
elderly care 
NA Electronic- still 
errors 
NA NA NA NA + 
Socio-
technical 
errors  
less 
severe 
NA NA NA 
Chen Y, 
Brennan N, 
and Magrabi 
F. 
2010 
Australia 
Elderly 
NA NA electronic 
+ 
electronic 
       + 
electronic 
      + 
 
NA NA NA electronic 
     + 
NA 
Yemm R, 
Bhattacharya 
D, 
Wright D, and 
Poland F. 
2014 
UK 
General 
NA Accuracy main 
concern 
(72%GPs and 
88% junior 
doctors)  
NA NA electronic 
      + 
NA NA NA NA NA 
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Conclusion  
Advantages ascribed to electronic solutions include improved legibility, 
information content accuracy, speed of transmission and GP satisfaction. The 
noted improvement in legibility does not necessarily concurrently improve 
information accuracy.   
Previous studies have highlighted the importance of accurate communication 
of information including medicine information at patients’ hospital discharge. 
None of the studies could equate patient harm with miscommunication and 
errors in discharge information. 
GAPS IN LITERATURE 
There is a paucity of literature regarding evaluation of HEPMA implementation. 
Policy documents and government strategies recommend systems 
implementation as solutions to reduce prescribing errors and improve 
communication, but with little evidence to support these claims. Seidling et al 
describe collaborative research in three European countries (Germany, 
Switzerland and Austria) and emphasise that IT solutions need to be infiltrated 
into existing working systems and people then need to modify behaviour 
accordingly (Seidling et al. 2013).  A limited number of studies have reviewed 
the impact of such solutions on communication of discharge information and 
none have encompassed HEPMA implementation. Most of the published 
literature has focused on interim solutions which still require transcription from 
a paper inpatient chart to an electronic discharge document.  
Concern has been expressed over the lack of publications relating to HEPMA 
implementation and that perhaps unfavourable data may be leading to a 
negative publication bias. There is therefore an urgent need for evaluative 
research to focus on the impact of HEPMA implementation, specifically relating 
to discharge communication. 
The majority of survey studies have focused on the GP perspective although 
interestingly one recent study also considered hospital doctors perspectives. 
Research of the hospital perspective initially to ensure that prescribing 
systems are working well there and to assess staff satisfaction with the 
prescribing tools available would provide additional insight to this complex 
area.  
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This study will be important to identify the impact of HEPMA implementation 
either favourably or otherwise in relation to discharge information 
communication and prescribing errors. 
OVERALL AIM OF DPP PROJECT AND AIM OF EACH PHASE 
The overall aim of the project was to assess the impact of HEPMA system 
implementation on medicines related discharge communication and prescribing 
errors, and to gain the perspective of hospital staff involved in the 
communication process. 
Phase 1 
Interpretative phenomenology to fully describe and understand the opinions of 
staff groups involved in discharge communication using the traditional paper 
based system prior to HEPMA implementation.   
Phase 2 
Interpretative phenomenology to fully describe and understand the opinions of 
staff groups involved in discharge communication after HEPMA 
implementation.   
Phase 3 
Experimental study to quantify the impact of HEPMA implementation on 
discharge communication errors and receipt of discharge communication at GP 
surgeries. 
Study design  
The project used convergent parallel mixed methods design consisting of both 
qualitative and quantitative components. 
Research Question Phase 1 (Qualitative research methods) 
What are the opinions of staff involved in the prescribing and discharge 
communication process using traditional paper based prescribing system? 
Aim  
The aim was to describe and understand perspectives of key staff groups (i.e. 
consultant doctors, junior doctors, pharmacists and advanced nurse 
practitioners) relating to patient discharge communication via  the traditional 
paper based system and prior to HEPMA implementation. 
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Objectives 
1. To describe and understand  staff views and experiences of the 
traditional paper based system 
2. To explore expectations and likely behaviours in relation to HEPMA 
implementation 
3. To highlight any differences in key themes identified amongst different 
professional staff groups 
Research question Phase 2 (Qualitative research methods) 
What impact did HEPMA implementation have on the experiences of hospital 
staff relating to prescribing and discharge communication and are these 
consistent with pre-implementation expectations of electronic prescribing? 
Aim 
The aim of this phase of the project was to describe and understand the 
perspectives of key staff groups (i.e. consultant doctors, junior doctors, 
pharmacists and advanced nurse practitioners) relating to patient discharge 
communication via the recently implemented HEPMA system. 
Objectives 
1. To describe and understand staff views and experiences of the HEPMA 
system 
2. To explore behaviours and behavioural determinants in relation to 
HEPMA implementation 
3. To highlight any differences in key themes identified amongst the 
different professional groups 
 
Research questions Phase 3 (Quantitative research methods) 
1. What impact does HEPMA implementation have on discharge 
information content, discharge information accuracy and number and 
severity of prescribing errors? 
2. What impact does HEPMA implementation have on discharge letter 
receipt and time of receipt at GP surgery 
3. What impact does HEPMA implementation have on patient re-admission 
rates? 
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Research question 1 is the primary question. 
Aim 
The aim of this phase of the DPP project was to determine if HEPMA 
implementation impacted discharge information. 
Objectives 
Pre-implementation objectives 
 To determine  the frequency and nature of prescribing errors on 
immediate discharge letters prepared using traditional handwritten 
processes 
 To determine discharge letter receipt and time of receipt at GP practices  
Post-implementation objectives 
 To determine the frequency, nature and severity of prescribing errors 
on immediate discharge letters post  HEPMA implementation 
 To determine discharge letter receipt and time of receipt at GP practices  
COMPARISON OBJECTIVES 
Primary Objective 
 To determine if HEPMA implementation impacted the frequency, nature 
and severity of prescribing errors on immediate discharge letters. 
Secondary Objectives  
 To determine if HEPMA implementation impacted discharge letter receipt 
and time of receipt by GP practices. 
 To determine if HEPMA implementation impacted patient re-admission 
to same specialty at 7, 14, 28 and 90 days after initial discharge date. 
Hypotheses 
 the null hypothesis was that HEPMA implementation did not impact 
discharge letter quality, number and severity of prescribing errors 
 the alternative hypothesis that HEPMA implementation impacted 
discharge letter quality, number and severity of prescribing errors 
 
 
44 
 
CHAPTER SUMMARY  
This chapter has provided the introduction to the thesis, with specific focus on 
the communication of medicines information to GPs following an inpatient 
stay. 
 A description of the local context and setting has been provided including 
background information relating to HEPMA implementation. 
The legal policies for prescribing of medicines in hospitals have been 
described, with particular emphasis on the legislation relating to discharge 
information communication and medicine prescribing at patients’ hospital 
discharge following an inpatient stay. 
Coverage of the evolution of prescribing systems over time has been provided 
to contextualise the implementation of HEPMA systems. 
A narrative critical appraisal of the limited available literature relating to 
HEPMA implementation and specifically discharge information communication 
has been provided 
The aims of the research have been described. 
Thus the proposed project fills a gap in the available evidence.  
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CHAPTER 2 RESEARCH METHODOLOGIES 
CHAPTER INTRODUCTION 
This chapter provides a brief description of research philosophies, 
methodologies, approaches and methods. Selected research methodologies 
and methods are justified, accompanied by an overview of potential theoretical 
frameworks with a justification for the selected framework. Finally there is 
consideration of research governance issues. 
GENERAL OVERVIEW OF RESEARCH PHILOSOPHIES 
Research paradigms deal with philosophical scope, which includes assumptions 
and beliefs that affects researchers’ behaviours, as outlined by Wahyuni, and 
Johnson et al (Wahyuni  2012, Johnson and Onwuegbuzie 2004). They 
espouse that ontology, epistemology and axiology are the three fundamental 
beliefs. Wahyuni and Durant-Law describe ontology as the researcher’s view 
on the nature of reality, epistemology as the consideration of what is 
acceptable knowledge and axiology describes the researcher’s values and 
ethics (Durant-Law). They claim that there are four distinct paradigms, which 
are positivism (naïve realism), postpositivism (critical realism), interpretivism 
(constructivism) and pragmatism, each described by different philosophical 
beliefs and summarised in Table 2.1.  
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Table 2.1 Summary of philosophical beliefs in research paradigms, adapted from work by Wahyuni (Wahyuni  2012). 
 Research Paradigms 
Philosophical 
belief 
Positivism Postpositivism Interpretivism Pragmatism 
Ontology Independent, 
hypothesis driven 
Independent but 
interpreted through 
experience/ conditions 
Subjective, multiple 
options 
Multiple- use what is 
most appropriate to 
answer research question 
Epistemology Observable and 
measurable, cause 
and effect 
Observable, 
explain data in context 
Subjective- analysis 
of details and 
meanings of details 
Observable and/or 
subjective,  
practice research- mixing 
different perspectives for 
data interpretation 
Axiology Independent, 
value-free and etic 
Researcher bias, 
value-laden and etic 
Researcher a part of 
what is being 
researched, 
value-bonded and 
emic 
Both objective and 
subjective- values used 
to interpret data, 
value-bonded and etic-
emic 
Research 
Methodology 
Quantitative Qualitative or 
quantitative 
Qualitative Qualitative and 
quantitative 
(Mixed methods) 
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TYPES OF RESEARCH METHODOLOGY 
Methodology is the approach the investigator uses to answer the specific 
research question. Methodology concerns the theory about the use of specific 
research methods and this theory is responsible for the selection of the 
appropriate research method. It explains why certain methods or tools are 
used.  
There are three different methodologies for undertaking research: 
quantitative; qualitative and mixed methods research. There are strengths and 
weaknesses in all methodologies. Thus, it is important to select the 
appropriate methodology to answer the research question, which has the most 
strengths and minimal weaknesses.  Creswell states that “when constructing a 
research plan it is vital to have a meaningful research question with an 
appropriate way to answer it” (Creswell  2013). It is therefore essential to 
consider the different types of methodologies and associated methods to 
ensure that the optimum methodologies are selected when constructing the 
research design to answer the required research question. Thus the selection 
of appropriate methods (research approach) will aid the research strategy and 
answering of the research question. 
QUANTITATIVE RESEARCH   
Quantitative research is described as “answering the questions of who, where, 
how many, how much, and what is the relationship between specific variables” 
(Schimmel  1996). Creswell notes that quantitative research is “deductive, 
objective and general” (Creswell  2013). 
Quantitative research collects numerical data by using structured research 
instruments which are finalised prior to data collection. It tends to rely on 
sampling of a population to produce results that should be representative of 
that larger population and tends to be easily replicated because of its high 
reliability. Bowling claims quantitative research is “appropriate in situations in 
which there is pre-existing knowledge, which will permit the use of 
standardised data collection methods, and in which it is aimed to document 
prevalence or test hypotheses” (Bowling  2014). Creswell adds that 
quantitative research methodologies “mainly comprises surveys and 
experiments to test a theory which produces objective data from empirical 
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observations and measures necessitating validity and reliability to permit 
meaningful interpretation of data” (Creswell  2013). It may be used to 
generalise concepts, predict future results or determine causality. Table 2.2 
provides an overview of quantitative research methodologies and is adapted 
from Creswell and Davies (Creswell  2013, Davies  2007). 
Key issues of sampling, and data validity and reliability are explained later in 
the text. 
Strengths of quantitative research include that it tends to be independent of 
the investigator, and is conducive to large sample sizes. 
Limitations of quantitative research include the multiple biases which may 
exist (see later) and that it may not generate hypotheses but will merely 
confirm or reject an existing hypothesis. 
While there is often confusion between methodologies and methods, methods 
have been described as “the tools to do the research” (Kinash  2006). 
Research methods are described by Bowling as “the practices and techniques 
used to collect, process and analyse the data” (Bowling  2014). Furthermore, 
Bowling claims that quantitative research methods are highly structured 
(Bowling  2014).
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Table 2.2 Summary of Quantitative Methodologies, adapted from Creswell and Davies (Creswell  2013, Davies  2007)  
Quantitative Methodologies 
Design Survey Design Experimental Design 
Specific 
methodologies 
Cross-sectional (one point in time) or longitudinal 
(repeated) surveys 
Randomised controlled trials (RCTs), quasi-RCT, before 
and after studies, cohort studies, case control studies, 
case series studies 
Description of 
general aims 
To describe and investigate issues such as trends, 
attitudes or opinions of a population or sample of 
that population 
Generally aim to determine if a specific treatment or 
intervention impacts the outcome. Treatment or 
intervention applied to one group and ideally another 
comparable group acts as a control. Random selection 
or random sampling or convenience sampling which 
makes a quasi-experiment.  
Main methods 
of data 
collection 
Questionnaires or structured interviews to collect 
objective data. Data may be collected at one 
point in time or over time.  
Completion of research tools to collect objective data. 
 
Approaches to 
sampling 
May use the entire population (depending on 
size). If sampling, ideally a random sample but 
may be stratified, systematic, convenience or 
clustered. 
May use the entire population (depending on size). If 
sampling, ideally a random sample but may be 
stratified, systematic, convenience or clustered. 
Approaches to 
data analysis 
Statistical analysis (descriptive and inferential), 
depending on the aim. 
Statistical analysis (descriptive and inferential), 
depending on the aim. 
Approaches to 
data 
interpretation 
To describe the population (sample) and to make 
inferences about particular population 
characteristics. May test or generate hypotheses. 
To accept or reject the null hypothesis. 
Issues of 
validity and 
reliability 
Need to demonstrate validity and reliability  Need to demonstrate validity and reliability. 
50 
 
Survey Designs 
Survey design methodologies largely employ questionnaires and structured 
interviews as methods of data collection. Data may be collected via face-to-
face, telephone, postal or internet based approaches (Davies  2007).  
Experimental Designs 
Bowling defines the experimental approach as “a situation in which the 
independent variable (also known as the exposure, the intervention, the 
experimental or predictor variable) is carefully manipulated by the investigator 
under known, tightly defined and controlled conditions, or by natural 
occurrence.”  Experimental designs are considered to have different levels of 
evidence. The quantitative hierarchy of evidence is described by the Scottish 
Intercollegiate Guidelines Network as shown in Table 2.3 (Scottish 
Intercollegiate Guidelines Network (SIGN) 2012). The ranking is from 1 with 
the highest evidence to 4 as the lowest. Randomised controlled trials (RCTs) 
are ranked top in the hierarchy of evidence. It may not always be possible to 
conduct RCTs for a variety of reasons so quasi-experiments would be an 
alternative design. Harris et al define a quasi-experiment as “a study that aims 
to evaluate interventions but that do not use randomisation. The aim is to 
demonstrate causality between an intervention and an outcome. Quasi –
experimental studies can use both pre-intervention and post-intervention 
measurements as well as non-randomly selected control groups” (Harris et al. 
2006). 
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Table 2.3  Levels of evidence obtained from SIGN (Scottish Intercollegiate Guidelines 
Network (SIGN) 2012) 
KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS 
Evidence 
Level 
Study Design 
1++ High quality meta-analyses, systematic reviews of RCTs, or RCTs 
with a very low risk of bias 
1+ Well conducted meta-analyses, systematic reviews, or RCTs with 
a low risk of bias 
1- Meta-analyses, systematic reviews, or RCTs with a high risk of 
bias 
2++ High quality systematic reviews of case control or cohort studies 
High quality case control or cohort studies with a very low risk of 
confounding or bias and a high probability that the relationship is 
causal 
2+ Well conducted case control or cohort studies with a low risk of 
confounding or bias and a moderate probability that the 
relationship is causal 
2- Case control or cohort studies with a high risk of confounding or 
bias and a significant risk that the relationship is not causal 
3 Non-analytic studies e.g. case reports, case series 
4 Expert opinion 
 
 
Experimental designs are divided into the following categories: 
Randomised controlled trials (RCTs) 
Bandolier defines an RCT as ”a group of patients is randomised into an 
experimental group and a control group. These groups are followed up for the 
variables/outcomes of interest. The point about using randomisation is that it 
avoids any possibility of selection bias in a trial. The test that randomisation 
has been successful is that different treatment groups have the same 
characteristics at baseline. For instance, there should be the same number of 
men and women, or older or younger people, or different degrees of disease 
severity” (Bandolier 2007). 
Bowling defines a RCT as “a study involving the random allocation of 
participants (i.e. patients) between experimental group(s), whose members 
receive the treatment or other intervention, and control group(s), whose 
members receive a standard or placebo treatment. The outcome of the groups 
is compared” (Bowling  2014). 
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By the nature of its design, an RCT cannot be employed when randomisation is 
not possible. Harris et al provides four situations: because of ethical 
considerations; difficulty to randomise patients; difficult to randomise locations 
e.g. wards; or small available sample size (Harris et al. 2006). Harris et al 
claim for medical informatics implementation, which would include HEPMA 
implementation, it is impossible to randomise to individual patients as the 
system needs to be on or off and for numerous reasons it is not possible to 
have half the patients on a ward with one system and half with the other. 
Quasi Experiment 
Davies describes quasi –experiments as those which aim “to compare groups 
that cannot assume to be strictly equivalent” (Davies  2007). Harris et al 
provide a relative hierarchy of quasi-experimental designs which is depicted in 
Table 2.4 (Harris et al. 2006).The lowest design quality is A with the hierarchy 
increasing in quality as you move down the table thus A6 is a higher quality 
than A5. In general, studies in category C are a lower design quality than 
category D. Harris et al claim that “the intervention proceeds the 
measurement of the outcome but that statistical association does not 
necessarily imply causality” which means that it is possible that there may be 
alternative explanations for the apparent causal association (Harris et al. 
2006). 
Major threats to internal validity of quasi- experiments include that concurrent 
events caused the noted effect; natural progression may have caused effect; 
and the measured intervention impact may in fact be dependent on another 
concurrent intervention. 
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Table 2.4  The hierarchy of quasi-experimental design, adapted from Harris et al 
(Harris et al. 2006). 
Quasi-experimental Study Designs Design  
A Designs without control groups 
1 One-group post-test only I M1 
2 One-group pre-test post-test M1 I M2 
3 One group pre-test post-test with a double 
pre-test 
M1 M2 I M3 
4 One-group pre-test post-test with  a non-
equivalent dependent variable 
(M1a, M1b) I (M2a, 
M2b) 
5 Removed treatment design M1 I M2 M3 remove I M4 
6 Repeated treatment design M1 I M2 remove I M3 M4 
B Designs with control group but no pre-test 
1 Post-test only with non-equivalent groups Intervention group: I M1 
Control group: I M2 
C Designs with control groups and pre-tests 
1 Untreated control group with dependent pre-
test and post-test samples  
Intervention group: M1a 
I M2a 
Control group: M1b M2b 
2 Untreated control group with dependent pre-
test and post-test samples using a double pre-
test 
Intervention group: M1a 
M2a I M3a 
Control group: M1b M2b 
M3b 
3 Untreated control group with dependent pre-
test and post-test samples using switching 
replications 
Intervention group: M1a 
I M2a M3a 
Control group: M1b M2b 
I M3b 
D Interrupted time series 
1 Multiple pre-test and post-test measurements 
at equal time intervals 
M1 M2 M3 M4 M5 I M6 
M7 M8 M9 M10 
M= measurement, I = intervention Time moves from left to right 
Before-and –after studies 
Before and after studies are a subset of quasi- experiments in which 
observations are made before and after intervention implementation, both in 
the treatment and control groups (Bowling  2014). 
Before and after studies are depicted in Table 2.4 as category A (2-4). These 
studies therefore fall into the lowest hierarchy of quasi-experiments (Bowling  
2014). 
Cohort studies 
Cohort studies involve identification of a group of people sharing a common 
feature or characteristic and following them over a period of time to see how 
their exposures to a particular variable affect their outcomes (Bowling  2014). 
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Case control studies 
This is a study involving people with a certain health problem “cases” and a 
similar group without “controls” to determine frequency of occurrence of 
factors in the case and control groups (Bowling  2014). 
Case series studies 
Case-series design involves the study of a series of cases of any particular 
condition. These cases suggest at best a hypothesis but as there is no 
comparison group, it is impossible to draw too many conclusions about the 
disease or the disease process.  
Sampling  
The majority of research design methods necessitate the use of a sample 
because the studied population is too large to be researched in its entirety. 
Therefore, both quantitative and qualitative (see later) research require 
sampling. The research design should describe whether the whole population 
will be studied or if sampling is required. 
Sampling is defined by Kotzab et al as “the process of using a small number of 
items or parts of a larger population to make conclusions about the whole 
population” (Kotzab et al.  2006). 
The sampling process consists of defining the population of interest, obtaining 
the population list (i.e. the sampling frame), determining the sampling method 
and the required sample size prior to recruitment and data collection or 
generation. 
There are several different sampling methods that may be used and these are 
selected dependant on the research questions, methodology and methods.  
Sampling is generally classified as probability or non-probability sampling 
(Creswell  2013).  
Sampling approaches used in quantitative research consist mainly of random 
sampling (probability). These approaches are outlined in Table 2.5. As the 
name suggests, in probability sampling there is a known probability for 
selection of a particular integer. 
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Irrespective of the selected sampling method, a clear record of how potential 
participants will be identified should be documented, which is usually 
presented as inclusion and exclusion criteria.  
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Table 2.5 Probability Samples adapted from Bowling, Creswell and Davies (Creswell  2013, Bowling  2014, Davies  2007). 
Type Cluster Random Stratified Random Systematic 
     
Description A large cluster of 
members of the 
population in proximity 
are selected 
Each member of the 
population will have an 
equal chance of selection 
Each member of the 
population will have an 
equal chance of 
selection based on a 
defined criteria 
Every nth member of the 
population will be selected 
Advantages Economic Easy Smaller sample size 
with better accuracy 
and representative of 
population of interest 
Simple  
Disadvantages Lower statistical 
efficiency 
Need a list of the entire 
population, time 
consuming, larger sample, 
produces larger errors, 
high cost 
Requires greater effort 
to design, and detailed 
advance  knowledge 
required 
Trends may cause bias, 
results may be skewed, 
medium cost 
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Sample size 
In quantitative research, which usually seeks to ascertain a difference between 
two groups except in descriptive surveys, an adequate sample size is obtained 
by means of a calculation based on three factors, namely: “an estimate of 
effect, appropriate confidence interval and P value” (Whitley and Ball 2002). 
Whitley et al state that “the confidence interval indicates the likely range of 
values of the true effect in the population: while the P value determines how 
likely it is that the observed effect in the sample is due to chance.” The 
statistical power of the study is also important and this is defined as “the 
probability of correctly identifying a difference between two groups in the 
study sample when one genuinely exists in the population from which the 
samples were drawn” (Whitley and Ball 2002). It is desirable to design a high 
power study as this correlates with a high chance of identifying a difference 
between studied groups if it exists. Study power is dependent on several 
factors; however a large sample size tends to produce a higher power.   
Whitely et al claim that “ the ultimate aim is to conduct a study that is large 
enough to ensure that an effect of the size expected, if it exists, is sufficiently 
likely to be identified” (Whitley and Ball 2002). In practice there are 
conventional choices for P values and power. The P value for significance is 
most commonly set at 0.05 and the power is usually between 80% and 95%. 
The size of the effect is usually based on either clinical judgement or from 
previous published studies. Tabulated values and formulae may then be used 
to calculate the required sample size (Whitley and Ball 2002). 
Type I and Type II errors 
The sample size needs to consider both statistical and practical components 
which necessitate taking into account two different error types. 
Type I error is defined as “the error of rejecting a true null hypothesis that 
there is no difference” whereas a Type II error is defined as “the failure to 
reject the null hypothesis when it is actually false” (Bowling  2014). 
Validity and reliability 
Validity and reliability are considered at all stages of research design. Validity 
is defined as “the extent to which an instrument measures what it is supposed 
to measure and performs as it is designed to perform” (Biddix). Reliability 
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refers to consistent measurement of the data. Consistent measurement aids 
the replication of the study (Creswell  2013). A robust quantitative research 
study should be both valid and reliable (Creswell  2013).  
Validity 
There are two main types of validity: external and internal.  
External Validity 
External validity, also known as generalisability, is the degree to which the 
study result is true for other situations for example other people, places or 
times (Creswell  2013).  
Internal Validity 
Internal validity has been defined by Roberts et al as “addressing the reasons 
for the outcomes of the study, and helps to reduce other, often unanticipated, 
reasons for these outcomes” (Roberts and Priest 2006). Thus, internal validity 
is concerned with establishing a causal relationship between the independent 
and dependent variable and it is based on the measures used, the research 
setting, and the whole research design.  
Roberts et al provides three approaches for internal validity: content, 
criterion-related and construct (Roberts and Priest 2006). 
They describe content validity as the “weakest level of validity” and it is 
concerned with whether the study measures what it is intended to measure in 
relation to the research questions. Face validity may be included as a subset of 
content validity and is an assessment at “face value” of whether it measures 
what it is meant to measure or in other words “looks valid” (Roberts and Priest 
2006). 
Roberts et al claim that criterion-related is at a higher level of validity and is 
used when a tool can be compared to a similar validated tool (Roberts and 
Priest 2006). 
Construct validity is defined as the “validity of a test or a measurement tool 
that is established by demonstrating its ability to identify or measure the 
variables or constructs that it proposes to identify or measure” (Anonymous 
2009). It is concerned with whether items measure hypothetical constructs or 
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concepts and is particularly relevant to whether the measurement provides a 
practical benefit in the actual situation. 
Additional aspects of validity less commonly applied in health service research 
as outlined by Bowling include precision; responsiveness to change; 
sensitivity; specificity; and sensitivity analysis, all of which are mainly related 
with internal validity (Bowling  2014). 
Reliability 
Reliability is the extent to which measurement gives consistent results 
(Bowling  2014). Bowling describes different types of reliability including test-
retest, inter-rater reliability and internal consistency (Bowling  2014). 
Test-retest 
Test- retest reliability is defined by Trochim as “to assess the consistency of a 
measure from one time to another” (Trochim,W,M,K. 2006). 
Inter-rater 
“The degree to which different raters/observers give consistent estimates of 
the same phenomenon” is the definition provided by Trochim for inter-rater 
reliability (Trochim,W,M,K. 2006). 
Internal consistency 
Internal consistency is described by Trochim as being “used to assess the 
consistency of results across items within a test” (Trochim,W,M,K. 2006). 
Bias 
Bias is a key threat to both the validity and reliability of quantitative studies.  
Types of bias in research 
Bias is defined by Bennet as “unknown or unacknowledged error created 
during the design, measurement, sampling, procedure, or choice of problem 
studied” (Bennet). An alternative definition is provided in a medical dictionary 
as “any trend in the collection, analysis, interpretation, publication, or review 
of data that can lead to conclusions that differ systematically from the truth; 
deviation of results or inferences from the truth, or processes leading to 
deviation” (Anonymous 2009). 
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Shuttleworth describes the main types of research bias as design; 
measurement; sampling; procedural; interviewer; response; and reporting 
(Shuttleworth 2009). 
Bowling provides additional potential biases including the following: 
acquiescence response set (“yes-saying”);assumption; bias in handling 
outliers; evaluation apprehension; mood bias; non-response bias; observer; 
publication; reactive effects (Hawthorne effect); recall (memory) bias; 
response style bias; and response set (Bowling  2014). 
The different types of biases with a brief description are outlined in Table 2.6. 
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Table 2.6 Bias in research, adapted from Shuttleworth 2009 and Bowling 2014 
(Bowling  2014, Shuttleworth 2009). 
Bias Description 
Acquiescence response set 
(“yes-saying”) 
More common for people to agree than refute 
statements 
Assumption Defective logic of investigator resulting in 
incorrect interpretation and conclusions 
Bias in handling outliers Not discounting unusual values in a small 
sample or not including unusual values which 
should be included 
Design Use of incorrect design, methods, sampling or 
analysis thus the observed value is not the true 
value 
Evaluation apprehension Anxiety caused by investigation results in 
people providing what they would expect the 
investigator would want to find rather than 
their actual opinion 
Interviewer Subconscious effect of investigator to bias 
response by perceived value stance or by 
asking leading questions 
Measurement Change over time in measurement process or 
use of faulty instruments 
Mood bias Depressed people may provide overly negative 
responses 
Non-response bias Effective sample size diminished due to people 
not responding 
Observer The perception of the observer is different from 
the reality 
Procedural Undue pressure applied to respondents to 
answer quickly 
Publication Published literature likely to contain only 
positive results and not negative studies 
Reactive effects (Hawthorne 
effect) 
The effect of study is altered by people 
knowing they are being investigated and thus 
altering their behaviour 
Recall (memory) bias Selectively remembering previous occurrences, 
experiences and conduct 
Reporting Failure to disclose requested information 
Response Respondent provides the answer either 
subconsciously or consciously that they think 
the investigator wants to hear 
Response style Respondent answers similarly to all questions 
irrespective of question 
Sampling Sampling method does not provide an equal 
opportunity for all of the population of interest 
to be included in the sample e.g. convenience 
samples or exclusion of ethnic minorities 
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Quantitative data analysis 
Analysis of quantitative data usually involves statistical methods which may be 
either descriptive or inferential (Davies  2007). Descriptive analysis is used to 
describe what happened with the actual study participants, whereas inferential 
analysis permits generalising results to the wider population (Davies  2007). 
The actual analysis may be undertaken by a manual process or by using 
computer software for example Statistical Package for the Social Science 
(SPSS©) (IBM 2013). 
Study design for quantitative component of DPP research  
Quantitative research normally adheres to the positivist philosophical world 
view and aims to “identify and assess the causes that influence outcomes” 
(Wahyuni  2012). The positivist position involves testing a hypothesis based 
on known theory, with a specific focus on factual information.  
An experimental design methodology was selected using a quasi-experimental 
before and after study method which is depicted in Table 2.4 as level A. The 
design study of the DPP project is classified as A2 which is a one group pre-
test post-test design. Harris et al claim that this is a frequently used study 
design (Harris et al. 2006). The pre-test is acting as the control so that there 
is some information about discharge information communication prior to 
HEPMA implementation. 
Bowling describes this study design as “before-after study with non-
randomised control group” and she claims a major limitation of this design is 
that changes in the dependent variable may be attributed to several other 
occurrences (Bowling  2014). It should be recognised that non- randomised 
controlled studies have limitations as the observed change could have 
happened without the intervention therefore consideration of concurrent 
events is essential (Davies  2007). 
This is one of the lowest levels in the design hierarchy. It would be impossible 
(and indeed inappropriate) to conduct a RCT when evaluating HEPMA 
implementation as a systematic ward by ward implementation approach was 
required. Hence, it was not feasible to randomly select individual patients with 
or without HEPMA prescribing. An alternative approach to increase the design 
hierarchy would be to use an interrupted time series design but this was also 
impossible as there was a definitive HEPMA implementation schedule which did 
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not allow sufficient time for completion of this study design. Therefore, a 
before and after study design was both feasible and practical for completion in 
the research setting. 
The study design comprised a retrospective case note review, an assessment 
of discharge letter receipt at GP practice and calculation of patient re-
admission rate. The focus of this part of the research was on discharge 
information content, discharge information accuracy and medication errors on 
discharge letters. 
Case notes eligible for review was any patient greater than or equal to sixteen 
years of age discharged home from hospital after an inpatient stay of at least 
24 hours from UHC during a defined three month period. Patients with shorter 
length of stays and/or not in the required time frame were excluded from the 
sample. In addition patients in mental health, maternity and paediatric wards 
were excluded from the study. A random sample list of eligible patients was 
obtained from the business intelligence department of NHS Ayrshire and 
Arran, who were provided with the inclusion and exclusion criteria information. 
This list was provided to the medical records department who accessed the 
case notes for review by the principal investigator (PI). The case note review 
patients were used for GP receipt time and re-admission rate calculation. 
Sample Size  
Identified error rates from the reviewed literature produced huge error rate 
variance ranging from 12.1% to 66% dependent on error category.  
The sample size calculation used a correlation analysis with 0.05 level of 
significance selected. Therefore, to show a clinically important difference of 
10% with a power of 80% (the study has an 80% chance of detecting if null 
hypothesis is not valid) i.e. a probability of 1 in 20 (Type 1 errors). Two 
different sample size calculators for determining differences in proportions 
were used to determine sample size (Casagrande 2013, Brant ). The 
calculated size was 159 case notes before and 159 case notes after i.e. a total 
of 318 when using P1 (the traditional system) =0.15 and P2 (HEPMA)=0.05 
with the first calculator or 141 case notes before and after i.e. a total of 282 
using the second calculator (Casagrande 2013, Brant ). 
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An initial 47 case note sample provided an actual error rate of 76.6%. It was 
originally planned to use the actual error rate to determine the final required 
sample size. As the actual error rate was higher than the initial literature 
review it would mean a much smaller sample size would be required with 30 
case notes before and after being sufficient to show a 50% reduction in errors 
(Casagrande 2013). Therefore, it was decided to review the originally 
calculated 159 case notes before and after HEPMA implementation to ensure 
sufficient information could be obtained for the study. 
Identified medication errors were severity scored using a validated scoring 
system. Documented GP receipt date of discharge letter was compared against 
recorded time of patient hospital discharge to determine actual receipt time of 
discharge letter. Patient re-admission rates were calculated from the hospital 
patient management system.  
Promotion of validity and reliability 
The case note review used a validated tool from SIGN 128 adapted for local 
use which enhanced external validity as the study result will be applicable to 
other healthcare organisation; face validity as the tool appears to measure 
what it should; and criterion validity as the tool used can be compared to a 
similar validated tool (Scottish Intercollegiate Guidelines Network (SIGN) 
2012). 
Reliability and minimising bias 
A random sample of 10% of case notes was checked by an independent 
assessor for reliability which provides inter-rater and internal consistency 
reliability. Test-retest reliability has been designed into the study by 
undertaking a before and after study design which means that consistency of 
measurement over time will be determined. 
Biases that have been possible to minimise were: measurement bias by the PI 
applying a consistent approach by using a validated tool; non-response and 
sampling biases by the using a random patient sample obtained from business 
intelligence and by systematic application of the sample by the PI. 
QUALITATIVE RESEARCH 
Qualitative research is best at answering “why and how questions” and is good 
for research examining processes (Schimmel  1996). Thus, qualitative 
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research is an exploratory process to discover thoughts, generate ideas and 
create hypotheses. Qualitative research has been defined as “inductive, 
subjective and contextual”. It may be used to ascertain the success or 
otherwise of interventions and to discover the reason why, usually by means 
of interviews (Creswell  2013). Table 2.7 provides an overview of qualitative 
research methodologies and is adapted from Creswell (Creswell  2013). 
Starks et al in a discussion of possible methodologies for qualitative research 
in healthcare settings propose three possible methodologies which are 
phenomenology; discourse analysis and grounded theory (Starks and Trinidad 
2007). They claim phenomenology concerns the lived experience; discourse 
analysis focuses on the use of language; and grounded theory generates 
hypotheses around social interactions studied in situ. They advocate that the 
use of different approaches necessitates different types of research questions, 
sampling methods and data handling. Data collection usually consists of 
observations and interviews. In their opinion, semi-structured interviews are 
appropriate for all three types of studies (Starks and Trinidad 2007).  
Creswell describes three further possible methodologies for qualitative 
research, namely: narrative, ethnography and case studies (Creswell  2013). 
Narrative research design is based on stories and storytelling and is described 
by Sandelowski as “the impulse to story life events into order and meaning” 
(Sandelowski  1991). Ethnography concerns observation and in-depth study of 
cultural groups in their own environment and tends to be over a lengthy time 
period (Creswell  2013). Yin claims that case study research “allows the 
investigators to focus on a “case” and retain a holistic and real-world 
perspective- such as investigating individual life cycles, small group behaviour, 
organisational and managerial processes, neighbourhood change, school 
performance, international relations and the maturation of industries” (Yin  
2014). All of these designs use small sample sizes ranging from perhaps one 
person in case- studies to a cultural group for ethnographic studies. 
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Table 2.7 Summary of Qualitative Methodologies, adapted from Creswell (Creswell  2013) 
Qualitative Methodology 
Design Case Study Discourse 
Analysis 
Ethnography Grounded theory Narrative Phenomenology 
Description of 
general aims 
Detailed long-
term study of 
an individual 
case  or cases 
 
How language 
is used by 
individuals 
Study of a 
particular group 
(actions, 
behaviour, 
speech) in the 
natural 
environment of 
the participants 
Multiple data 
collection periods 
to obtain a 
general, abstract 
theory of a 
process, outcome 
or interaction 
from view of 
participants 
about lived 
experience 
Studied life of  
individual(s) by 
obtaining life 
stories of 
participant(s) 
Participants 
description of a 
phenomenon, 
usually obtained 
by conducting 
interviews 
Main methods of 
data generation 
Observations, 
interviews 
Observations, 
interviews 
Observations, 
interviews 
Interviews, focus 
groups 
Story collection Interviews, focus 
groups 
Approaches to 
data analysis 
Non-statistical analysis using coding and indexing. Data analysis should be rigorous so that have demonstrated 
aspects of trustworthiness. Computer programmes may be used to aid management of analysis. 
Approaches to 
data 
interpretation 
Patterns and 
themes 
categorised 
and described 
Use of coding 
to prepare 
concepts 
Patterns and 
themes to 
understand and 
explain them 
Probability of 
concepts and 
relationship 
between concepts 
Conceptual Patterns and 
themes 
categorised and 
described 
Trustworthiness 
 
Achieved by 
data 
triangulation 
and peer 
review and by 
providing 
detailed 
description so 
may be 
repeated 
Achieved by 
provision of 
text detail to 
explain concept 
and by 
providing 
detailed 
description so 
may be 
repeated 
Achieved by 
confirmation 
from participants 
and by providing 
detailed 
description so 
may be repeated 
Achieved by fit, 
relevance, 
workability and 
modifiability and 
by providing 
detailed 
description so 
may be repeated 
Achieved by data 
triangulation and 
peer review and 
by providing 
detailed 
description so 
may be repeated 
Achieved by data 
triangulation and 
peer review and by 
providing detailed 
description so may 
be repeated 
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Qualitative methods mainly comprise interviews, focus groups, observational 
studies, or in-depth investigation of one particular case or cases (Creswell  
2013). 
Interviews  
There are several different types of interviews which are described as 
structured; semi-structured; or unstructured, and these may be conducted 
either face-to-face or by telephone (Bowling  2014). Davies describes six types 
of data that may be obtained through conducting interviews:” facts about the 
here and now; what the interviewee knows; facts about past events; feelings; 
attitudes or opinions; and beliefs” (Davies  2007). A comparison of the 
different interviews is provided in Table 2.8. 
In structured interviews the questions are asked in a predetermined sequence; 
whereas unstructured interviews are usually conducted with a pre-prepared 
topic list but not consisting of detailed questions with the purpose of doing an 
“in-depth” investigation (Bowling  2014). 
Semi-structured interviews aim to obtain more detailed information by the use 
of  pre-determined open questions which then permit the interviewer to probe 
further to clarify and extract further information of interest (Bowling  2014). 
Interviews are advantageous where participants may have poor literacy or are 
illiterate (Bowling  2014). Limitations of interviews include that they are 
restricted to the opinions of the interviewees, interviewer presence may bias 
replies, and interviewees perception and articulation may be wide ranging 
(Creswell  2013).  
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Table 2.8 Comparison of different interview types adapted from Bowling (Bowling  2014). 
Type Structured Semi-structured Unstructured 
Description An interviewer asking an 
interviewee a list of pre-
determined questions on a 
specific topic 
An interviewer asking an 
interviewee a list of pre-
determined questions with the 
ability for more in-depth 
questioning in light of provided 
responses 
An interviewer searching for in-
depth responses from 
interviewee about a particular 
topic perhaps about unknown 
information 
Advantages Interviewer determines 
questions and directs 
discussion, consistency of 
questioning, tends to be a  
formal situation 
Able to obtain more in-depth 
information than with structured 
interview,  reliability, 
comparability of data 
Particularly suited to learn 
about individual interviewee 
experience about a specific 
topic and feelings about the 
experience; results may be 
used to prepare a more 
structured interview 
Disadvantages Lack of flexibility, interviewer 
must stick to pre-defined 
questions, limited depth of 
information obtained 
May be time consuming, skill of 
interviewer may influence 
responses obtained, not as reliable 
as structured interviews 
Lack of consistency in approach, 
questions and  order of 
questions may vary among 
interviewees so lacks 
transferability of findings 
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Interview Format 
Bowling claims that characteristics of a good interviewer include early 
establishment of rapport between the interviewer and the interviewee, 
development of effective listening skills without interrupting interviewee as 
well as being amiable and trustworthy (Bowling  2014). The aim is to minimise 
influence of the interviewer on the interview i.e. to reduce interviewer bias 
(Bowling  2014). Bowling describes other possible biases while conducting a 
personal interview as being due to “the characteristics, expectations and 
attitudes of the interviewer” and also the interviewer behaviour i.e. not 
following the script, “directive, non-neutral probing” and inaccurate recording 
of response”. The last bias may be minimised by recording the interview and 
transcribing verbatim the response. 
Good preparation is essential and a suitable location should be selected which 
is comfortable, free from interruption and mutually convenient (Bowling  
2014).  
Wahyuni advocates that prior to the interview, information should be provided 
to the participant by either e-mail, letter or direct communication (Wahyuni  
2012). She asserts that the initial component of the interview should consist of 
outline of the purpose of the interview with explanation about confidentiality 
and anonymity and the right to withdraw from the study at any time (even 
after the interview completed). A consent form must be signed by both the 
interviewee and interviewer and content of interview audio recorded with 
participant consent. At the end of the interview, the participant is given the 
option to add any additional information not already covered (Wahyuni  2012). 
Data collected should be securely stored in locked filing cabinet and password 
protected computer only accessible by the researcher (Wahyuni  2012). 
Interview transcription 
Transcribing has been proposed as the first part of analysis and enables the 
researcher to become immersed in the data. Transcription is time consuming 
and it is estimated that one hour of recorded data takes approximately 
between two and four hours to transcribe (Wahyuni  2012). 
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Focus groups  
Focus groups involve detailed discussion of specific issue(s) by a number of 
individuals brought together by a facilitator (researcher) to create information 
(Bowling  2014). 
Observational Studies  
The observation of participants is undertaken by the researcher who may 
declare the purpose of the study to participants or they may be blinded hence 
unaware of the research activity. The researcher observes and documents 
observations with an annotation of observant comments where applicable to 
provide a more detailed analysis than that possible by interviews (Bowling  
2014). 
Case study 
Bowling defines a case study as “a research method which focuses on the 
circumstances, dynamics, and complexity of a single case, or a small number 
of cases” and states that it is “a valuable method of study of complex social 
settings and is useful in exploratory, early stages of research, and for 
generating hypotheses” (Bowling  2014). 
Sampling 
Sampling has been described earlier in the quantitative research section. As 
stated previously, the majority of research design methods necessitate the use 
of a sample because the studied population is too large to be researched in its 
entirety. The research design should describe whether the whole population 
will be studied or if sampling is required. Non-probability sampling approaches 
are mainly used in qualitative research and details about the different 
approaches are provided in Table 2.9. In non-probability sampling, the 
population as a whole is unknown, but there is a shared characteristic (Davies  
2007). Bowling claims that for qualitative research, sampling is normally 
undertaken using convenience, purposive, snowballing or theoretical sampling 
methods (Bowling  2014). Starks et al in a discussion of possible 
methodologies for qualitative research in healthcare settings suggest that 
irrespective of the selected approach that purposive sampling should be used 
to capture participants who have knowledge of the investigated experience 
(Starks and Trinidad 2007). 
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Table 2.9 Non-probability Samples adapted from Bowling 2014, Creswell 2013 and Davies 2007 (Creswell  2013, Bowling  2014, Davies  
2007). 
 
Type Convenience Purposive Quota Snowball 
Description Selection based on 
ease of accessibility 
Select individuals of a 
population with a 
particular goal or 
purpose in mind 
Various sub groups 
represented by 
certain characteristics 
 
Later respondents found 
from response of initial 
respondents (selected by 
probability) 
Advantages Cheap, easy More accurate results 
as unsuitable cases 
eliminated, quick and 
relatively cheap 
Trying to create a 
representative 
sample, quick and 
easy 
Access to difficult to reach 
respondents, more time- 
consuming 
Disadvantages Least reliable Open to researcher bias Unable to determine 
sampling error, must 
be able to clearly 
divide into subgroups 
Unable to determine 
sampling error, limits 
transferability 
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Sample Size 
The determination of an adequate sample size in qualitative research is 
ultimately a matter of judgement and experience and depends on the selected 
qualitative design. Creswell claims that ”narrative research includes one or two 
participants; phenomenology to typically range from three to ten; grounded 
theory, twenty to thirty; ethnography to examine one single culture-sharing 
group; and case studies to include four to five cases” (Creswell  2013). 
Whereas Starks et al suggest that the required sample size for 
phenomenological studies is usually one to ten people; in discourse analysis, 
one person may suffice if there is sufficient depth of discussion or a greater 
number may be required if insufficient depth; grounded theory explores 
multiple dimensions of the investigated experience and therefore adds 
participants until data saturation has been achieved. Typical sample sizes 
range from 10 to 60 individuals (Starks and Trinidad 2007). 
There continues to be a great deal of debate about what constitutes an 
adequate sample size. Baker et al asked both experienced (n=14) and novice 
(n=5) researchers how they decided how many interviews to conduct in their 
research (Baker and Edwards 2012). They concluded that the answer was that 
it depended on the research design and methods as well as practicalities and 
philosophical beliefs. It is important to ensure the sample size is adequate for 
the research purposes without being larger than needed as research funds and 
participants’ time are wasted (Francis et al. 2010).  
Another conventional approach is to continue until “data saturation” is 
achieved. Data saturation is defined as “the point in data collection when no 
new additional data are found that develops aspects of a conceptual category” 
and Francis et al claim that it is essential to reach data saturation to ensure 
that content validity has been achieved for the sample (Francis et al. 2010). 
The principles should be agreed by the research team prior to starting the 
study so that consensus may be reached about when to stop (Francis et al. 
2010). Francis et al propose an approach for achievement of data saturation 
(Francis et al. 2010). This is by agreeing the minimum number of interviews to 
be analysed first and then subsequently to state the number of further 
interviews to be completed without any new ideas being voiced. They claim 
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that this method may not be suitable for research using interviews with sub-
groups but that a modified version may be applicable (Francis et al. 2010). 
Trustworthiness and Reflexivity 
There is debate around the appropriateness of the concepts of validity and 
reliability in qualitative research and therefore many subject experts 
recommend trustworthiness. 
Trustworthiness and reflexivity must be considered when designing research 
methods for qualitative research methodology to minimise any bias of the 
investigating team.  
Trustworthiness  
Qualitative research should be conducted with a rigorous approach to ensure 
trustworthiness. Miles et al argue that the conclusion should be verified to 
prevent arriving at “incorrect” answers (Miles and Huberman  1994). Rigorous 
data analysis should be thorough and careful. Shenton states four criteria are 
necessary for ensuring trustworthiness in qualitative research studies 
(Shenton  2004). 
These are “credibility, transferability, dependability and confirmability”. 
When planning the proposed research design, trustworthiness should be 
considered, to ensure the aims of the research are fully met without 
compromising the integrity of the findings. 
Credibility can be achieved by ensuring essential components are included in 
research design. This consists of the selection of reputable research methods 
which have been effectively used in similar studies; appropriate sampling 
(here need to consider random sampling of population versus purposive); 
triangulation – in a mixed methods study this may be achieved by the 
integration of the data from the different research components; permitting 
interviewees the opportunity to refuse to participate in study; inclusion of 
probing questions to extract comprehensive information from the 
interviewees; frequent discussion with the full research team about emerging 
data; seeking out feedback from peers by presenting at conferences; and  
comparing results with existing work (unpublished) in studied organisation. 
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Can the results of the study be applied to other situations is important when 
considering transferability?  As qualitative studies use a limited number of 
participants it is important to clearly define the study range and explicitly 
detail the participants, data collection methods, number and type of data 
collection and the time period of data collection. 
Dependability is reliant on the actual research design being clearly articulated 
with sufficient provision of information about data collection and appropriate 
reflection and evaluation of study on completion. 
Confirmability is achieved by ensuring that it is the true voice of the 
participants that is related and not the researchers’ opinions by robust audit 
and use of triangulation (Shenton  2004). 
Starks et al also consider trustworthiness of data due to the essential 
subjective nature of qualitative research (Starks and Trinidad 2007). A 
rigorous approach to data analysis may be facilitated by the use of established 
computer programmes for example N-Vivo© (QSR International). 
Reflexivity 
Another important consideration when undertaking qualitative methods of 
research, particularly when using interview design is reflexivity. Reflexivity is 
defined by Creswell as “the inquirer reflects about how their role in the study 
and their personal background, culture and experiences hold potential for 
shaping their interpretations, such as the themes they advance and the 
meaning they ascribe to data” (Creswell  2013). Thus, reflexivity involves 
researchers reflecting on their ability to be unbiased when conducting the 
research and to consider the effects of this on the study and any subjective 
bias that may be present. 
Strengths of qualitative research include that it permits the detailed analysis of 
a small number of cases, facilitates complex description, allows individual 
perspective to be described and is usually concerned with local settings. 
Limitations of qualitative research include the limited transferability due to the 
small study numbers used, time taken to collect and analyse data and the fact 
it is open to researcher interpretation bias. 
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Approaches to qualitative data analysis 
Bowling described three possible methods of data analysis: thematic; 
framework; and content analysis (Bowling  2014). Analysis of qualitative data 
usually involves dividing the collated data according to themes. Creswell states 
that this is usually between five to seven key themes (Creswell  2013). The 
identification of themes may be facilitated by use of computer software to then 
enable interpretation and meaning to be deduced by the investigator. 
Thematic analysis 
Thematic analysis consists of deconstructing content, sorting by themes and 
arranging data into themes.  This is the most traditional method of analysis for 
qualitative studies and traditionally was sorted manually which more recently 
has been superseded by the use of computer software packages (Bowling  
2014). 
Framework analysis  
Bowling describes framework analysis as consisting of the following phases: 
 familiarisation by reading interview transcripts to acquire a general 
impression- (This has also described as the researcher becoming 
immersed in the data (Pope, Ziebland and Mays 2000)) 
 identification of thematic framework (themes emerging from 
interviewees, themes included in interview schedule or themes 
emerging from repeated analyses 
 systematic application of thematic framework by coding 
 data rearranged to the identified themes 
 mapping and interpretation (aggregating patterns, searching for 
structure, synthesising the findings) 
Bowling claims that framework analysis is more informed by reasoning of 
existing knowledge than thematic analysis (Bowling  2014). 
Content analysis 
Bowling describes content analysis as consisting of collecting data, coding 
according to theme or category and then the coded data are analysed and 
presented (Bowling  2014). 
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Framework analysis 
Smith et al describe the use of the framework approach in healthcare which 
they claim to be a systematic approach to data analysis (Smith and Firth 
2011). They claim the benefit of use of the framework approach includes that 
it is “particularly suited to analysing cross-sectional descriptive data”, 
transparency of analysis of interviewee descriptions, and facilitation of 
systematic data analysis. Srivastava et al claim that framework analysis is 
ideal for research with specific questions and with limited time (Srivastava and 
Thomson 2009) They claim benefits include fundamentally related to 
experience of interviewees, fluidity so alterations possible during research, 
systematic and comprehensive as well as transparent (Srivastava and 
Thomson 2009). Another advantage is the ability to perform both within-case 
or between case analysis and it is accessible to other researchers (Srivastava 
and Thomson 2009). 
Study design for qualitative component of DPP research  
Qualitative research normally adheres to the interpretivism philosophical world 
view and aims to “understand the participants’ views of the situation being 
studied” (Wahyuni  2012, Creswell  2013). A phenomenology methodology has 
been selected using semi-structured interviews as the design method. 
Face-to-face semi-structured interview design was selected because as 
described in Table 2.8 this permits more detailed information acquisition whilst 
promoting trustworthiness and data comparison. Focus groups would be a 
suitable alternative method however disadvantages of focus groups include a 
lack of confidentiality, the influence of some members of group may prevent 
all participants contributing freely to the discussion and the difficulty in 
scheduling the group when all participants are available to attend. The 
interview format was focused by use of an interview schedule, to allow the 
interviewee to provide their personal opinion of the process and the PI had key 
questions with associated probing to ensure important topics were covered 
during the interview but allowed for flexibility of discussion. Types of probing 
questions include a request for more detail about a specific item, clarification 
of actual meaning of statements and asking for specific examples (Bowling  
2014).  
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The interviewed participants were members of staff groups involved in the 
discharge communication process between the hospital service and general 
practitioners (GP). These groups consist of consultant medical staff, junior 
medical staff, advanced nurse practitioners and pharmacists. Purposive 
sampling was used to interview a diverse group of people in relation to 
experience and demographics (sex, ethnicity, years worked at research 
setting).  As outlined in Table 2.9 purposive sampling enabled the targeting of 
key individuals involved in the discharge process to enable accurate result 
generation.  Service leads were asked by the PI to nominate five to six staff 
members and to minimise bias were asked to select staff with a broad 
demographic range in relation to sex, ethnicity and years worked at the 
hospital.  Exclusion criteria in the pre-implementation phase included staff 
routinely using HEPMA system at University Hospital Ayr. The PI invited the 
nominees by either personal communication or by e-mail to participate in the 
study and followed the order provided by the service lead to recruit to 
interview until data saturation was achieved. It was anticipated interviewing a 
sample of five members of each professional group would achieve data 
saturation (Francis et al. 2010). Further or fewer participants were interviewed 
as required to achieve data saturation. 
Interviews were audio recorded with participant consent. The recorded 
information was transcribed verbatim by the primary investigator immediately 
after the interview or as soon as possible after the interview. The transcription 
used a denaturalised style and names of participants were not included in the 
transcript (Oliver, Serovich and Mason 2005).  The recorded information was 
deleted after transcription. All collected transcribed information was entered 
into NVivo 10© software by the PI (QSR International). Framework analysis 
has been selected as the data analysis method because of its previous use in 
healthcare research and it provides a systematic, structured approach to data 
analysis whilst permitting data transparency (Smith and Firth 2011). Pope et 
al claim that framework analysis is especially suited for qualitative research 
with pre-defined objectives (Pope, Ziebland and Mays 2000).This is therefore 
consistent with the DPP project design as the framework approach suits 
studies with pre-identified questions set in short time frames and related to 
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policies and procedures.  Data was sorted by looking for principal themes from 
the interviews, evolving themes and issues of interest in relation to the 
objectives. Data analysis involved theme analysis, cataloguing of information, 
mapping and data interpretation. 
Promotion of trustworthiness and reflexivity 
The study design and conduct of the PI when undertaking the qualitative 
component of the DPP project aimed to promote trustworthiness and reflexivity. 
Credibility was achieved by the use of the following: selection of  purposive 
sampling to ensure participants were actively engaged in the studied process; 
selection of the semi-structured interview method was consistent with published  
similar studies; interviewees were able to refuse to participate in study and this 
information was included in the  participant information sheet which stated they 
could withdraw from the study at any time even after the interview was 
completed; by the use of probing questions to elicit information from 
interviewees; the PI had frequent discussions with university supervisors as the 
interviews were conducted and transcribed; and pre-implementation interview 
results were presented at a national conference which permitted comparison of 
results with other unpublished studies. 
Transferability was achieved by providing a detailed description of the study 
design, including the number of interviews and type of interviewees. 
Dependability was achieved by having content validation of the interview 
schedule by university supervisor review and regular reflection on the study by 
the PI with university supervisors. 
Confirmability was achieved by having a sample of five transcripts and 
interview recordings reviewed and validated by the university supervisors to 
ensure that the PI was accurately transcribing the interviews and truly 
recording the participant voice. 
Trustworthiness was also promoted by having a rigorous approach to data 
analysis by use of the framework approach within the NVivo© computer 
programme. Identified themes in the transcripts by the PI were confirmed by 
university supervisor review. 
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Reflexivity to minimise bias 
The PI reflected on the ability to be unbiased when undertaking interviews and 
analysis of interviews. The role of the PI within the organisation may impact 
on the completion of the qualitative research and results obtained. Wherever 
possible biases were minimised but it was impossible to minimise all bias 
types. A review of a sample of transcripts and recordings and theme 
generation by university supervisors minimised assumption basis; whilst the 
use of an interview schedule meant the same questions were asked 
consistently so minimising interviewer bias. 
Mixed methods research  
Mixed methods is a recently evolved methodology which captures the benefits 
of the two previous systems by amalgamating the results and findings of each 
methodology to provide a fuller picture than that achieved by using either 
individual method alone and aims to minimise weakness by limiting occurrence 
of similar weaknesses in the study design.  Mixed methods research has been 
defined by Johnson et al as “the class of research where the researcher mixes 
or combines quantitative and qualitative research techniques, methods, 
approaches, concepts or language into a single study “(Johnson and 
Onwuegbuzie 2004).This may be applicable to circumstances where either 
quantitative or qualitative methods alone would not suffice (Johnson and 
Onwuegbuzie 2004). The use of mixed methods allows the combination of 
stories from research participants to be combined with statistical analysis to 
create the actual picture of what is happening in relation to the research 
question.  For certain research questions, if quantitative methods are used 
alone there is a some degree of understanding of the participants’ situation; 
whereas if qualitative methods are used alone it is difficult to make wide 
recommendations because of the limited number of people included in the 
data analysis and also analysis is dependent on the interpretation of the 
researcher and may be open to bias. Johnson et al postulate that mixed 
methods utilisation produces higher quality research than use of a single 
method alone when answering certain research questions (Johnson and 
Onwuegbuzie 2004). The benefits of each type of research method can be 
combined to produce a synergistic effect which is particularly suited to practice 
research.  Mixing of research methods provides maximum opportunity to 
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answer several research questions with consideration of experience and 
practical consequences. This may result in a greater knowledge of the 
situation and not merely confirmation of findings. 
Study design should describe the timing of the qualitative and quantitative 
phases which may be either concurrent or sequential (Johnson and 
Onwuegbuzie 2004). Creswell provides detail recommendations about possible 
designs for conducting mixed methods research (Creswell  2013). Table 2.10 
provides an overview of mixed methods research methodology and is adapted 
from Creswell (Creswell  2013).
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Table 2.10 Summary of Mixed Methods Methodologies adapted from Creswell (Creswell  2013) 
Mixed Methods Methodologies 
Design Convergent Parallel Explanatory 
sequential 
Exploratory sequential Embedded Transformative Multiphase 
Description Qualitative & 
quantitative data 
individually collected 
and analysed 
independently. 
Results are compared 
to see if are 
confirmatory. 
Quantitative research 
completed initially 
with more detailed 
analysis of results 
using qualitative 
research 
Qualitative research 
completed initially with 
more detailed analysis of 
results using quantitative 
research 
 
Either qualitative 
or quantitative is 
primary research 
with the other 
answering a 
secondary question 
Both qualitative and 
quantitative data 
which may be 
convergent or 
sequential 
Concurrent or 
sequential methods 
used together over 
long timescale to 
enable evaluation of 
lengthy studies. 
Measurement Requirement for both qualitative and quantitative measures to be collected using a combination of approaches outlined in Tables 2.2 & 2.5. 
Data Collection 
and Generation 
Both qualitative & 
quantitative at 
approximately same 
time 
Quantitative data 
collected first followed 
by qualitative 
Qualitative data collected 
first followed by 
quantitative 
Both collected 
together but 
primary research 
guides secondary 
Both collected 
simultaneously for 
convergent or 
sequentially for 
sequential 
Both collected 
concurrently or 
sequentially 
Data Analysis Analysis of both data 
types concurrently  
 
Quantitative data 
analysed first and 
used to prepare 
qualitative component 
which is then 
analysed later 
Qualitative data analysed 
first and used to prepare 
quantitative component 
which is then analysed 
later 
Primary research 
analysed first 
supported by 
secondary analysis 
of alternative 
method 
Data analysed 
concurrently or 
sequentially 
Data analysed 
concurrently or 
sequentially 
Data  
Interpretation 
Data integration using 
either: side by side 
comparison; data 
transformation; joint 
display of data. 
Data integration using 
connecting data 
Data integration using 
connecting data 
Data integration by 
embedding data 
Data integration 
using either: side by 
side comparison; 
data transformation; 
joint display of data. 
Data integration 
using connecting 
data, side by side 
comparison or joint 
display of data. 
Validation, 
trustworthines
s procedures 
Validity and trustworthiness should be demonstrated using appropriate procedures for the composite quantitative and qualitative components 
as outlined in Tables 2.2 & 2.7. 
Anticipated 
Outcomes 
To demonstrate 
agreement or 
disagreement  
Greater knowledge 
about quantitative 
research 
Greater knowledge about 
qualitative research to 
aid better measurement 
Greater depth of 
knowledge about 
participants’ views  
To create radical 
change 
A decisive and 
collective 
assessment 
Limitations Complex research design, time and resources required and resolution of discrepancies between methods 
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Data analysis 
In mixed methods design the two components i.e. the quantitative and the 
qualitative should be analysed independently before being combined (Creswell  
2013) . 
Advanced mixed method design uses the addition of a framework for example 
an experiment, theory or philosophy. 
Strengths of mixed method research include being able to answer more 
complex and detailed research questions and using the strengths of one 
methodology to surmount the limitations of the other methodology. 
Limitations of mixed method research include the complexity of the research 
design, the amount of time and resources required to complete and the 
difficulty of resolution of discrepancies between the different data types. 
Theory in research 
Creswell states that a theory is “a scientific prediction or explanation for what 
the researcher expects to find” (Creswell  2013). Whereas Kerlinger  defines a 
theory as “a set of interrelated constructs (variables), definitions, and 
propositions that present a systematic view of phenomena by specifying 
relations among variables, with the purpose of explaining natural phenomena” 
(Kerlinger  1979). Reeves et al provides a further definition as “an organised, 
coherent, and systematic articulation of a set of issues that are communicated 
as a meaningful whole”  and considers that “theories are used to help design a 
research question, guide selection of relevant data and propose explanations 
of underlying cause”(Reeves et al. 2008). “A theory may be included in 
research as an argument, a discussion, a figure or a rationale and it helps 
explain (or predict) phenomena that occurs in the world” (Creswell  2013). 
Creswell states that “in quantitative research theories are often tested; in 
qualitative research a theory may be generated or may be used to shape 
questions asked; and mixed methods may contain a theoretical framework 
within which both quantitative and qualitative data are collected” (Creswell  
2013). 
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APPLICATION AND USE OF CHANGE THEORY AND THEORETICAL FRAMEWORKS IN 
DPP RESEARCH 
Change theory guides the development of health interventions (Lewin  1947). 
Change theory is worthy of consideration when designing research methods as 
HEPMA implementation requires behaviour change in multiple professional 
groups within the hospital setting. Thus, the use of interventions based on 
evidence-based principles of behaviour change should be incorporated within 
the research proposal. Suggested methods include obtaining opinions of users 
by conducting interviews and assessing the effect of system implementation 
on specific factors including errors, patient safety and care quality. A 
prospective study method is recommended to aid assessment of the 
juxtaposition of the technology and the situational environment (Cresswell and 
Sheikh 2014). Evans et al advocate the use of theoretical framework when 
utilising mixed methods research methods as they claim this provides helpful 
organisation of what is a complex assessment (Evans, Coon and Ume 2011). 
Cresswell et al propose theoretical frameworks to be used when evaluating 
health information technology implementation such as HEPMA system 
implementation (Cresswell and Sheikh 2014). They stress the importance of 
consideration of not only the IT solution but how the human and 
organisational setting interacted when assessing the effects of 
implementation. Cognisance of changes that have occurred over time to make 
the system work in the actual setting should be discovered and assessed. 
Undertaking this robust and rigorous evaluation will allow the results to be 
considered in other contexts and not just in the implementation setting. 
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Figure 2.1 Dimensions commonly explored in sociotechnical evaluations of health 
information technologies. Reproduced from Cresswell et al (Cresswell and Sheikh 2014) 
 
Figure 2.1 describes the various dimensions that may be evaluated for 
implementation of health information technologies. Sociotechnical perspective 
demonstrates an interdependency of both the technology and the social 
context with mutual influence. Therefore, sociotechnical evaluation entails 
assessment of the impact of technology on social processes, e.g. alteration in 
prescribing after HEPMA implementation and sequential alteration of 
technology by local customisation to make the technology work in the actual 
setting. 
 
 
 
 
Usability Design 
Quality and 
safety of care 
Technology 
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Cresswell et al propose five separate frameworks worthy of consideration as 
possible assessment tools when implementing health information technologies 
(Cresswell and Sheikh 2014). These are: 
1. diffusions of innovation 
2. normalization of process theory 
3. social shaping of technology 
4. HOT-fit 
5. an evaluation framework.  
Additional frameworks have been identified during an on-going literature 
review which are equally applicable to healthcare implementation (Michie et 
al. 2005, May  2013, Price and Lau 2014). IT related theories have been 
discounted for consideration in this particular study because HEPMA 
implementation is a specific healthcare IT system. Cresswell 
recommendations apply directly to healthcare settings and therefore HEPMA 
implementation is an applicable situation for use of these frameworks 
(Cresswell and Sheikh 2014). Thus, in total there were eight possible 
frameworks considered in devising the research questions, methods and 
aiding the analysis (Creswell  2013). 
Table 2.11 provides an overview of the frameworks considered. 
In conclusion, after the review in Table 2.11, there were five possible 
frameworks worthy of more in-depth consideration when evaluating the 
implementation of complex IT systems like HEPMA in healthcare settings. 
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Table 2.11 Theoretical Frameworks for Consideration
Theoretical Framework Authors 
Publication year 
Brief Description Relevance to assessment of impact of HEPMA 
implementation 
The Theory of the 
Diffusion of Innovation 
Rogers E. 
1983 
Describes how innovation is spread 
into organisations and why this may 
or may not be successful. 
Included in Theoretical Domains Framework therefore 
will not be considered in isolation 
Evaluation framework Cornford T, 
Doukidis G, 
Forster D. 
1994 
Provides an ordered evaluation for IT 
system implementation in developing 
countries. 
Framework specifically devised for developing 
countries; HEPMA implemented into a developed 
country therefore excluded. 
Social Shaping of 
Technology 
Williams R, 
Edge D. 
1996 
Assesses how IT systems evolve in 
relation to the past, finance and 
cultural context. 
Not relevant for assessment of the specific research 
question therefore excluded. 
Theoretical Domains 
Framework 
Michie S, 
Johnston M, 
Abraham C, 
Lawton R, 
Parker D, 
Walker A. 
2005 
Assessment of behaviour change in 
healthcare implementation 
intervention. 
Needs consideration 
Normalization Process 
Theory 
May Carl 
2006 
Investigates how innovations are 
sustained in clinical situations over 
time and what promotes or hinders 
this. 
Needs consideration 
HOT-fit Yosuf MM, 
Kuljis J, 
Papazafeiropoulou A, 
Stergioulas LK. 
2008 
Discovers the association among 
technology, human and 
organisational factors to assess 
successful implementation 
Needs consideration 
Implementation theory May C. 
2013 
 
Assesses both outcome and process 
implementation in healthcare by 
identifying essential components. 
Needs consideration 
Clinical Adoption Meta-
model 
Price M, 
Lau F. 
2014 
Describes acceptance of 
implementation through time. 
Needs consideration 
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POTENTIAL FRAMEWORKS FOR ASSESSMENT OF COMPLEX INTERVENTION 
IMPLEMENTATION INCLUDING HEALTH INFORMATION SYSTEMS 
As outlined in Table 2.11 there were five theoretical frameworks that required 
to be considered for inclusion in the research design. 
Theoretical Domains Framework  
Michie et al undertook a consensus approach to identify the key domains 
required for successful implementation of interventions in healthcare which 
focused specifically on the behaviour change of healthcare staff (Michie et al. 
2005). The result produced the Theoretical Domains Framework (TDF). Since 
its inception in 2005, the TDF has been content validated and refined by Cane 
et al to include 14 domains and 84 component constructs and captures 33 
theories of behavioural change (Cane, O’Connor and Michie 2012). TDF has 
been used successfully in studies of interview and questionnaire design and 
has been used specifically to assess behaviour change in healthcare 
intervention implementation (Francis, O'Connor and Curran 2012, French et al. 
2012). Lipworth et al also confirmed the applicability of TDF to quality 
improvement interventions (Lipworth, Taylor and Braithwaite 2013). TDF is 
established as an effective method to design interviews and questionnaires in 
healthcare. Duncan et al used semi-structured interviews based on TDF as 
part of the PROTECT study when interviewing junior doctors about prescribing 
errors (Duncan et al. 2012). Huijg et al used TDF to design questionnaires to 
determine implementation success in healthcare (Huijg et al. 2014). Patey et 
al used interviews based on TDF to assess behaviour change in doctors 
ordering tests (Patey et al. 2012). Therefore, the TDF would be appropriate to 
be adopted in the DPP project when designing an interview schedule. 
Normalization of Process Theory 
Normalization of Process Theory (NPT) investigates how innovations are 
sustained in clinical situations over time and what promotes or hinders this 
(May et al. 2009). May considers that the diffusion of innovations model does 
not provide a framework for assessing the conditions for practical 
implementation of complex interventions in healthcare.  He advocates a need 
to assess not only if the system is functional but also if it has the ability to 
assimilate into the organisation and therefore suggests that NPT would be 
better as this examines “how complex interventions can become embedded in 
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clinical work” (May, Murray, et al. 2010). Normalization is defined as “the 
embedding of a technique, technology or organisational change as a routine 
and taken-for-granted element of clinical practice” (May, Murray, et al. 2010). 
This concentrates on the daily user and actual circumstances of use rather 
than on “special champions and early adopters”. It takes into consideration 
that local adaptations may occur to allow systems to meet local requirements. 
“Normalization acknowledges that technological and organisational change in 
healthcare settings is often imposed”. “NPT focuses on actions and processes” 
(May, Murray, et al. 2010). NPT requires looking at all the diverse people who 
use the system or are involved in making the system become routinely used 
and therefore concentrates on what people actually do rather than what they 
think.  May states that” NPT can aid the creation of the research question and 
associated aims and objectives for qualitative research” (May, Murray, et al. 
2010). 
An internet toolkit is available to aid the use of NPT which provides an 
overview of how to use it and clear explanations for what it is intended (May, 
Murray, et al. 2010). NPT has been rejected as a theoretical framework 
because the DPP project is concerned with reviewing the outcomes of HEPMA 
system implementation specifically relating to discharge information 
communication and not system implementation evaluation per se. 
HOT-fit Theory 
An alternative framework for evaluation to determine if Health Information 
Technology Systems (HITS) are well implemented is described by Yusof et al 
and is called HOT-fit (Yusof et al. 2008). This examines the association among 
human, organisation and technology fit components. The authors claim that 
“culture and process changes are reported to be barriers to the wider use of 
health care systems” which includes changes to traditional models of working, 
organisational issues include hospital culture and risk adverse behaviours. 
They believe that human and organisational components are ranked equal 
with the technical functionality in what they call “fit”. The human component 
considers individual HITS use i.e. how much and how often they use it; do 
they use it as intended; as well as user satisfaction. This includes satisfaction 
with particular aspects, the ease-of-use and general satisfaction with the 
system. 
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The organisation component concerns the managerial support and leadership 
including planning as well as environmental factors including politics and 
finance. 
The technology component concerns the actual system with evaluation to 
include “system quality measures include ease of use, ease of learning, 
usefulness, availability, response time, system flexibility (adapt and fit in 
clinical setting) and security” (Yusof et al. 2008). 
The impact of HITS implementation on organisational benefits is assessed by 
the impact on performance using both quantitative and qualitative measures. 
Measurement of clinical outcomes for example medication errors may be used 
as a quantitative measure whilst impact on communication and quality of care 
used as a qualitative measure. 
The HOT-fit framework has been developed to evaluate HITS implementation 
in healthcare as a totality and thus it was beyond the scope of the planned 
DPP project. 
Implementation theory 
May initially developed NPT with colleagues. Subsequently he proposed a 
further theory called implementation theory which is described as an extension 
of NPT providing more detailed consideration of implementing and embedding 
an innovation or intervention into practice in healthcare (May  2013).  May 
describes implementation as “a process-that is, as a continuous and 
interactive accomplishment- rather than as a final outcome” (May  2013). 
Implementation theory provides assessment of implementation of both 
outcomes and processes by identifying essential components: implementation; 
embedding; and integration.  He defines implementation as “a deliberately 
initiated process, in which agents intend to bring into operation new or 
modified practices that are institutionally sanctioned, and are performed by 
themselves or other agents” (May  2013). He proposed four components to be 
studied “capacity, potential, capability and contribution” (May  2013).  
Capability concerns whether the innovation is workable in practice and if it can 
me subsumed into the local context.  Capacity is dependent on individuals 
working together collectively to make implementation successful. Potential is 
dependent on individual’s ability to implement or use the complex 
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intervention. Contribution is dependent on individuals continuing to engage 
and develop the complex intervention. There is a need to assess what 
individual attitudes and intentions are and also what it takes to make the 
system “business as usual” (May  2013).  Do practitioners continually use the 
system? The evaluation should include personal accounts of practitioner’s 
experience with the system to try to explain why what happened occurred. 
The implementation occurs in a complex environment with multiple 
practitioners facing time pressures and competing priorities. Are the 
individuals motivated both individually but also communally to make the new 
process work? Whilst these are essential questions that require to be asked 
when carrying out an assessment of the full HEPMA implementation, the focus 
of the DPP project was one component of the implementation. Also this 
framework concentrates specifically on the actual implementation rather than 
the outcomes of the implementation, so this framework was considered to be 
beyond the scope of the planned project. 
Clinical Adoption Meta-Model 
The clinical adoption meta-model (CAMM) as described by Price et al may be 
used to specifically evaluate implementation of health information systems 
(Price and Lau 2014). They define adoption as the process that “involves the 
multitude of activities, decisions and evaluations that encompass the broad 
effort to successfully integrate an innovation into the functional structure of a 
formal organisation” (Price and Lau 2014). They claim that CAMM describes 
acceptance through time. The use of CAMM ascertains how information 
systems are incorporated into routine situational working. It can be applied to 
a variety of system implementation and thus would be applicable to HEPMA 
implementation.  
CAMM consists of four dimensions:  
1. availability; describes the ability of required users to access the system 
2. system use; describes how practitioners actually use the system for 
example the amount of use and includes practitioner know-how  
3. clinical/health behaviour; describes customisation of system into the 
actual clinical setting and includes consideration of capacity  
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4. clinical outcomes; describes the impact of the system implementation 
which could be at different levels for example patients, costs etc The 
outcomes may be assessed over time e.g. initial outcomes and later 
outcomes. 
CAMM may be used for evaluation although there is no evaluation format 
provided. They compare this model with other adoption models, for example 
diffusions of innovation and conclude that CAMM is superior because not only 
has it been contextualised to healthcare but it also assesses adoption in 
relation to clinical outcomes. 
The results of CAMM are graphically depicted to show simultaneously the 
impact of all four dimensions necessitating data collection of at least some 
aspect of all dimensions. Thus, this method of assessment was beyond the 
scope of the DPP project. 
Therefore, after consideration of these potential frameworks, the TDF was 
selected as the framework to use when undertaking the qualitative component 
of the DPP project. Notably, it is a validated framework that has been 
successfully used in similar research. TDF was used for analysis of semi-
structured interview findings. 
JUSTIFICATION OF SELECTION 
The overall DPP project used a mixed methods methodology comprising of a 
quantitative quasi-experimental before and after study method and a 
qualitative interpretive phenomenology. Therefore, the overall DPP project 
adopted a pragmatic research approach. 
Alignment to research methodologies 
The alignment of philosophical belief, required research outcomes and 
research questions suggests mixed methods methodology is suitable to 
answer the research question.  The rationale for selecting an overall pragmatic 
approach is because the researcher wants to use the most appropriate 
methodology to answer the research question which may be achieved by 
mixing different perspectives. 
Johnson et al postulate that mixed methods utilisation produces higher quality 
research than use of a single method alone (Johnson and Onwuegbuzie 2004). 
92 
 
The benefits of each type of research method can be combined to produce a 
synergistic effect which is particularly suited to practice research.  Mixing of 
research methods provides maximum opportunity to answer the research 
questions with consideration of experience and practical consequences. 
It is important to ensure data integration from both methods to complete the 
expected study outcomes. When undertaking practice research, the study 
involves an examination in the actual context but using careful study design 
ensures that the results may be able to be generalized to a wider context. 
Furthermore, Cresswell et al advocate mixed methods research using both 
quantitative and qualitative components as being optimal for assessing 
implementation of complex systems like IT systems (Cresswell and Sheikh 
2014). They also advocate using purposive sampling when completing the 
qualitative component so that the targeted individuals are familiar with the 
system and the investigating phenomenon (Cresswell and Sheikh 2014).  
Thus, mixed methods methodology has been selected because the use of 
pragmatism (not being committed to any one epistemological or ontological 
position) will enable the research questions to be fully answered in the actual 
practice research setting. The mixed methods methodology permits measured 
assessment of the real situation with considered evaluation. The use of mixed 
methods allows the combination of stories from research participants to be 
combined with statistical analysis to create the actual picture of what is 
happening in relation to the research question.  If quantitative methods are 
used alone there is some degree of understanding of the participants’ 
situation; whereas if qualitative methods are used alone it is difficult to make 
wide recommendations because of the limited number of people included in 
the data analysis and also analysis is dependent on the interpretation of the 
researcher and may be open to bias.  
Study Design 
The required research aim was to assess the impact of HEPMA system 
implementation on medicines related discharge communication, from the 
perspective of the hospital staff involved in the communication process. 
Reviewing study design from identified literature has facilitated development 
of study methods. Careful consideration of research questions has also aided 
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study design.  Study design should minimise the personal attitudes, values 
and beliefs of the PI. Thus by ensuring external validation and internal 
validation of data collection bias is minimised.  
Therefore, multiphase mixed methods methodology was selected for the study 
design. The quantitative component consisted of an experimental study of 
quasi-experimental before and after study design to quantify the impact of 
HEPMA implementation on discharge communication prescribing errors and 
receipt of discharge communication at GP surgeries. The qualitative 
component consisted of interpretive phenomenology of semi-structured 
interviews so that the opinions of the staff groups involved in the discharge 
communication could be fully described and understood both before and after 
HEPMA implementation.  
The use of theoretical domains framework (TDF) is established as an effective 
method to design questionnaires to determine implementation success in 
healthcare (Huijg et al. 2014). TDF was selected as the theoretical framework 
of choice when analysing the semi- structured interview findings. TDF has 
been established as an effective method to design interviews in healthcare 
(Duncan et al. 2012, Huijg et al. 2014, Patey et al. 2012). 
 Data integration is extremely important when conducting mixed methods 
research. A convergent method of data integration as outlined by Creswell was 
used to answer the research question (Creswell  2013).  
It should be noted that throughout the DPP project, patients were excluded 
from the research focus. Whilst individual patients are the topic of the 
inpatient prescription chart and discharge communication, they are not directly 
involved in the prescribing of medicines and routinely do not have access to 
their prescription chart nor are involved in the communication process in 
either the traditional or newly implemented system. 
RESEARCH GOVERNANCE  
The project was registered with Robert Gordon University (RGU) using the 
Research Degree Registration (RDR) and Research Ethics: Student and 
Supervisor Appraisal (RESSA) forms. This ensured maintenance of appropriate 
governance and ethical principles.   
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The Research and Development department of NHS Ayrshire and Arran was 
notified of the project. Information received from the Research and 
Development department indicated that NHS ethical approval was not required 
for any phase of the project in compliance with the requirements of the NHS 
Research Ethics Committee (NHS Research Ethics Committee 2006). The 
project consisted of a service evaluation and did not directly impact on 
patients, staff or the investigators. 
The data collected contained commercially sensitive information so were 
treated confidentially and stored on a secure “H” drive and compliance with 
NHS confidentiality procedures was maintained throughout (NHS Ayrshire and 
Arran Information Governance Team 2010). The “H” drive was only accessible 
by the PI and the laptop used for access was kept securely in the pharmacy 
department or on the person of the PI. Paper copies of consent forms were 
stored securely in the pharmacy department in a locked drawer only accessible 
by the PI. The data collected and stored were fully anonymised and names did 
not appear on any study documentation or reports.  Compliance with Data 
Protection Act 1998 requirements (Data Protection Act 1998), the updated 
Caldicott Principles (Caldicott  2013) and the Common Law Duty of 
Confidentiality were also maintained. The National Research Ethics Service 
Defining Research paper indicates for projects designed to judge current care 
with a question of “What standard does this service achieve?”, and only uses 
usual intervention with involvement of interviews without randomisation do 
not require Research Ethics Committee review (NHS Research Ethics 
Committee 2006).  
PATIENT SAFETY IMPLICATIONS 
The study included retrospective case note review which raised the potential 
for patient safety issues to be identified. The PI is a practising pharmacist 
registered with both the pharmacy regulatory body, the General 
Pharmaceutical Council (GPhC); and the pharmacy professional body, the 
Royal Pharmaceutical Society (RPS) and as such is bound by both professional 
and ethical considerations when working as a pharmacist especially in relation 
to actions of professional judgement. Both the GPhC and RPS provide ethical 
guidance for pharmacists (General Pharmaceutical Council  2012, Royal 
Pharmaceutical Society of Great Britain  2014). Both organisations cite “make 
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patients your first concern” (General Pharmaceutical Council  2012, Royal 
Pharmaceutical Society of Great Britain  2014). The GPhC further describes 
this as to “take action to protect the well-being of patients and the public” and 
“consider and act in the best interest of individual patients and the public” 
(General Pharmaceutical Council  2012). To mitigate problems in 
circumstances where issues were identified, the PI planned to discuss with a 
senior member of medical staff any details of concern. The PI planned to refer 
any issues considered of a serious and/or ongoing nature to the patient’s 
general practitioner for consideration and appropriate action. No such issues 
were identified during the project. 
CHAPTER SUMMARY 
This chapter has provided a brief outline of research philosophies, 
methodologies and possible research approaches. The different types of 
research methods have been described with a justification of the selected 
methodology and methods. Details of potential theoretical frameworks to be 
used in study designs gave been discussed with a justification for the selected 
framework. Finally, the consideration of research governance issues has been 
described. 
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CHAPTER 3 PRE-IMPLEMENTATION INTERVIEW 
CHAPTER INTRODUCTION  
This chapter describes the aim and research questions for the pre-
implementation qualitative interview phase of the DPP project. There is a brief 
description of methodology prior to detailed coverage of study methods, 
findings and discussion. 
Contextualisation 
Implementation into hospitals of innovative electronic solutions for discharge 
communication has been described in detail in Chapter 1. Previous studies 
investigating the implementation of these solutions have involved mainly 
quantitative studies which tended to include an assessment of specific aspects 
for example information content, accuracy and receipt time of discharge 
letters at GP surgeries (Pillai, Thomas and Garg 2004, Alderton and Callen  
2007, Scullard et al.  2007, Callen, Alderton and McIntosh 2008, Abdel-Qader 
et al. 2010, Callen J, McIntosh J and Li J  2010, Chen, Brennan and Magrabi 
2010, Hammad et al. 2014). Qualitative research was undertaken to a lesser 
extent, mainly ascertaining GPs’ opinions regarding the discharge 
communication process but with little focus on the perspectives of hospital 
staff (Pillai, Thomas and Garg 2004, Alderton and Callen  2007, Scullard et al.  
2007, Callen, Alderton and McIntosh 2008, Chen, Brennan and Magrabi 2010). 
The only study ascertaining opinions from hospital staff perspectives was 
reported by Yemm et al who invited (n=74) junior hospital doctors to prioritise 
the content of discharge letters in a questionnaire survey (Yemm et al. 2014). 
There is therefore a clear deficiency in the published literature relating to 
hospital staff perspectives of the systems prior to implementation of electronic 
innovations.  
AIM 
The aim of this phase of the project was to describe and understand 
perspectives of key staff groups (i.e. consultant doctors, junior doctors, 
pharmacists and advanced nurse practitioners) relating to patient discharge 
communication via  the traditional paper based system and prior to HEPMA 
implementation. 
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OBJECTIVES  
1. To describe and understand  staff views and experiences of the 
traditional paper based system 
2. To explore expectations and likely behaviours in relation to HEPMA 
implementation 
3. To highlight any differences in key themes identified amongst different 
professional staff groups 
QUALITATIVE STUDY DESIGN 
As described in Chapter 2, the philosophical stance of the PI was pragmatism 
and thus the DPP project utilised multiple approaches appropriate to the 
research aim and objectives. The DPP project comprised mixed qualitative and 
quantitative research approaches. 
This phase of the research employed a qualitative methodology, which 
described in Chapter 2 as best at answering “why and how questions” and 
most suitable for research examining processes (Schimmel  1996).   
Methodology and method 
The study design used interpretative phenomenology to fully describe and 
understand the perspectives of staff groups involved in discharge 
communication using the traditional paper based system prior to HEPMA 
implementation.  As described in Chapter 2 phenomenology usually involves 
conducting interviews or focus groups. In this case, the selected study method 
was face-to-face semi-structured interviews. A literature review had identified 
that semi-structured interviews were previously used in a similar study and 
literature review indicated that this would be a suitable method to achieve this 
phase study objectives (Wilson et al. 2001). Semi-structured interviews 
permitted more detailed information acquisition whilst promoting 
trustworthiness and data comparison as described in Table 2.8.   
Interview Format  
The interview was guided by use of an interview schedule, to allow the 
interviewees to provide their personal views and experiences, which allowed 
the PI to ask core questions which were supplemented by probing questions. 
These probing questions included requests for further details of specific items, 
clarification of actual meaning of statements and asking for specific examples 
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(Bowling  2014).  The interview format was developed in line with the criteria 
outlined in Chapter 2 so that the influence of the interviewer was minimised. 
At the end of the interview, the participant was given the option to add any 
additional information not already covered, as recommended by Wahyuni 
(Wahyuni  2012). 
Interview Schedule 
The interview schedule is provided in Appendix 3.1 The questions were 
developed after conclusion of a narrative literature review (Chapter 1), review 
of local incident reports concerning medicines and consideration of SIGN 128 
guideline recommendations (Scottish Intercollegiate Guidelines Network 
(SIGN) 2012).  As described in Chapter 1, SIGN guideline 128 is national 
Scottish guidance defining the ideal content of hospital discharge 
documentation. This guidance states the minimum requirements (comprising 
of 29 sections) of essential information to be communicated at hospital 
discharge to primary healthcare professionals. This information may also be 
provided to patients and carers. 
The interview schedule required gathering information which included: the 
code number of the participant (rather than name to maintain anonymity); 
interview date; and start and stop time of interview (enabled calculation of 
interview duration). Demographic information was included in the initial 
section of the semi-structured interview schedule. 
The schedule consisted of five main components: inpatient prescribing; 
discharge prescribing; discharge letter process; incident reports and significant 
adverse event reviews; and HEPMA implementation. Questions about both 
inpatient and discharge prescribing were included because any prescribing 
errors present on the inpatient prescription chart may be transferred to the 
discharge letter. Verification of the initial interview topic guide was achieved 
by review from a senior pharmacist involved in the education and training of 
junior doctors in NHS Ayrshire and Arran and also by the university 
supervisory team. 
Interview Pilot 
The verified interview schedule was pilot tested by the PI with a consultant 
doctor, allowing any identified deficiencies to be rectified before 
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commencement of the participant interviews. The pilot interview enabled the 
PI to ensure that the questions permitted the participant to speak freely and 
tested the ability of the investigator to formulate probing questions. Feedback 
from the pilot participant was positive and no amendments were made to the 
interview schedule. Furthermore, the pilot lasted 22 minutes, within the 
planned 20 to 30 minutes. The pilot interview was excluded from data 
analysis. 
Sampling 
Non-probability sampling approaches are mainly used in qualitative research 
and details about the different approaches have previously been outlined in 
Chapter 2. In non-probability sampling, the population as a whole is unknown, 
but there is a shared characteristic (Davies  2007).  Bowling claims that for 
qualitative research, sampling is normally undertaken using convenience, 
purposive, snowballing or theoretical sampling methods (Bowling  2014). 
Starks et al, in a discussion of possible methodologies for qualitative research 
in healthcare settings, suggest that irrespective of the selected approach that 
purposive sampling should be used to capture interviewees who have 
knowledge of the investigated experience (Starks and Trinidad 2007). 
In this instance purposive stratified sampling was used. As outlined in Table 
2.9, purposive sampling enabled the targeting of key individuals involved in 
the discharge process to enable accurate result generation.   
Inclusion and exclusion criteria 
To be included in the sample, the individual had to be a member of the 
identified staff groups currently working at UHC and involved in the discharge 
communication process. The identified staff groups consisted of consultant 
medical staff, junior medical staff, advance nurse practitioners and 
pharmacists. Staff were excluded if they worked at University Hospital Ayr 
(UHA), at both UHA and UHC, or had routine experience of HEPMA systems 
which was assessed by asking about previous HEPMA use and frequency. 
The aim was to recruit a diverse sample in terms of the following criteria: 
gender and years worked at research setting. The length of time an individual 
had worked in the organisation may impact on their perceptions of systems 
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and identified problems. More junior staff may be less aware of process and 
procedural problems.  
The number of eligible members of each professional group currently 
employed at UHC is as follows: consultant medical staff 46; advance nurse 
practitioners 38; pharmacists 35; and junior doctors 64. 
Sample size  
The determination of an adequate sample size in qualitative research is 
ultimately a matter of judgement and experience and depends on the selected 
qualitative design. Creswell claims that, “phenomenology typically range from 
three to ten” (Creswell  2013), whereas Starks et al suggest that the required 
sample size for phenomenological studies is usually one to ten people (Starks 
and Trinidad 2007). 
It is important to ensure the sample size is adequate for the research 
purposes without being larger than needed as research funds and 
interviewees’ time are wasted (Francis et al. 2010).  
Another conventional approach is to continue until “data saturation” is 
achieved. Data saturation is defined as “the point in data collection when no 
new additional data are found that develops aspects of a conceptual category” 
and Francis et al claim that it is essential to reach data saturation to ensure 
that content validity has been achieved for the sample (Francis et al. 2010). 
The principles should be agreed by the research team prior to starting the 
study so that consensus may be reached about when to stop (Francis et al. 
2010). Francis et al propose an approach for achievement of data saturation 
(Francis et al. 2010). This is by agreeing the minimum number of interviews to 
be analysed first and then subsequently to state the number of further 
interviews to be completed without any new ideas being voiced. They claim 
that this method may not be suitable for research using interviews with sub-
groups but that a modified version may be applicable (Francis et al. 2010). 
Anticipated Sample Size 
It was anticipated prior to starting the interviews that to achieve total 
population data saturation a sample of five to six members of each 
professional group would be sufficient. If necessary, this number could be 
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amended upwards or downwards to achieve overall data saturation and not 
necessarily for each individual professional group. 
Recruitment 
Service leads (who are managerially responsible for staff within their 
respective areas i.e. associate medical director, lead pharmacist, associate 
nurse director, and assistant director of medical education) were initially asked 
verbally by the PI to nominate individual staff members from their jurisdiction 
to participate in this service evaluation. This initial verbal communication was 
followed by an e-mail request. The service leads were each asked to nominate 
five to six staff members as this was thought to be a suitable number to 
achieve data saturation as described above. Sampling bias, as outlined in 
Chapter 2, was minimised by requesting the service leads to select staff with a 
broad demographic range in relation to gender and years worked at hospital. 
The PI then invited the nominees by e-mail to participate in the study. The e-
mail invitation is provided in Appendix 3.2. All nominated staff responded 
positively to the request.  
Participant Information and Informed Consent 
All nominated staff were e-mailed a copy of the information sheet to their 
secure NHS email accounts (which are readily accessible) a week before the 
scheduled interview. Every interviewee was provided with a participant 
information sheet (Appendix 3.3) by the PI and asked to sign an informed 
consent form (Appendix 3.4) if they agreed to be included in the study. They 
were asked to confirm that they were still willing to proceed by e-mail reply. 
The investigator obtained a signed copy of the consent form on the day of 
interview. Staff kept a copy of both the participant information sheet and a 
signed copy of the informed consent form. 
Interview Procedure 
The PI conducted all face-to-face interviews at a location and time convenient 
to the interviewee. The interview locations were either the interviewee’s 
private office or a private room located in the pharmacy department of UHC. 
No interviews were conducted in public spaces. The interviews were completed 
during February to August 2013. 
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The PI used a mixture of key questions and associated probing to ensure all 
relevant topics were covered, whilst permitting flexibility of discussion. The 
interview format allowed the interviewee to provide their personal opinion of 
the prescribing and discharge communication process. The interview schedule 
was developed iteratively as the interviews progressed. This required very 
little change to the content, merely an initial description of the interview 
structure was provided in the introduction and clarification of a minor aspect. 
The initial question of what, if any, impact will this (HEPMA implementation) 
have on your present role or profession was separated into two distinct 
questions. 
Interviews were audio recorded with interviewee consent. The recorded 
information was transcribed verbatim by the PI immediately or as soon as 
possible after the interview. The transcription used a denaturalised style and 
names of interviewees were not included in the transcript (Oliver, Serovich 
and Mason 2005). A denaturalised approach was selected as the interview 
content rather than the delivery of the speech was of interest (Oliver, Serovich 
and Mason 2005). The recorded information was deleted from the recording 
device and computer after transcription and verification of transcription had 
been completed. 
Theoretical Frameworks 
The use of a theoretical framework is recommended by both Evans et al and 
Cresswell et al, as described in Chapter 2, because it provides helpful 
organisation of complex assessments (Evans, Coon and Ume 2011, Cresswell 
and Sheikh 2014). 
Theoretical Domains Framework  
The Theoretical Domains Framework (TDF) was developed to identify key 
domains for successful implementation of healthcare interventions with a 
specific focus on behavior change interventions, as described in Chapter 2. 
TDF has been validated and refined by Cane et al to include 14 domains and 
84 component constructs and captures 33 theories of behavioural change as 
described in Chapter 2 (Cane, O’Connor and Michie 2012).  The use of 
theoretical domains framework (TDF) is established as an effective method to 
design questionnaires and semi-structured interviews and to determine 
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implementation success in healthcare (Cane, O’Connor and Michie 2012, 
Duncan et al. 2012, Huijg et al. 2014). Duncan et al used semi-structured 
interviews based on TDF as part of the PROTECT study when interviewing 
junior doctors about prescribing errors (Duncan et al. 2012). Patey et al used 
interviews based on TDF to assess behaviour change in doctors ordering tests 
(Patey et al. 2012). Furthermore, Fleming et al applied TDF to semi-structured 
interview findings regarding antibiotic prescribing (Fleming et al. 2014). 
Application of the Theoretical Domains Framework 
The Theoretical Domains Framework (TDF) was used in this research to aid 
analysis of results for behavioural aspects of the traditional prescribing 
processes. Once inductive coding had been completed, data were mapped to 
the domains of the TDF.   
Table 3.1 is adapted from Cane et al and provides a list of the domains and 
associated constructs. The interview transcripts were mapped to the 14 
domains of the theoretical domains framework (Cane, O’Connor and Michie 
2012).  
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Table 3.1 Theoretical Domains Framework adapted from Cane et al (Cane, O’Connor and 
Michie 2012) 
Domain Domain Definition Example Constructs 
 Knowledge An awareness of the existence of 
something 
Procedural Knowledge 
Knowledge of task 
environment 
Skills An ability or proficiency adapted 
through practice 
Competence 
Practice 
Social/professional 
role and identity 
A coherent set of behaviours and 
displayed personal qualities of an 
individual in a social or work 
setting 
Professional role  
Professional confidence 
Beliefs about 
capabilities 
Acceptance of the truth, reliability 
or validity about an ability, talent 
or facility, that a person can put to 
constructive use 
Self-confidence  
Perceived competence  
 
Optimism The confidence that things will 
happen for the best or that desired 
goals will be obtained 
Optimism  
Unrealistic optimism  
Beliefs about 
consequences 
Acceptance of the truth, reliability 
or validity about outcomes of a 
behavior in a given circumstance 
Outcome expectancies  
Consequences 
Reinforcement Increasing the probability of a 
response by arranging a 
dependent relationship or 
contingency between the response 
and the given contingency 
Rewards  
Punishments 
 Intentions A conscious decision to perform a 
behaviour or a resolve to act in a 
certain way 
Stability of intentions  
Stages of change 
model 
Goals Mental representation of outcomes 
or end states that an individual 
wants to achieve 
Target setting 
Implementation 
intention 
Memory, attention 
and decision 
processes 
The ability to retain information, 
focus selectively on aspects of the 
environment and choose between 
two or more alternatives 
Decision making 
Cognitive 
overload/tiredness 
Environmental 
context and 
resources 
Any circumstances of a person’s 
situation or environment that 
discourages or encourages the 
development of skills and abilities, 
independence, social competence, 
and adaptive behaviour 
Resources 
Critical incidents 
 
Social influences Those interpersonal processes that 
cause individuals to change their 
thoughts, feelings or behaviours 
Social pressure  
Group conformity  
Emotion A complex reaction pattern, 
involving experiential behavioural, 
and physiological elements, by 
which the individual attempts to 
deal with a personally significant 
event or circumstances 
Anxiety 
Stress 
 
Behavioural 
regulation 
Anything aimed at managing or 
changing objectively observed or 
measured actions 
Self-monitoring 
Action planning 
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Data Analysis 
Data transcription has been proposed as the first part of analysis and enables 
the researcher to become immersed in the data. Transcription is time 
consuming and it is estimated that one hour of recorded data takes 
approximately between two and four hours to transcribe (Wahyuni  2012). 
Data immersion is also achieved by repeated reading of the interview 
transcripts. Verification of the transcribed data was achieved by university 
supervisor review of a random sample of 20% of the transcripts against the 
recordings. 
All generated transcribed information was entered into NVivo 10© software by 
the PI (QSR International). NVivo© is computer software package which is 
designed for qualitative research and facilitates structured organisation and 
analysis of interviews and other qualitative research methods. The data 
included anonymised interviewee details including gender, years worked at 
UHC and professional group of interviewee.  
Framework analysis was the selected data analysis method because of its 
previous use in healthcare research and because it provides a systematic, 
structured approach to data analysis whilst permitting data transparency 
(Smith and Firth 2011). Gale et al state that “the framework method is most 
commonly used for thematic analysis of semi-structured interview transcripts” 
(Gale et al. 2013). An advantage of thematic analysis is that the data tends to 
be a true reflection of the interviewee statement and it is usually presented as 
anecdotes or direct quotes.   
Pope et al claim that framework analysis is especially suited for qualitative 
research with pre-defined objectives (Pope, Ziebland and Mays 2000).This is 
therefore consistent with the DPP project design as the framework approach 
suits studies with pre-identified questions (or objectives) set in short time 
frames and related to policies and procedures.  Data were sorted by looking 
for principal themes from the interviews, evolving themes and issues of 
interest in relation to the objectives. This reflects an inductive approach as 
outlined by Gale et al when “themes are generated from the data through 
open (unrestricted) coding, followed by refinement of themes” (Gale et al. 
2013). 
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Coding of Key Themes 
Nodes were created for each identified concept in the interview transcripts. A 
node is defined as “a representation of an idea, theme or category” (QSR 
International). This is the coding method used in NVivo 10© (QSR 
International). FrameWork© has been integrated into NVivo 10© which assisted 
with data analysis.  Data analysis consisted of deconstructing the content, 
sorting by themes and arranging data into themes. Gale et al outline seven 
stages in the process of data analysis using the framework approach (Gale et 
al. 2013). The stages and actions taken are provided in Table 3.2. 
In NVivo 10©, a free node is defined as “a node not connected to anything else 
and represents ideas, concepts and themes in the dataset.” Further review of 
the data identified that certain nodes were connected or expressed similar 
ideas so that a tree map was additionally created. The tree structure aided the 
organisation and classification of concepts. An example of a tree map is 
provided in Figure 3.2. 
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Table 3.2 Data Analysis Stages as described by Gale et al and project specific actions 
(Gale et al. 2013). 
Stage Actions undertaken 
Transcription Audio recorded interviews were transcribed verbatim 
using denaturalised style by the PI. The interview 
content was more important than the speech nuance. 
Interview 
familiarisation 
The PI listened to the audio recordings repeatedly 
and also read the transcripts several times to aid 
with identification of developing themes in the 
interviews. 
Coding The PI completed coding by highlighting certain 
sections of the transcripts using an inductive method. 
The codes generated were topics repeatedly raised 
during the interviews. A sample of interview 
transcripts was independently coded by university 
supervisor. In addition TDF constructs were applied 
to identify behavioural components of the 
interviewees. 
Framework 
development 
After code agreement between the PI and the 
university supervisor the agreed codes and the TDF 
constructs were applied to all transcripts to create a 
framework. 
Application of 
framework 
Codes entered into computer software package NVivo 
10© by PI to aid data analysis. 
Data charting to 
framework 
Development of framework matrix by using the 
computer software package which included a direct 
link to the original transcript so that the original text 
could be viewed in the context of the interview. 
Data interpretation Data interpretation using the original inductive codes 
and also deductive coding using the TDF to describe 
and understand interviewees’ views and behaviours 
associated with the themes and also allow the 
exploration of relationships amongst themes. 
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PROMOTING QUALITY 
Trustworthiness  
Consideration of the four criteria for trustworthiness, as outlined in Chapter 2, 
was applied in conducting this qualitative research. 
Credibility was promoted by selecting a semi-structured interview method 
which has been used in similar studies and therefore was an appropriate 
research method. The purposive sampling approach ensured that the 
interviewees interviewed were representative of the staff familiar with using 
the traditional handwritten discharge communication systems. Staff were able 
to refuse to participate in the study and were informed of the possibility of 
withdrawal from the study even after completion of the interview. The PI held 
frequent discussions with the university supervisory team throughout this 
phase of the DPP project and an oral communication of the early results of this 
study were presented at The Royal Pharmaceutical Society Conference in 
September 2013 and therefore allowed discussion amongst peers and 
academics about the research and permitted feedback to be obtained. 
Transferability of results is possible as a clear description of the methods used 
has been provided along with an in-depth description of the setting and 
interviewees.  
Dependability was achieved by provision of full details of the research design 
and data collection methods. 
Confirmability has been achieved by use of robust audit trail including 
transcript and thematic review by the university supervisory team. However, it 
is impossible to discount that the role of the PI in the organisation may have 
impacted the interviewees’ response during the semi-structured interviews. 
The role of the PI aided access to staff for interviews and all potential 
interviewees contacted agreed to partake in the interviews. This response may 
not have been achieved if a researcher external to the organisation had been 
undertaking the interviews. The PI attempted to minimise bias stance 
concerning the traditional prescribing systems and the perceived benefits of 
HEPMA implementation. One of the biggest challenges the PI faced when 
conducting the interviews was being directly questioned by the interviewee 
about HEPMA implementation and HEPMA benefits. The skill of the PI at 
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deflecting these questions was iteratively developed during the course of 
completing the pre-implementation interviews. 
Finally, a rigorous approach to data analysis was applied by the use of 
framework analysis in the established NVivo 10© computer programme to 
maximise trustworthiness. 
Research Governance 
The study did not require NHS Ethics approval as the work was considered a 
“service evaluation” as outlined in Department of Health Guidance 
(Department of Health 2013). The communication from UHC Research and 
Development Department is provided in Appendix 3.5. The research was 
approved by the ethical review panel of the School of Pharmacy and Life 
Sciences, Robert Gordon University (RGU). The communication from RGU is 
provided in Appendix 3.6.The audio recorded interviews were anonymous and 
likewise identities were excluded from interview transcripts and all 
documentation. Once transcription was completed the audio recordings were 
deleted. The completed consent forms were securely stored in a locked filing 
cabinet in the secure environment of the pharmacy department. The 
generated data were securely stored in a locked filing cabinet and password 
protected computer only accessible by the principal researcher. Data 
Protection Act 1998 requirements, the Caldicott Principles and the Common 
Law Duty of Confidentiality were adhered to throughout the study (Act  1998, 
Caldicott  2013). 
FINDINGS 
Interviewed Staff 
A total of 19 staff members were interviewed from the 22 that agreed to be 
interviewed. Three staff were not interviewed: one ANP and two junior 
doctors. No staff refused to participate in the interviews. One of the consultant 
interviews needed to be rescheduled due to service pressures. One of the 
ANPs interview could not proceed as the individual had been working at UHA 
for the previous six months. Demographic details of the interviewees are 
provided in Table 3.3. The PI experienced the greatest difficulty in scheduling 
interviews for junior medical staff. This was resolved by certain doctors 
coming in early before their shift commenced to participate in the interview. 
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The interview length ranged from 14 minutes to 42 minutes; with a median of 
26 minutes.  All interviewees were familiar with and regularly used the 
traditional paper based inpatient prescribing, discharge prescribing and 
communication processes. The interview phase was completed when total 
population data saturation was achieved which accounts for the difference in 
numbers interviewed amongst the professional groups. 
Table 3.3 Interviewee demographics 
Advanced 
Nurse 
Practitioner 
Gender Years worked at 
UHC 
Any prior electronic 
system use 
1 F 15-16 Yes 
2 F 27  Yes 
3 F 13  Yes 
4 F 15  Yes 
Consultant 
Medical 
Gender Years worked at 
UHC 
Any prior electronic 
system use 
1 M 11 Yes 
2 M 9  Yes 
3 M 15  No 
4 F 5  Yes 
5 M 5.5 No 
6 M 8  Yes 
Junior 
Medical 
Gender Years worked at 
UHC 
Any prior electronic 
system use 
1 F < 1 year Yes 
2 F < 1 year Yes 
3 F < 1 year Yes 
Pharmacist Gender Years worked at 
UHC 
Any prior electronic 
system use 
1 M 2  Yes 
2 M 7  Yes 
3 F 13  No 
4 F 5  Yes 
5 F 4  Yes 
6 F 26  Yes 
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Prior Exposure to HEPMA 
Table 3.3 shows that the majority of interviewees had some previous exposure 
to electronic discharge systems, however no one individual had routine prior 
HEPMA experience. All the ANPs had minimal experience with HEPMA at UHA; 
the maximum number of HEPMA system usage that any individual 
acknowledged was up to four times. In the pharmacist staff group, one 
pharmacist had witnessed HEPMA as a pharmacy student at UHA; another was 
familiar with the system from previous work at UHA limited to the dispensary; 
and three other pharmacists had used electronic discharge systems in other 
hospitals in different Health Board areas in Scotland. One of the consultants 
had used a discharge module of HEPMA as a pilot at UHC; one had used an 
electronic discharge system in a different Scottish Health Board area; another 
had used a bar-coded system in England; whilst another had experience of an 
electronic prescribing system in Australia. None of the junior medical staff had 
prior HEPMA exposure but all had experience of using an electronic discharge 
module in a different Scottish Health Board area. 
Framework Analysis Results 
Initially 28 free nodes (as defined on page 11) were created including 
experiences with the inpatient charts, immediate discharge letters and the 
discharge letter process. 
Staff Experience 
The interviewees described their experiences with the traditional prescribing 
systems and discussed difficulties at all patient journey stages. 
One particular issue during the inpatient stay was the difficulty of knowing 
whether a medicine had been administered as the traditional system relies on 
alpha/numerical code and the same medicine may be associated with different 
letters/numbers if it has been rewritten. As described by one junior doctor, 
‘it’s on a different sheet and I think sometimes it’s confusing when there’s a 
few kardexes and it’s A1 or A2’ [JD1] 
 
This was reinforced by a pharmacist,  
 
‘It’s not quite clear what has and hasn’t been given’ [Ph4] 
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The structure of the IDL was discussed and a lack of space and not having 
specific sections were highlighted. As one ANP stated, 
 
‘There isn’t anywhere to record the patients’ drug allergy status.’ [ANP1]  
 
Likewise a pharmacist described the recording of compliance device 
information as, 
 
‘There’s no specific part on the prescription again for that (compliance device 
information)’ [Ph 5] 
 
The experience of the existing discharge process was described as leading to 
significant delays, as discussed by one consultant,  
 
‘so three to four month delay in getting them (final typed letter) done, 30% of 
discharge letters are never done’ [C1] 
Staff behavioural determinants 
The TDF was used to explore behavioural determinants of the interviewees in 
relation to the traditional prescribing and discharge communication processes. 
Six of the 14 domains of the TDF were applicable to discussion topics identified 
during review of the interview transcripts. The relevant domains and 
associated constructs are depicted in Figure 3.1. While there is a difference in 
terminology with TDF referring to constructs and NVivo© to nodes, these are 
now described as themes. 
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Figure 3.1 TDF Domains and associated constructs mapped to interview findings
Knowledge 
Procedural 
knowledge 
Knowledge of 
task 
environment 
Skills 
Competence 
Practice 
Social/ 
professional role 
and identity 
Professional 
role 
Professional 
confidence 
Beliefs about 
capabilities 
Perceived 
competence 
Self 
confidence 
Beliefs about 
consequences 
Outcome 
expectancies 
Consequences 
Environmental 
context and 
resources 
Resources 
Critical 
incidents 
114 
 
THEORETICAL DOMAINS 
Knowledge Domain 
All interviewees (i.e. ANPs, consultants, junior doctors and pharmacists) 
described knowing what to do and how to do it in association with the 
traditional documentation. The process of completing a handwritten immediate 
discharge letter followed by a typed formal discharge letter was understood 
and followed, although deficiencies in the process were acknowledged 
especially with delays in process completion. As one ANP described,  
‘I like the sheet that’s there, I think it is easy enough to read through, I think 
it is easy enough to see what drug has been prescribed and when the patient 
is to get it. I’ve worked with it for over a decade as a qualified nurse and very 
much used to that system of prescribing –I don’t have any issues with that.’ 
[ANP1] 
However, another ANP described limitations of the traditional discharge 
documentation, 
‘There is not much room to prescribe – I think there is only about six boxes to 
actually prescribe drugs so again you have to use about two or three different 
sheets for some patients that are on lots of polypharmacy.‘[ANP 4]  
One consultant articulated the failure of the paper immediate discharge letter 
to meet the national standards described in the SIGN discharge document 
(Scottish Intercollegiate Guidelines Network (SIGN) 2012), 
‘Our current drug charts do not easily lend themselves to meeting SIGN 
requirements for discharge letters, so it’s not easily apparent to see which 
drugs have been discontinued purposefully, which have been crossed off 
maybe with the intention being re-commence but weren’t recommenced ‘ [C2] 
 
The delivery method for the IDL to reach the patients GP was described by one 
interviewee whilst acknowledging limitations in the letter content as, 
 
‘Patients are quite well informed about handing the letter to their GP as soon 
as possible but I think communication in relation from prescribers what is on 
the letter is something to be desired.’ [ANP3] 
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The description of the traditional prescribing documentation layout and of the 
discharge letter process was outlined by interviewees who articulated their 
opinions regarding the design of the documentation. 
One pharmacist described problems with the inpatient chart as, 
‘You know if it is maybe azithromycin three times a week or something like 
that or if you want to give a diuretic on alternate days it’s not the easiest thing 
to do using the particular paper kardex that we have.’  [Ph 2] 
 
Whilst the immediate discharge letter was viewed more favourably as, 
 
‘What works well on the immediate discharge letter is that there is space on it 
to write the accurate diagnosis, what tests and investigations have been done 
and because you are able to write that, that should correlate with what is 
prescribed. ‘[ANP4] 
Although a pharmacist highlighted difficulties when controlled drugs need to 
be prescribed, 
‘Because it doesn’t lead the prescriber to provide the legal requirements- it’s a 
generic chart intended for any medicine and it doesn’t prompt for example the 
words and figures requirement under the Misuse of Drugs Act.’ [Ph6] 
Several interviewees explained familiarity with the documentation was 
important to them. This ensured that the staff knew what to do when they 
were prescribing medicines and completing the discharge process.  One 
consultant described, 
 ‘Ok well the positive side is familiarity with the concept in terms of what 
we’ve always done so people understand particularly the permanent staff how 
the kardex works, how it’s written out, how it’s administered ‘ [C1] 
 
Interviewees describing how to use the current documentation, explained how 
they individually completed it and also described systems they had developed 
to improve information accuracy on the prescribing documentation.  A junior 
doctor described their personalised process as, 
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‘I’ve just finished working in haematology/oncology and as patients maybe 
became more palliative there was maybe screeds… a couple of pages of 
kardexes when one would have done. I personally if I’ve got the time do try 
and re-write kardexes to try and make it easier because some of them are 
very confusing if you’ve got a list of ten or twelve medications and most of 
them have been crossed off apart from maybe one amongst there – it can get 
lost quite easily.’ [JD1] 
 
Whilst a consultant described their actions to improve safety as, 
 
‘If the drug chart is not reviewed and I will review them at least twice a week 
on my ward rounds. I make a point of looking at every drug chart for my 
patients as part of consultant review...so we always try to at least act to make 
sure that everything is re-charted on a single chart wherever possible’ [C5] 
 
However, inconsistencies in the application of processes were described by 
some interviewees. 
‘How consistent we are in documenting it on the form I think again it’s very 
variable with inconsistency.’ [C6] 
Skills Domain 
The interviewees discussed their skill to prescribe and practice within the 
existing traditional system. Ease of access was cited as a positive factor by 
one pharmacist, 
‘I think that what works well is obviously that it is easy to hand, the doctors 
are used to the system- they don’t have to learn how to do anything they just 
have to write out the doses and things like that’ [Ph6] 
And this was reinforced by an ANP, 
‘The current system is accessible so if a patient takes unwell you can quickly 
prescribe there and then what has to be administered’ [ANP 4]  
The traditional documentation is not conducive to enabling prescribing in 
accordance with accepted standards which is exemplified by the comments of 
one consultant. 
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‘In a number of cases it can be unsatisfactory if the junior doctor doesn’t 
prescribe it in a clear manner. If the dose is not specified clearly you know 
sometimes it is difficult to give micrograms, milligrams or these kind of 
abbreviations that can be sometimes mixed up. Sometimes also about slow 
release tablets if it has not been written as a slow release that can sometimes 
cause problems’. [C3] 
 
A pharmacist provides an additional example specifically related to the IDL as, 
 
‘Quite often the regular medicines are omitted from the paper prescriptions for 
discharge and they are only prescribed the acute medicines antibiotics, 
nebules whatever and they are only prescribed new medicines and quite often 
… they just write below “no changes to regular medications” which isn’t the 
best for GPs to understand what the patient’s taking. Again quite often it’s 
omitted whether or not a patient’s medicine has been stopped’ [Ph2] 
 
The interviewees did not claim a lack of training or deficiency in prescribing 
skills as an individual consideration. The one skill that was repeatedly 
highlighted as an issue was handwriting; with legibility a specific concern for 
both inpatient and discharge documentation. 
‘Quite often it is illegible.’ [C6] 
It (IDL) is usually done in a hurry, usually the writing is very difficult to read 
once the medication has been written and there have been some mistakes of 
course because of missing tablets and writing the wrong duration or wrong 
frequency. So this is definitely not satisfactory. [C3] 
 
Social /professional role and identity domain 
A change to prescribing legislation in the UK in 2006 enabled nurses and 
pharmacists to practice as independent prescribers. The newer prescribing 
professions (nurses and pharmacists) focused on the professional aspect of 
prescribing and their professional confidence about prescribing during the 
interviews. One ANP described as, 
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‘If I’m asked to prescribe something I’ve never prescribed before I won’t do it 
unless I go and look up the BNF but if there is a doctor there that is willing to 
prescribe it..’ [ANP4] 
Whilst a pharmacist considers the changes that HEPMA will bring in relation to 
ability to prescribe as, 
‘Prescribing medicines myself as a pharmacist with HEPMA will be fine, it will 
be straightforward.’ [Ph2] 
The SIGN discharge document recommends consultant review and sign-off 
wherever possible of the immediate discharge letter (Scottish Intercollegiate 
Guidelines Network (SIGN) 2012).  Difference in the opinions amongst the 
professional groups was evident. All professional groups except consultant 
medical staff reported consultant counter signing never occurred as 
exemplified by the comments below 
‘None of them (the consultants) have ever signed.’ [ANP 2] 
‘I don’t think it ever is- I’ve never seen that done.’ [JD2] 
‘Never absolutely, I have never seen a consultant sign off a discharge letter.’ 
[Ph3] 
 
It should be acknowledged that the consultants reported infrequent signing of 
the document themselves. 
‘Rarely, I would say if I guess 1 in 30, 1 in 40 maybe if a consultant sees or I 
do it myself very occasionally – maybe 1 in 100 I think so that’s about it.’ [C6] 
Beliefs about capabilities domain 
Some staff described anxiety when currently prescribing using the systems 
available to them as described by one ANP as, 
 ‘From a prescriber sometimes I don’t feel very secure.’ [ANP 3]  
Whilst others described how they had changed their practice to improve 
competence as highlighted by one junior doctor, 
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‘I was guilty of just writing “No changes to meds” because when I was doing 
surgical admissions and if you’ve get ten discharge scripts to do to write 
everybody’s medicines and if all their antihypertensives have stayed the same 
it seems a bit excessive……. and I do write even though they take longer.’ 
[JD1] 
Consultant medical staff expressed concern about the abilities of junior doctors 
when completing certain tasks as, 
‘...it is written by juniors and they take the information from what they 
understand happened and quite often they might not have a full 
understanding. It depends very much on the person who writes it, when they 
write, how legible they write it and of course, everyone is different so there’s 
no set standard to that process – it’s just pure luck really.’ [C6]  
Variability was also cited as an issue by another consultant. 
‘Not everybody prescribes in block capitals, not everybody puts a diagnosis, 
not everybody details what’s been stopped- so very variable.' [C4] 
Apprehension was expressed when changing to HEPMA and its potential 
impact on prescribing competence. Interviewees described how the current 
system means they need to check doses and become familiar with routinely 
prescribed medicines which may disappear with HEPMA. 
You probably have to be quite careful if you were starting someone on 
something that it could come up with a whole range of different doses for 
somebody or amitriptyline you might want to give someone a small dose for it 
but say you type in and it’s giving you a range of doses you might want to be 
careful to pick the right dose which I think could easily go wrong- so many 
options you accidentally click the wrong one. [JD1]   
I think there is a worry that people will become complacent or not be so 
responsible for their own prescribing practice. I think if you put any system in 
place where the system does it all for you, you just come complacent, stop 
thinking and you just let the system guide you and I think there is a danger in 
that and I would like to be able to think that I am on top of my responsibilities 
as a prescriber. [ANP1] 
120 
 
Beliefs about consequences domain 
Interviewees described patient safety concerns and discussed issues with 
inadequate information provision on discharge as exemplified by one 
consultant. 
 
‘There are deep concerns about the safety around about using the paper 
kardex, legibility, frequency, recording of administrations, start and finish 
times and reasons for drugs?.....There are significant delays on the system. It 
is pressurised, tends to be batched and held in a holding pattern and often 
there’s big delays to it getting done. That it does lead to medication errors 
across the boundary into primary care and it also leads to readmissions.’ [C1] 
Almost all interviewed staff reported receiving GP queries about the 
information content of handwritten immediate discharge letters. They reported 
the majority of queries related to missing or inaccurate information with a 
need to clarify certain information as described by one consultant as, 
 
‘Always just about please tell me why they are no longer on x,y,z, what have 
you done with their antihypertensives? Am I meant to be continuing this- it is 
just lack of clarity on the immediate discharge letter.’ [C4] 
 
And reiterated by a pharmacist as, 
 ‘A few doctors have phoned in and said they can’t read the discharge 
prescription and you’ve to go over it.’ [Ph1] 
 
In relation to GP query resolution, interviewees were mostly able to 
successfully provide the required information although they conceded that it 
usually took time as they frequently needed to access the patient’s case notes 
to answer queries as described by one consultant as, 
 
‘Yes- but it usually involves getting notes out and spending time doing it.’ [C4] 
Whilst pharmacists stated they may be required to pass enquiries to medical 
staff. 
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‘Sometimes – I would say probably about 70% or 80% of the time we can 
resolve it. They may then come back with a further question which may be 
more appropriately answered by the medical staff in which case they are 
passed in that direction.’ [Ph6] 
Environmental context and resources domain 
The interviewees described the current documentation and processes required 
for prescribing and completing the required information on the discharge 
letters. They frequently expressed experienced constraints due to the existing 
documentation design, and the necessary processes to be completed for 
patient discharge information communication and provide examples of 
problems associated with these systems with delay in information provision to 
GPs highlighted as a specific issue. 
‘At the moment there is a very significant delay between the immediate 
handwritten letter and the final discharge letter and that’s just pressure of 
work...often by the time the final discharge letter is dictated, things are 
different again -the person has perhaps come back in, the GP has maybe 
changed things so the two things are not always the same.’ [C4]  
 
‘there was changes made at the very last minute to discharge medicines and 
the doctor came down and made several annotations but the yellow copy 
didn’t go into the notes...and so the final discharge letter was from the kardex 
and there were several changes and I noticed that when the patient got re-
admitted when I compared what we had dispensed here (in pharmacy) to the 
kardex. [Ph3] 
An area of concern highlighted by interviewees was pressure to complete 
discharge documentation quickly to hasten patient discharge which may lead 
to prescribing errors. 
‘It’s often filled out by a passing doctor trying to facilitate a discharge in a 
pressurised system.’ [C1] 
Individual patients requiring several pages of immediate discharge letter 
documentation were mentioned by interviewees as a potential source of error 
and they described instances where pages had been mislaid or become mixed 
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up with another patient’s documentation and cited the number of pages as 
problematic. 
‘We’re in the era of polypharmacy now so there’s more and more of these 
multiple pages and what very much annoys me if I’m having to dictate some 
summaries and somebody has just written the new medications that they’ve 
been on and it’s therefore not immediately apparent to me which of the old 
ones were continued – I might have to go back and look at the drug kardex 
and see what their meant to be on and the general practitioner has no way of 
doing that so that’s a big problem’ [C2] 
‘The only thing I will say about the number of pages is that obviously things 
can go missing – it’s easier for it to go missing if it’s a two or three page long 
prescription and there’s controlled drugs with it etc things like that.’ [Ph2] 
The formal documentation of incident reports in relation to prescribing 
documentation was only completed by the pharmacist professional group. The 
pharmacist interviewees provided examples of reported incidents for example, 
‘One and it was for when the wrong patient label was put on a discharge 
prescription for a patient the only reason that was caught was because there 
was a problem and I had to phone up the ward to speak to a nurse to ask the 
nurse looking after the patient and went through the medicines and they said 
”Well they are not on any of that” and it came to that it was actually the 
patient in the next bed – so that’s the only one I’ve ever datixed.’[Ph1] (Datix 
is the hospital incident reporting system) 
They also highlighted the infrequency with which they formally document 
errors due to the preponderance of errors detected during their routine work. 
‘I will have done about the discharge letter – things like wrong stickies going 
on to the discharge letters ... but other wrong doses and things like that I 
don’t tend to datix them to be honest because sometimes you can have lots in 
one patient. [Ph4] (Stickies is the colloquialism for patient identification 
stickers). 
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Future aspirations with HEPMA 
The pre-implementation interviews also consisted of exploring staff 
expectations of HEPMA implementation hence TDF was less relevant at this 
stage. A tree map has been used to convey staff opinions and expectations 
about HEPMA implementation.  The tree map is provided in Figure 3.2. HEPMA 
implementation was viewed as a solution with expectations of improved 
legibility, clarity, decision support and discharge communication. 
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Figure 3.1 Tree map of nodes of future aspirations for HEPMA from all interviewees (source NVivo 10©) 
The greater the size of the rectangles, the greater the number of interviewees raised this concept with the colour of the 
rectangle depicting the number of nodes coding the sources also with dark green the most comments to red the fewest. 
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The majority of comments about HEPMA implementation were positive as 
demonstrated in Figure 3.2. Improved safety was the most frequently voiced 
hope with aspirations for discharge process system improvement. 
The comments below illustrate the similar thoughts amongst the different 
professional groups in relation to HEPMA implementation. 
‘I think it (HEPMA) will be safer, I think it will be more accurate.’ [ANP4] 
 
‘I think it (HEPMA) will make us safer and it will improve communication 
between primary and secondary care.’ [C4] 
‘I think it (HEPMA) would be a much more efficient system and safer and 
probably a lot easier to use and save probably both people on the wards and 
in the pharmacy quite a lot of time.’ [JD2] 
 
‘I think it (HEPMA) will be much safer for the patient and much safer for us...if 
you do become a prescriber it will be a much safer system as well.’ [Ph4] 
 
The ability to prescribe remotely was not viewed favourably by the ANP staff, 
which was the only professional group to raise this point as exemplified by,  
 
‘They (nursing ward staff) can get a bit annoyed that you’re not going to 
prescribe from wherever you are, for what they deem a simple thing: 
analgesia, antiemetic, things that people think are simple but are not always 
simple...I think you can get a bit pressurised to hurry up and prescribe.’ 
[ANP2]  
Another highlighted concern was about the perceived lack of individual thought 
process that might occur as outlined by, 
‘I think sometimes because it is very available, because of the dosages and 
things are there, sometimes it makes you a bit lazy so you are not really 
thinking about dosages and you are just choosing a dose within what is 
offered to you as opposed to actually you know having that knowledge in your 
head is that reasonable, is this the right drug or the wrong drug.’ [ANP2] 
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‘You probably have to be quite careful if you were starting someone on 
something that it (HEPMA) could come up with a whole range of different 
doses for somebody...you might want to be careful to pick the right dose...so 
many options you accidentally click the wrong one.’ [JD1]   
An additional expressed issue concerned adequate availability of computers to 
enable prompt access to HEPMA as described by a junior doctor, 
‘I don’t know what kind of access you would have to it whether or not it would 
be some sort of tablet at the end of everybody’s bed or it would be a computer 
per ward or a computer per bay because access could maybe be a bit tricky...if 
you had limited access to the electronic... then things might get missed 
because you might think oh that’s busy I’ll do that later and you never get 
round to doing it.’ [JD1]  
This was supported by an ANP, 
‘It should work fairly well and as long as people have got accessibility to 
laptops and computers.’ [ANP3] 
Several interviewees identified potential teething problems during HEPMA 
implementation although this was considered necessary to achieve the long-
term perceived benefits. 
‘I think initially it will be time consuming because it’s a new system that you 
have to get familiar with and again that’s going to take time but I think 
certainly once it is up and running I think it will save time in the long run with 
regards to doing the discharge scripts.’ [ANP4] 
‘The transition period is always difficult, people will be unhappy not liking it, 
need to get used to it, slow down things initially but like anything else after 
three, four months it will run smoothly and the whole process will be much 
smoother and safer.’ [C6] 
‘I think everyone is quite looking forward to having electronic prescribing...but 
it’s not perfect and we will probably have problems when we first use it but 
hopefully as we get used to the system everyone will be quite happy how it 
goes and it will lead to better care for the patients.’  [Ph5] 
127 
 
A summary of the findings from each construct within a domain is provided in 
Table 3.4 to illustrate the applicability of the TDF to the findings. 
Table 3.4 Summary of Findings from TDF 
Domain Construct Summary of Findings 
Knowledge Procedural 
knowledge 
Staff knew what to do and 
familiarity described as important 
Knowledge of task 
environment 
Limitations of documentation and 
processes described 
Skills Competence Staff mainly felt competent and ease 
of access cited as a positive factor, 
although illegibility described as 
problematic 
Practice Limitations in practice described 
especially omitted medicines  
Social/ 
professional role 
and identity 
Professional role Non – medical prescribers described 
professional aspect of prescribing 
Professional 
confidence 
All groups positive  
Beliefs about 
capabilities 
Perceived 
competence 
Anxiety described due to existing 
documentation and processes and 
concern expressed by consultants 
about junior doctors’ capabilities   
Self confidence Changes in individual practice to 
increase confidence described 
Beliefs about 
consequences 
Outcome 
expectancies 
Patient safety a major concern with 
prescribing errors reported by 
numerous interviewees 
Consequences Queries from GPs regarding missing 
or incomplete information frequently 
related to medicines were reported 
Environmental 
context and 
resource 
Resources Constraints due to documentation 
design and time pressures were 
described 
Critical incidents Incident reports only completed by 
pharmacist professional group  
 
DIFFERENCES IN KEY THEMES AMONGST PROFESSIONAL GROUPS 
The themes expressed by the different professional groups were on the whole 
consistent. Differences emerged amongst the professions in the following 
themes: 
Documentation 
The design of the existing documentation appeared to be viewed more 
favourably by the ANP staff who all had worked in the hospital for more than 
128 
 
10 years; whereas all junior doctors who had worked in the organisation for 
less than two years articulated a preference for different documentation. 
Professional Prescribing Aspects 
The non-medical prescribers (ANPs and pharmacists) articulated aspects of 
professional prescribing practice which were not discussed by the traditional 
prescribing groups (junior and consultant doctors). 
Remote prescribing 
ANPs were the only staff group to raise concerns about the ability to remote 
prescribe once HEPMA was implemented. Concern was expressed that they 
may feel pressurised by ward nurses to prescribe without prior patient review. 
Completion of incident reports 
All staff groups described problems and patient safety issues with the 
traditional paper based prescribing documentation. Pharmacists were the only 
professional group to report completion of incident reports.  
Discharge process 
The hospital consultants provided most detail regarding issues with the current 
discharge process.  
DISCUSSION OF KEY FINDINGS 
This phase of the DPP project provided an insight into the perspectives of 
hospital staff regarding the traditional paper based inpatient prescribing and 
discharge communication documentation and processes. 
The findings contribute original knowledge about the perceived benefits and 
difficulties of the traditional system as described by the various staff groups. 
The complexity of the prescribing and discharges communication process has 
been described from the users’ perspectives. The interviewees articulated a 
perceived complexity when prescribing and administering medicines using the 
current documentation. They also expressed challenges with the traditional 
discharge information communication processes. This research detected multi 
factorial contributors to adverse outcomes including legibility, documentation 
design, polypharmacy, high patient turnover and communication delays.  
The interviewees provided multiple examples of system deficiency including 
individual instances of adverse outcomes with patient hospital readmission 
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identified as a consequence of inadequate discharge information 
communication. In fact, the traditional discharge information communication 
process was described as an anachronism and insight has been gained into the 
diverse challenges faced by the varying staff groups when using these 
systems. Furthermore, contributing organisational issues were identified 
including patient flow pressures, time restrictions for task completion, and 
inconsistencies of approach despite the availability of guidelines and policies.  
Framework analysis identified initial themes whilst the application of specific 
domains of the TDF aided data analysis in relation to staff experience and 
behavioural aspects of the prescribing and discharge communication process. 
Utilisation of TDF enabled systematic identification of behavioural 
determinants to be explored. Six domains were pertinent to topics discussed 
during the interviews (knowledge, skills, social professional role and identity, 
beliefs about capabilities, beliefs about consequences, and environmental 
context and resources) and influenced the behaviour of staff working with the 
traditional prescribing and discharge communication processes.  
An exploration of hospital staff aspirations for HEPMA implementation revealed 
general optimism about the implementation benefits; with an improvement in 
patient safety the most frequently quoted expectation.  Although initial 
implementation problems were expected by the majority of interviewed staff, 
the consensus was that the ultimate benefits would exceed the initial 
disruption.  Remote prescribing and overreliance on the electronic prescribing 
system were cited as the main concerns regarding HEPMA implementation. 
The difference amongst the composition of the staff groups in relation to 
length of time that they had worked in the hospital may have influenced their 
responses. All of the junior doctors and one pharmacist had worked in the 
organisation for less than two years; whereas all advanced nurse practitioners 
(ANP) had worked in the organisation for greater than ten years. These results 
reflect what would be expected. Junior doctors by the nature of their role will 
have limited hospital work experience. Whereas, the role of an advanced nurse 
practitioner is a relatively new position and the staff recruited to these 
positions tend to have several years general nursing experience prior to 
assuming an extended role. 
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The main differences in themes described by the various professional groups 
included familiarity with traditional documentation, detailed knowledge of the 
discharge process, completion of incident reports and concern about remote 
prescribing. The difference in the majority of these themes may be attributed 
to the different roles of the various professional groups and the length of 
experience associated with the different professional groups. For example 
hospital consultants described issues with the discharge process not discussed 
by other participants which is perhaps explained by a lack of direct 
involvement by the other professional groups with the final typed document. 
Also pharmacists were the only professional group to complete incident 
reports, however under reporting of medicine incidents is a recognised 
phenomenon in the published literature (Hartnell et al. 2012). Finally, the 
ANPs thoughts about future HEPMA implementation were different from the 
other staff groups. This was perhaps because they were more informed about 
HEPMA due to discussions with ANP colleagues familiar with HEPMA use at 
UHA and because of limited personal HEPMA exposure. They were the only 
staff group to express concerns about remote prescribing and feeling 
pressurised to prescribe in an unsafe manner due to the availability of 
technology.  
Patient safety was the primary concern for all staff groups with traditional 
paper based systems. The interviewees were knowledgeable about existing 
documentation; did not claim lack of training as an issue and described 
individual processes devised to overcome identified challenges. GP queries 
regarding discharge communication occurred frequently and query resolution 
took time. Pharmacists uniquely reported formal incidents relating to medicine 
prescribing systems with lack of time cited as an inhibitor to further reporting. 
HEPMA implementation was viewed favourably with an improvement in patient 
safety the most anticipated outcome. 
Strengths and weaknesses  
The strength of this research included adoption of a rigorous approach in 
relation to study design to minimise design bias. A rigorous approach was 
utilised as described previously to ensure trustworthiness for this qualitative 
study. Additional bias was minimised by adopting the principles recommended 
by Shuttleworth and Bowling as outlined in Chapter 2 (Bowling  2014, 
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Shuttleworth 2009). Sampling bias was minimised by using stratified 
purposive sampling which is a recognised sampling method for this study type 
as described earlier. 
The role of the PI (interviewer bias) may have influenced interviewees’ 
responses (response bias) but the consistency in replies throughout the study 
would suggest that staff felt comfortable to answer honestly. The interviews 
were audio recorded and transcribed verbatim to minimise reporter bias in 
relation to recorded information accuracy. 
The PI was a novice at conducting semi-structured interviews and completing 
framework qualitative analysis. Therefore there was a possibility of introducing 
researcher interpretation bias. This was minimised by verification of analysis 
by the university supervisors who were external to the hospital. 
Weaknesses include the relatively small sample of staff interviewed which 
limits the applicability of these results to other organisations. Additionally, the 
difference in experience of the varying professional groups may have coloured 
their knowledge and hence responses about certain aspects of the studied 
processes. 
Interpretation of the data 
Key findings identified in the narrative literature review (Chapter 1) in studies 
solely investigating traditional communication methods were information 
content and accuracy, medicine information accuracy, legibility, time to GP 
receipt and patient harm.   
Deficiencies in information on the IDL were described by interviewees which 
was identified by Wilson et al and Foster et al (Wilson et al. 2001, Foster, 
Paterson and Fairfield 2002). Information accuracy was also described as 
problematic which is consistent with published literature of Wilson et al, 
Grimes et al and Witherington et al (Wilson et al. 2001, Grimes et al. 2011, 
Witherington, Pirzada and Avery 2008). 
Missing medicine information was highlighted as a concern; especially only 
new medicines prescribed on the discharge letter which is consistent with 
Wilson et al stating that 21% of letters had no medicines information recorded 
(Wilson et al. 2001). Receipt of GP queries by the majority of interviewees 
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confirmed information accuracy problems as highlighted by Wilson et al, Foster 
et al and Witherington et al (Wilson et al. 2001, Foster, Paterson and Fairfield 
2002, Witherington, Pirzada and Avery 2008). 
Several interviewees cited legibility as a problem which was described by both 
Wilson et al and Foster et al (Wilson et al. 2001, Foster, Paterson and Fairfield 
2002). 
Interviewees opined that final discharge letter preparation may be delayed by 
several months which is consistent with Foster et al, who identified delays in 
preparation of the FL (Foster, Paterson and Fairfield 2002); whilst 
Witherington et al stated that 62% of FL were not completed on patients 
hospital readmission (Witherington, Pirzada and Avery 2008). 
Hospital readmissions due to deficiencies in information communication were 
described by interviewees and this is supported by McMillan et al who 
identified a rate of 1.8% of readmissions due to this problem (McMillan, Allan 
and Black 2006). 
Interviewees intimated that HEPMA implementation may result in different 
error types which are supported by Abdel-Qader et al who identified 
sociotechnical errors related to the electronic system (Abdel-Qader et al. 
2010). 
Unique findings 
This study uniquely obtained hospital staff opinion about the existing 
prescribing and discharge communication systems prior to HEPMA 
implementation and explored their future aspirations for its implementation. 
Patient safety improvement was the major aspiration for HEPMA 
implementation. Despite this, some interviewees identified potential patient 
safety problems with HEPMA implementation including sociotechnical errors 
which were described by Abdel-Qader et al (Abdel-Qader et al. 2010).  
Therefore, these findings support the requirement to complete the planned 
post- HEPMA implementation evaluation and especially its impact on patient 
safety.  
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The mixed methods methodology of this DPP project permitted comparison of 
these findings with results obtained from the quantitative project component. 
This will be discussed in a later chapter. 
Clinical Governance  
The reported findings are consistent with known incidents reported through 
the health board incident reporting system. No additional clinical governance 
issues were raised that required action by the PI. 
Further work 
A later phase of the DPP project re-examined staff views and opinions in 
context with the identified behavioural aspects of the TDF six months post 
HEPMA implementation and is provided in Chapter 4. 
CHAPTER SUMMARY 
This chapter described the aim and research questions for the pre-
implementation interview phase of the DPP project. A description of the 
methods used was provided with a particular focus on findings and discussion 
of findings. 
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CHAPTER 4 POST-IMPLEMENTATION INTERVIEWS 
CHAPTER INTRODUCTION 
This chapter describes the aim and research questions for the post-
implementation qualitative interview phase of the DPP, and provides the 
findings and discussion of findings. 
AIM 
The aim of this phase of the project was to describe and understand the 
perspectives of key staff groups (i.e. consultant doctors, junior doctors, 
pharmacists and advanced nurse practitioners) relating to patient discharge 
communication via the recently implemented HEPMA system. 
OBJECTIVES 
1. To describe and understand staff views and experiences of the HEPMA 
system 
2. To explore behaviours and behavioural determinants in relation to 
HEPMA implementation 
3. To highlight any differences in key themes identified amongst the 
different professional groups 
QUALITATIVE STUDY DESIGN 
This phase of research employed a qualitative methodology, as outlined in 
Chapter 3. 
Methodology and method 
This phase used interpretative phenomenology to fully describe and 
understand the perspective of staff groups involved in discharge 
communication using the HEPMA system. As outlined in Chapter 3, the 
selected method was semi-structured face to face interviews which were 
planned to be undertaken six months after completion of HEPMA 
implementation.  
Interviews conducted following this time interval to provide focus on the actual 
performance of the new prescribing and administration system and not on the 
immediate implementation with incipient change factor issues.  
The change process involves creating the change, implementation and 
sustainment of change. Lewin’s seminal work on action research described this 
stepped process (“unfreeze, change, refreeze”) as essential to ensure a 
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permanent change (Lewin  1947). Furthermore, the change curve developed 
from Kubler- Ross’s grief model depicts how performance is impacted by the 
change over time (Kubler-Ross  1970).  An illustration of the change curve is 
provided in Figure 4.1. This clearly illustrates the importance of leaving 
sufficient time for the intervention to be accepted into practice before  any 
meaningful measurement may be assessed. 
 
Figure 4.1 Change curve adapted from Kubler-Ross grief curve 
Interview format 
The interview was guided by the use of a semi-structured interview schedule, 
as described in Chapter 3. 
Interview schedule 
The interview schedule is provided in Appendix 4.1. The questions were 
developed after completion of the pre-implementation interviews. The 
interview schedule was similar in layout to the schedule described in Chapter 3 
and required gathering information which included: the code number of the 
participant (rather than name to maintain anonymity); interview date; and 
start and stop time of interview (enabled calculation of interview duration). 
Demographic information was included in the initial section of the semi-
structured interview schedule. 
The schedule consisted of five main components: inpatient prescribing; 
discharge prescribing; discharge letter process; incident reports and significant 
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adverse event reviews; and general opinion about HEPMA. Questions about 
both inpatient and discharge prescribing were included because any 
prescribing errors present on the inpatient prescription chart may be 
transferred to the discharge letter. Confirmation of the initial interview topic 
guide was achieved by review from the university supervisory team. 
Interview Pilot 
The confirmed interview schedule was pilot tested by the PI (PI) with a senior 
pharmacist, allowing any identified deficiencies to be rectified before 
commencement of the participant interviews. The pilot interview enabled the 
PI to ensure that the questions permitted the participant to speak freely and 
tested the ability of the investigator to formulate probing questions. Feedback 
from the pilot participant was positive and no amendments were made to the 
interview schedule. Furthermore, the pilot lasted just under 22 minutes, within 
the planned 20 to 30 minutes. The pilot interview was excluded from data 
analysis. 
Sampling 
The sampling approach was consistent with the purposive stratified sampling 
approach as described in Chapter 3. 
Inclusion and exclusion criteria 
To be included in the sample, the individual had to be a member of the 
identified staff groups currently working at UHC and involved in the discharge 
communication process. The identified staff groups consisted of consultant 
medical staff, junior medical staff, advance nurse practitioners and 
pharmacists. Staff were excluded if currently working at UHA. It was aimed to 
recruit a diverse sample in terms of the criteria outlined in Chapter 3 and the 
number of eligible members of each professional group is provided in Chapter 
3. Wherever possible, staff interviewed in the pre-implementation phase were 
re-interviewed which was included in the pre-implementation consent 
procedure. Inevitably it was impossible to re-interview all staff due to 
turnover; either staff leaving the organisation or on special leave.  
Sample Size 
To achieve total population data saturation, as described in Chapter 3, it was 
anticipated prior to starting the interviews that a sample of five to six 
members of each professional group would be sufficient. Likewise, fewer or 
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additional interviews would be conducted to achieve overall data saturation as 
described in Chapter 3. 
Recruitment 
Service leads were again contacted as described in Chapter 3 to nominate 
individual staff members from their jurisdiction. The PI invited the nominees 
by e-mail to participate in the study. The e-mail invitation is provided in 
Appendix 4.2. One ANP declined to participate because she was not involved in 
discharge communication. 
Participant Information and Informed Consent 
Participant information and informed consent was identical to the process in 
Chapter 3. Every interviewee was provided with a participant information 
sheet (Appendix 4.3) by the PI and asked to sign an informed consent form 
(Appendix 4.4) if agreed to be included in the study. The investigator obtained 
a signed copy of the consent form on the day of interview. 
Interview Procedure 
The interview procedure was as outlined in Chapter 3. The interviews were 
planned to commence six months after final completion of HEPMA 
implementation. Once again, the PI conducted all face-to-face interviews at a 
location and time convenient to the interviewee. The interview locations were 
either the interviewee’s private office or a private room located in the 
pharmacy department of UHC. No interviews were conducted in public spaces. 
The interviews were completed during April to June 2015. 
Data Analysis 
Data analysis was as described in Chapter 3 and utilised the framework 
approach and application of TDF behavioural determinants. 
FINDINGS 
Interviewed Staff 
A total of 19 staff members were interviewed from the 24 that agreed to be 
interviewed. Five staff were not interviewed: three ANPs and two junior 
doctors as total population data saturation had been achieved. A few 
interviews needed to be rescheduled due to service pressures; one consultant, 
one junior doctor and one pharmacist. One of the nominated ANPs was 
ineligible for interview as was not involved in discharge communication. 
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Demographic details of the interviewees are provided in Table 4.2. The PI 
experienced the greatest difficulty in scheduling interviews for ANPs. The 
hospital was experiencing high patient volumes and service pressures which 
resulted in difficulty freeing up staff time. This was resolved by re-contacting 
the ANP service lead to ask for assistance. The interview length ranged from 
10 minutes to 45 minutes; with a median of 19 minutes.  All interviewees 
were familiar with and regularly “used” the HEPMA system. The interview 
phase was completed when total population data saturation was achieved 
which accounts for the difference in numbers interviewed amongst the 
professional groups. 
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Table 4.1 Interviewee demographics 
Advanced Nurse 
Practitioner 
Gender Years worked at UHC 
1 F 23 
2 F 15 
3 F 6 
Consultant Medical Gender Years worked at UHC 
1 M 2 
2 M 2.5 
3 M 12 
4 M 17 
5 F 7 
6 M 10 
Junior Medical Gender Years worked at UHC 
1 F < 1 year 
2 F < 1 year 
3 M < 1 year 
4 F <1 year 
Pharmacist Gender Years worked at UHC 
1 M 4.5 
2 F 6.5 
3 F 10 
4 F 6 
5 M 8 
6 F 12 
 
Framework Analysis Results 
Initially 14 free nodes (as defined in Chapter3) were created including 
experiences with HEPMA electronic inpatient charts, immediate discharge 
letters, the discharge letter process, patient safety and incidents and adverse 
events. 
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Staff Experience 
The interviewees described their experiences with the newly implemented 
HEPMA system. Mainly positive experiences were articulated with suggestions 
for minor system improvement as outlined by one pharmacist as, 
‘I am a big fan of the system. I think it is really good and I do think it 
improves like prescribing and administration of drugs for the patients. It’s not 
a perfect system there are things that we would like to tweak…’ [PH4] 
 
Whilst a consultant summarised the benefits as, 
 
‘I think there are lots of advantages in term of efficiency, in terms of access, 
in terms of safer prescribing…I think it is a fantastic innovation for Crosshouse’ 
[C6] 
 
Positive thoughts included predictive functionality when prescribing. As one 
consultant stated, 
‘I think it is quicker and it’s easier to fill out a HEPMA chart than it is to write 
the kardex, particularly once you are used to the system with the kind of 
predictive element of the prescribing’ [C1] 
 
Availability to additional information was also viewed favourably, 
 
‘I like you can get the information about the medication on the system as well 
I think yeah from a prescribing point of view, I think it works really well’ [JD2] 
 
A positive HEPMA prescribing experience was discussed by a junior doctor as, 
 
‘I think it works rather well – really basic things like it helps with spelling a lot 
of the drugs. It gives you baseline doses…..in terms of prescribing yeah I think 
it’s very good yeah’ [JD1] 
 
Viewing the inpatient chart was described as improved especially the ability to 
easily read the prescribed medicines as discussed by one consultant as,  
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‘So first of all it’s amazing compared to paper prescription charts because it’s 
legible. There’s no problem like reading the actual medications...it’s all on one 
sheet even if there are 30 medication you might have to scroll down a little bit 
rather than turning 10 pages’ [C2] 
 
The ability to suspend medicines was mentioned positively by all professional 
groups, as outlined by one junior doctor, 
 
‘in terms of suspending medications.......it’s just quite clear which medicines 
are suspended and which aren’t. You can be confident if you suspend 
something electronically that it is not going to be given inadvertently which is 
good.’  [JD3] 
 
IDL improvement was remarked upon by the majority of interviewees,  
 
‘It’s just the quality of the letters that are coming out now, is far better than 
what we had before with the handwritten prescriptions particularly the clinical 
information, much more detailed and will be much better for the GP.’ [C1] 
 
Working practice changes to facilitate improvements to this communication 
were outlined by one consultant as, 
 
 ‘We’ve worked very hard with the juniors to try and populate it properly so 
that it is actually a complete record of what has happened, and then obviously 
try to use that as a first and final discharge letter.’ [C5]  
 
Pharmacists described inputting additional information to IDLs which would 
have been virtually impossible with the paper version, 
‘It’s got a section for pharmacy...today I was doing someone’s discharge and I 
wrote to the GP to say digoxin and the bisoprolol were stopped because they 
were bradycardic on admission, heart rate currently is ok so it’s not been 
restarted...there was no space on the previous system to write all that 
information you could try and squeeze it in...I can write in a bit more depth 
and he or she knows it coming from the pharmacist’ [PH2] 
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There was a stated expectation that electronic systems for prescribing would 
currently be available in healthcare as a junior doctor said, 
 
‘I think that it’s reasonable to assume that we are going to have an electronic 
system for prescribing, like we are definitely at that time.’ [JD1] 
 
Nevertheless, interviewees recognised HEPMA limitations, with allergy 
recording an especially highlighted issue as described by this comment, 
 
‘Difficult, hugely difficult trying to type quickly enough to get the drug in and 
knowing which column to put it in….the recorded what kind of allergy it is then 
you don’t always have the right option or even anything close to it…it’s very 
un.. user unfriendly’ [PH4] 
 
Unsurprisingly staff described initial problems using the system which were 
resolved with familiarisation as described by one ANP as,  
‘it took a while to get the used to the system but now that I’ve become a lot 
more familiar with it I think definitely prescribing, inputting the data is 
certainly a lot quicker and a lot clearer’ [ANP2] 
Staff behavioural determinants 
The TDF was used to identify behavioural determinants of the interviewees in 
relation to HEPMA use post implementation. In the pre-implementation phase 
only six of the 14 domains of the TDF were applicable to discussion topics 
identified during review of the interview transcripts. A further two domains 
were applicable to discussion topics raised during the post-implementation 
interviews. The relevant domains and associated constructs are depicted in 
Figure 4.2. While there is a difference in terminology with TDF referring to 
constructs and NVivo to nodes, these are now described as themes. The initial 
domains are depicted in blue with the new domains in green.  
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Figure 4.2 TDF Domains and associated constructs mapped to interview finding
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Theoretical Domains 
Knowledge domain 
All interviewees described HEPMA knowledge and processes for inpatient 
prescribing. One consultant described the requirement of completion of allergy 
information prior to prescribing medicines and ability to view allergy 
information as, 
‘…when you are trying to prescribe medication it won’t allow you to go any 
further until you’ve prescribed the allergy…or you’ve mentioned the allergy 
status and obviously when you are trying to prescribe your new medication 
obviously allergy status is at the top of your prescriptions and it’s quite legible 
and clear.’ [C2] 
Another consultant described how the system facilitated prescribing of 
medicines with the available menu choices as, 
 
‘Yeah I think the kind of drop down options…you usually find everything that 
you want...to input the individual times that seems fairly straight forward even 
if you need to do that for Parkinson’s medicines or anything’  [C1] 
 
Whilst a further consultant highlighted the ability to know what had happened 
with a particular medicine, 
 
‘If you have the drug prescribed you can follow them up through the 
admission- so you know what was stopped, what was withheld...I can actually 
track any medication when it was stopped and who stopped it.’ [C4] 
 
The ability to view additional medicine related information via the system was 
described as, 
 
‘You have linked with the prescribing any potential contra-indications, allergies 
the patient might have to the drugs. You can obtain information about side-
effects relatively quickly…it is a much more efficient system of prescribing and 
provision of information...you can all do it on-line’ [C6] 
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The viewing of the medicine administration records was described by a 
pharmacist as, 
 
‘it’s a simple process…you can just  look up charting or administration then to 
see whether or not the patient’s had their medication you can actually just 
look to see for a prn it tells you whether they have had some doses or none at 
all...or the reason that they didn’t have it.’  [PH5] 
 
The creation and information on the IDL was described by interviewees as, 
 
 ‘you have plenty of space to write down all the information for the GP so not 
just about the diagnosis …you can update clinical information…if you’ve had to 
make any changes to their medication, they can see it listed down below and 
they can see when you’ve changed it and why you’ve changed it…’ [ANP1] 
 
‘it gives the option for the doctors to write exactly what’s happened 
throughout the patient journey in hospital…medications that have been 
stopped again it gives you the allergy status it gives you all these things it 
tells you whether or not if patients got their own medication all these things if 
GPs should continue it or not so again it’s very clear.’ [PH5] 
 
The interviewees described more sophisticated system use learned over time 
as described by, 
 
‘It’s only more recently that I’ve known you can look back to see what meds 
patients are discharged on if they have been in an admission before…I’ve 
learned how to look on the admin charts and things and I use that quite 
frequently especially when it comes to things like pain relief meds to see how 
much pain relief someone is requiring’ [JD1] 
 
‘It’s very useful…to have things like details of Blister Packs, details of level 3 
MAR that kind of transfer from one admission to the next so you’re not 
constantly hunting for that information.’  [PH3] 
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Interviewees confirmed sufficient training prior to system use as described by 
a junior doctor as, 
 
‘I thought the training was good…’ [JD4] 
Skills domain 
Interviewees tended to express themselves as skillful HEPMA system users. A 
junior doctor described their general prescribing ability as, 
‘Yeah no I think that I can do it (prescribe on HEPMA) quite well- I don’t have 
any issues’ [JD1] 
 
Whereas, a pharmacist articulated in-depth skills and described sophisticated 
system use, 
 
‘I feel I can use it quite well, the system, I know how to like modify things, 
and can suspend things and resume them...I am probably better at using 
HEPMA than the doctors are and I know more of the functions, I’m like oh you 
can do this, and I can tell them information’ [PH2] 
 
One ANP highlighted how to communicated information using the system, 
 
 ‘So you can put a note in and also things like high dose dalteparin until their 
INR is therapeutic and things like that you can put all that information in’ 
[ANP1] 
 
Junior doctors, pharmacists and ANPs mostly claimed to be skillful system 
users as described by this junior doctor, 
 
‘Yeah I find that (prescribing medicines) quite simple, quite straight forward’ 
[JD3] 
Whereas consultant doctors described varying abilities with some describing 
routine skills for inpatient prescribing, 
 
147 
 
‘Yeah I mean it is quite easy so it gives you the choices or whatever. So when 
you type the name it gives you the doses for the administration so it’s quite 
straight forward’ [C4] 
 
And discharge prescribing, 
 
‘on the discharge letter is quite easy all you do is tick the boxes which takes it 
on to the discharge prescription’ [C2] 
 
Whilst another stated he didn’t use the system for prescribing at all, 
 
‘My skills are probably limited because I don’t do it.’  [C3] 
Social/professional role and identity domain 
HEPMA implementation was reported to have impacted professional roles to a 
varying degree, as described by certain individuals feeling more confident in 
their professional role. Increased job satisfaction and changes in role that had 
occurred as a result of HEPMA implementation were apparent,  
 
‘Certainly it’s made me feel like I’m doing a better job, so I get more job 
satisfaction…it does allow you to have that kind of slightly different level of 
you know professional status’  [ANP1] 
 
 
‘I’m still fulfilling the same role, probably just better than we were before 
yeah’ [JD3] 
 
‘I think probably I’m writing much more on the discharge letters than maybe I 
would have done previously, maybe prescribing a bit more than previously. I 
don’t know if that’s the system or just the confidence...I think it has had a 
positive impact on the pharmacy profession’ [PH6] 
 
‘I think I spend less time on formal discharge summaries I think that it allows 
us as a team to get much better information into the GP earlier...’ [C1] 
 
Although one consultant considered HEPMA implementation to have a negative 
impact on the medical profession, 
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‘It has increased the administrative time for prescribing on the medical 
profession, particularly those at foundation level’ [C3] 
 
Despite described changes to the discharge letter process there was still no 
progress to consultants signing off and reviewing the IDL but more consultant 
input to IDL was mentioned,  
‘…generating this document is also an integral part of the ward round now, 
where previously that was done by the junior medical staff at the end of an 
admission without our input at all, so we have some input into the generation 
of this document collaboratively with the junior staff and potentially with allied 
healthcare professionals so that makes it much more real and actually at the 
time when the patient case you are dealing with is still very fresh in your 
mind. So it is pretty real time way of generating a document.’ [C6] 
 
When asked if the consultants have changed their processes to input into the 
creation the IDL, one junior doctor replied,  
 
‘One of our consultant does, the other two don’t bother’ [JD2] 
 
Furthermore, some consultant teams had not changed their processes at all as 
described by one ANP, 
‘The consultants are doing exactly the same process. I mean they’ve been in 
with the bricks and mortar. They are not going to change anything with the 
electronic system.’  [ANP1] 
Improvements to clinical governance by having a clear audit trail were also 
highlighted as advantageous as mentioned by one consultant, 
 
‘I mean I guess just in terms of governance knowing who has prescribed what 
and when is good to know.’ [C5] 
Beliefs about capability domain 
Feeling competent at inpatient prescribing and discharge communication was 
outlined by this range of interviewees, 
‘Yeah absolutely confident I don’t have any issues with most of the stuff’ 
[ANP1] 
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‘Yeah for prescribing things no problem......Yeah I’m pretty confident now’ 
[JD1] 
 
‘I would say that I was reasonably skillful...very competent’ [PH5] 
 
An increase in confidence in prescribing by use of the HEPMA system was 
mentioned by several interviewees 
‘Probably I think my confidence has improved to prescribing and I think that is 
because I know there is a bit of a safety back up with it’ [ANP1] 
 
The exception was consultant medical staff who tended to have more limited 
use and therefore described themselves as being less competent. As one 
consultant stated, 
‘My skills are in the early stages I would say, as I rely very much on the junior 
staff. So we do it together you know, the juniors, you know, staff does it 
because they are so much quicker and slicker than I am, so my skills are in 
the early stages I would say.’ [C6] 
Beliefs about consequences domain 
This theme produced the greatest number of comments and therefore to aid 
communication of the findings, sub-themes have been included in this section. 
Patient safety 
Prior to HEPMA implementation, patient safety improvement was the biggest 
aspiration and this was articulated by interviewees from all professions, 
 
‘Compared to what we did with paper it’s just night and day for patient safety’ 
[ANP1] 
 
‘it’s definitely safer than the paper prescription chart’ [C2] 
 
‘I think it’s definitely made a huge difference, a huge improvement in patient 
safety.’ [PH6] 
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‘In terms of adverse events once people have gone home it might well have 
had an impact on reducing them because of better information’ [JD3] 
IDL quality 
Improvements to the quality of the IDL were frequently cited as a 
consequence of HEPMA implementation as mentioned, 
‘the quality of the discharge prescription has improved because the doctors 
now use it as a letter to the GP and they start it off by writing dear doctor this 
patient was admitted with blah blah blah and it’s much, much better as 
opposed to just the one word lines that they were putting in on the 
handwritten discharge letter so I think GPs are getting a lot more information. 
It’s much easier for the doctors to put in all the medicines that the patient 
came in on so they are more complete now’ [PH4] 
 
First and final communication 
The move to making the IDL the first and final discharge was also described as 
a consequence of HEPMA implementation as articulated by one consultant, 
‘the move to having the IDL as the principal discharge document, whereas I 
felt before that it was the final discharge summary that contained most of the 
important information and now the final letter is just you know yeah nothing 
more to add you know kind of just to ensure the GP is aware that we have 
chased up appropriate investigations…’ [C1] 
GP information 
The quicker availability of more detailed discharge information for GPs was 
thought to be positive, 
‘the GP is getting a copy of the discharge letter much quicker and they don’t 
have to wait for the final discharge letter so it allows for a good seamless 
process in terms of patient care’ [PH5] 
HEPMA engagement 
An apparent failure by certain consultant medical staff to engage with HEPMA 
was described and this behavior influenced the junior doctor’s perceived 
pressure when prescribing medicines, 
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‘Well some consultants don’t even use it all – some consultants won’t touch it 
because they don’t understand how it works – they don’t like it...it leaves a lot 
of responsibility for the junior members of staff to sort out the medications 
and it is reliant on just verbal communication from senior doctors telling them 
to adjust things’ [JD1] 
GP queries 
The impact on GP queries was variably described as either having no impact or 
causing a decrease in calls, 
‘It is not any more than the previous system, so about some medication that 
was missed’ [C4] 
‘I’ve had probably one or two queries in the entire time it’s been up and that 
would be all because you are able to put so much more information down. We 
used to have frequently so maybe 2 or 3 phone calls per week from GPs about 
things.’ [ANP1] 
Remote prescribing 
Remote access to the system was also seen as a positive consequence, 
‘anyone dealing with a patient can access the prescription chart...wherever 
they are in the hospital which I think again is a big advantage to check a 
prescription if you are in a clinic or elsewhere make sure it’s correct or change 
it if need be...’[C6] 
HEPMA new error types 
New error types were suggested to have occurred due to HEPMA 
implementation as described by these interviewees, 
‘The drop down boxes it’s very easy for them to pick the first one that comes 
up when they choose a drug and they don’t actually scroll down to find the 
correct form for the drug…so it’s a different type of error’ [PH3] 
 
‘it’s quite easy to type, if you are working quite quickly on a ward round for 
example it’s quite easy to type an incorrect drug, to type the drug name and 
get an incorrect concentration, or  incorrect tablet’ [JD3]  
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Prescriber identification 
An identified concern was failure to update the prescriber identification for 
completion of the discharge document when different staff added information 
as outlined, 
 
 ‘Sometimes you phone up the doctor whose name is on the bottom of the 
prescription to ask about a query...and they don’t know...I think when one 
doctor starts to formulate it and they don’t complete it and another doctor 
comes and adds in to it there’s not really anyway of identifying... ‘[PH1] 
Discontinue/suspend information 
Reasons for stopping or suspending medicines were not considered to be fully 
adequate as described by a pharmacist as, 
‘Sometimes the reason for withholding them (medicines) doesn’t just fall into 
the reasons that are there’ [PH4] 
Electronic limitations 
Interviewees described frustrations due to the electronic nature of the system, 
 
‘The nurses can’t give medications because they’ve missed it by a minute and 
then you need to…prescribe a stat dose because it’s not the right time 
whereas I suppose if it was a paper kardex they could just give it…’ [JD2] 
Insufficient section space 
The clinical progress section of the IDL was highlighted as having insufficient 
space as described by one junior doctor as, 
 
‘the character limit we have at the moment is quite limiting often...you would 
actually want to write more but you are limited as to what you can write by 
the character limit’ [JD3] 
Electronic transmission 
Whilst a failure to move to a completely electronic IDL system with electronic 
transmission to pharmacy was described as annoying by one consultant as, 
 
‘…why some wards have to print it out, it goes in a dooket to get somebody to 
take it down to pharmacy…when we are trying to get people home from 
hospital earlier in the day’ [C3] 
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Educational impact  
A junior doctor expressed concern that HEPMA implementation may impact on 
their education as, 
 
‘As a junior, I think that will probably, will definitely impinge on my learning so 
if that I have an electronic system taken away from me at a later stage then I 
may not know the doses of some basic drugs just because I become so used 
to it telling me automatically’  [JD1] 
 
Rotation to non- electronic prescribing area 
Whilst another expressed anxiety having to revert to paper prescribing 
systems in their next work placement, 
 
‘I’m going to work in (place name obscured) next year and I’m a bit 
apprehensive about going back to using a kardex.’ [JD2] 
 
Dispensing process impact 
Pharmacists indicated that changes to the IDL dispensing processes impacted 
workload and time as these pharmacists describe, 
 
‘very time consuming for validation…then you have to print 3 copies off again 
make sure it’s (IDL) got its watermark on it’ [PH2]  
 
‘You have to go in and do all the verification on the computer and then print it 
(IDL) off – it definitely slows you down- it almost doubles your time to do a 
prescription from a validation point of view.’ [PH1] 
Improvement suggestions 
Examples of some suggestions for HEPMA improvement as recommended by 
the interviewees are provided. 
 
System integration would be welcomed as described, 
 
‘I think HEPMA requires to have the ability to pull in primary care prescribing 
data...it would reduce transcribing errors. It would allow people to temporarily 
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suspend and hopefully comment on why they had suspended medications and 
it would just cut risk being more time efficient.’ [C3] 
 
‘I would really like to see everything integrated that would be ideal to open up 
a system and click that button you get drugs, click that button you get blood 
results and you don’t have to log in and out of everything- so that would be 
my dream.’ [C5] 
 
Possible improvements to the creation of the discharge letter were articulated, 
 
‘when you are going into Patient’s own, so if there is a whole host of medicines 
it is quite time consuming to go through them all and click which one’s the 
patient has and doesn’t have and I think it would be quite useful to have a 
little chart that you could select all and then deselect the ones that are the 
new prescriptions to start.’ [JD4] 
 
‘If they had like something easier, like if you put someone’s Blister Pack like it 
automatically put on 7 days and we don’t then have to change the quantity of 
everything ourselves’ [PH2] 
 
The ability to electronically transmit the IDL would also be welcomed, 
 
 ‘I find very difficult to know whether or not it’s (the IDL) gone because there 
is no way of knowing if it was handed to the patient, put in the post you’ve got 
no way of knowing or not whether the GP has got it so we’re assuming the 
GPs have these things but maybe they don’t. Maybe we could move to an 
electronic delivery of those so we would know it’s gone and you would have a 
record’ [C5] 
Environmental context and resources domain 
The design and layout of both the HEPMA inpatient and discharge sections was 
commonly viewed favourably, 
‘you can see what the patient is on and what has been discontinued’ [C4] 
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 ‘The layout is very good and I like the box at the bottom of the discharge 
where it gives you the discontinued drugs and why they have been 
discontinued’ [PH3] 
Although the ability to alter the medication according to the prescribed route 
would be a suggested enhancement as outlined by a junior doctor, 
‘I don’t think it is very clear when you are looking at the drug chart of 
everything that patient is on as to which drugs are oral, which drugs are 
intravenous and sometimes I’ve seen myself miss the route and assume that 
an antibiotic for example was intravenous and then it turns out actually it’s 
oral.’ [JD4] 
 
General computer login was described as slow and additional ward computer 
equipment would be welcomed, although pharmacists were provided with 
laptops. 
‘invariably it should only take you 10 or 20 seconds they say to log in but 
invariably it takes longer than three or four minutes and it’s quite frustrating’ 
[ANP1] 
 ‘There’s certain wards there’s a lack of computers and it can take a while to 
log in and then that adds time to the process…and I think that is peoples 
major frustration with it – not the system itself  but access to it’ [C1] 
 
‘well, I’ve got my own laptop so it makes it easier…there are laptops spread 
throughout the wards but quite often they are getting used by nursing and 
medical staff so it can make it more difficult to get on to it’ [PH5] 
 
‘sometimes when the nurses are all doing their drugs and stuff it can be 
difficult to get access to a computer or access to the medications because 
they’re on them as well’  [JD2] 
 
Multiple user access to the same patient file is system prevented which was 
described as beneficial by a pharmacist as, 
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‘it’s good that only one person can be in it at a time because if we’re on the 
ward round and change stuff and the nurses are trying to administer it then 
we might be changing it when they are administering it so obviously from a 
safety point that’s good’ [PH4] 
 
Whilst other interviewees described failure to gain access as problematic, 
 
‘A big disadvantage is that it’s not on every desktop...it can take a while to log 
in...when you are on the ward round and when you quickly need to access a 
patient’s current drug history again logging in and out the system...in a 
cardiac arrest situation when you want a quick access someone has to run and 
get a laptop and then if it hasn’t been charged...’ [ANP2] 
 
Poor battery life of laptops described as, 
 
‘the laptops especially run out of battery and you’re right in the middle of a 
patient entry you’ve got to wait 15 minutes for it to log you out automatically 
before you can access the patient information again and get back in’ [ANP1] 
 
Also issues in relation to printers and malfunction of printers was highlighted 
as described by a junior doctor as, 
‘As long as your printer is working it’s fine but I’ve had quite a lot of times 
when the printers not been working and you can’t get it printed anywhere. It’s 
actually probably more of a printer issue than an e-prescribing issue – printers 
seem to break all the time.’ [JD2] 
Integration of the different organisational computer systems was identified as 
problematic by several interviewees as described by one junior doctor, 
 
‘one of the things that’s annoying about it is that the nurses... sometimes 
people go home and they take them off the system before you’ve actually 
done the letter and I now know how to put them back on but I didn’t used to 
before and it was a big hassle’  [JD2] 
 
Whilst another doctor described the difficulty of patient flow exacerbated by 
the technology interplay as, 
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‘having to admit patients into A&E waiting areas before they come up here – it 
seems more time consuming whereas if you were doing a paper copy 
downstairs it would come up with the patient….I find it difficult and I think it 
would be better if there was better access to it (HEPMA) in all departments’ 
[JD4] 
 
None of the interviewees had completed a formal incident report regarding 
HEPMA since implementation and the consensus was that incidents and 
adverse events were reduced. Formal evidence to support this claim could not 
be provided as described by one consultant as, 
‘I would guess and I can’t back it up with any figures that it actually has 
improved the number of incidents and adverse events’ [C6] 
Social influences domain 
Social pressures to change working practices were described although group 
conformity was not achieved as described by these doctors, 
‘Yeah I know other consultants are less comfortable with it, but having used it 
before…it took me a week or two and then I was back up to speed with it.’ 
[C1] 
 
‘I will ask my junior staff to do it. The role of a consultant is to produce 
oversight...so I would tend to defer the prescribing to the junior member of 
staff who is with us.’ [C3] 
 
‘Probably a lot less consultant prescribing because they don’t know how to 
work it .... no not all of them, the younger ones can deal with it but a lot of 
the older ones.. so you will get called on an on-call shift to say doctor such 
and such has been to see this patient and he’s suggested these medications 
but he can’t work the prescribing so can you come and put them on...’ [JD2] 
 
Variability in how different teams working within the hospital was articulated, 
‘I think it varies a lot between different departments. Certainly, I think a lot of 
the departments in medicine are gearing more towards the IDL being the main 
discharge letter...’ [JD1] 
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Pressure on ANPs and junior doctors to complete sufficient IDL information 
was considered to be an issue, 
‘I think it is more time consuming for the junior doctors and that is one 
drawback and there are a number of demands on their time and everything is 
a priority….so I think that’s a barrier to producing good letters even though 
the system allows you to produce much better letters and I think sometimes 
the juniors feel under a bit of pressure to get them done in good time but also 
have the degree of information we’re looking for on them.’ [C1] 
 
‘We are using the HEPMA IDL as a first and final discharge letter. It’s very time 
consuming for us...some days...you are discharging ten patients at a time so 
theoretically you really need somebody purely on scripts the full day because 
some of our patients have been in for six weeks and to try and summarise 
that adequately’ [ANP2] 
 
‘it actually probably delays the discharges a bit from our team because it 
obviously takes us a longer amount of time to go through the notes and write 
all that down whereas...when I started you could kind of quickly... jot it down 
on the ward round and get it in the box to go down…I think it is more difficult 
to do when you are on ward rounds because the consultant will be asking to 
look at the bloods, you’ve got the prescribing open trying to do the discharge 
letter so it might be that more discharges are in the afternoon because of the 
amount of detail but the GP gets more information quicker’ [JD2] 
Behavioural regulation domain  
The potential for HEPMA system errors to occur was raised by several 
interviewees and they described actions to avert these.  
‘I think as with any kind of prescribing and checking of anything you’ve got to 
get into your own system of checking things and if I prescribe I go back and 
double check it straight after and yeah I do find the occasional mistake when 
I’ve put in the wrong strength or put in the wrong frequency but I’ll go and 
change that right there and then’ [PH3] 
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‘Usually as a kind of safety thing I will write on the discharge letter to the GP 
that we have made no changes to the patient’s routine medicines so that... 
the GP can see that they maybe haven’t had the drug because we didn’t know 
about it and that we haven’t made any changes to routine medicines so they 
understand ’ [ANP1] 
 
‘I check more often now... I always try to look at the PDF version to look 
through and scan that I’ve done the patients’ own correct, because I feel like 
that’s easily done incorrectly sometimes so you do accidentally tick the wrong 
thing or you don’t tick one or you’ve thought you’ve ticked it and maybe 
unticked it again I think that’s an issue sometimes’ [PH2] 
 
Table 4.2 describes a summary of the findings from the TDF after HEPMA 
implementation. 
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Table 4.2 Summary of Findings from TDF 
Domain Construct Summary of Findings 
Knowledge Procedural 
knowledge 
Staff provided detailed descriptions 
of HEPMA processes 
Knowledge of task 
environment 
Staff described how to complete 
tasks using HEPMA 
Skills Competence ANPs, junior doctors and 
pharmacists rated themselves as 
skilful HEPMA users; consultant 
doctors had varying skill levels 
Practice All staff used HEPMA regularly 
Social/ 
professional role 
and identity 
Professional role Positive impact on professional role 
Professional 
confidence 
An increase in confidence described 
by ANPs and pharmacists 
Beliefs about 
capabilities 
Perceived 
competence 
ANPs, junior doctors and 
pharmacists all perceived 
competent; variability with 
consultant doctors 
Self confidence ANPs, junior doctors and 
pharmacists all highly self 
confident; variability with 
consultant doctors 
Beliefs about 
consequences 
Outcome 
expectancies 
Improvement in patient safety, 
quality of IDL and number of first 
and final discharge letters 
Consequences Lack of engagement by some 
consultant doctors and  introduction 
of new error types 
Environmental 
context and 
resource 
Resources IT equipment problematic due to 
speed of access, availability and 
condition of equipment 
Critical incidents No documentation of  a formal 
incident about HEPMA 
Social influences Social pressure Pressure to provide detailed IDLs 
with limited time 
Group conformity Variability evident amongst 
different specialties 
Behavioural 
regulation 
Self-monitoring Process for self-checking developed 
by some staff 
Action planning Additional actions documented on 
IDL to prevent inadvertent errors 
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Differences in key themes amongst professional groups 
Consistency in themes expressed by the different professional groups was 
apparent. Areas of difference included the following themes: 
Professional prescribing aspects 
Non–medical prescribers (pharmacists and ANPs) claimed that HEPMA 
implementation had increased their prescribing confidence and identified 
potential skill enhancement due to the system. Consultant doctors prescribing 
self-confidence varied and one voiced the opinion that the consultant role 
consisted of decision making and not the task of prescribing. 
Junior doctor issues 
One junior doctor thought their educational experience may be impacted by 
HEPMA implementation and another was anxious about returning to paper 
based systems in other hospitals. 
Pharmacist processes 
Pharmacists raised time concerns for the completion of the discharge 
prescription process including clinical checking (validation) and printing 
multiple copies of IDLs. 
Discussion  
This phase of the DPP project provided an insight into the perspectives of 
hospital staff regarding the recently implemented HEPMA inpatient prescribing 
and discharge communication documentation and processes. The findings 
contribute original knowledge about the perceived benefits and limitations as 
described by the various staff groups as well as providing insight into 
behaviour changes adopted by the various professional groups. All 
interviewees were regular system users either being “hands on” users or 
viewing HEPMA on computer screens.  
It should be noted that for several months prior to and during the period of 
the interviews, the hospital service had experienced significant pressures with 
increased patient numbers leading to patient flow challenges. Despite these 
difficulties, HEPMA implementation was generally described in positive terms 
and was considered a successful hospital innovation. Framework analysis was 
used to identify initial themes with TDF used to analyse behavioural changes. 
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The study findings highlight the complexity of prescribing medicines for 
hospital inpatients and communication of discharge information using a HEPMA 
system from the users’ perspective. There was staff expectation that electronic 
prescribing systems would be available because of widespread IT system 
accessibility in most facets of modern life. Medicine prescribing with HEPMA 
was reported to be quicker although delays to system access could occur due 
to computer logon and availability. Clarity of viewing the inpatient prescription 
chart and administration was highly rated and complete legibility was stated to 
have been achieved for both inpatient and discharge components. This is 
consistent with published literature by Hammad et al with electronic discharge 
letters providing full legibility (Hammad et al. 2014)). Access to additional 
electronic medicine information for example the British National Formulary was 
described as a positive feature with decision support also mentioned as helpful 
in reducing prescribing errors. Vast quality improvements to the IDL were 
frequently quoted with increased clinical and medication information 
documentation including medicine change information which is consistent with 
publications demonstrating electronic systems increased dataset compliance 
(Hammad et al. 2014, Scullard et al.  2007), and also fulfils a requirement of 
SIGN guideline 128 to provide medicine change information (Scottish 
Intercollegiate Guidelines Network (SIGN) 2012). The quick GP receipt of 
necessary patient information was cited as contributing to enhancements in 
seamless patient care with potential prevention of adverse outcomes. 
Interviewees reported either unchanged or markedly reduced phone calls from 
GPs regarding IDL content which is in keeping with increased quality of 
information provision and Alderton et al’s study demonstrating information 
enhancement with electronic letters (Alderton and Callen  2007). Received GP 
queries mostly enquired about medicine changes which may reflect failure to 
complete medicine reconciliation on hospital admission rather than poor 
prescribing or use of HEPMA. Patient safety improvements were claimed to 
have occurred because of complete legibility of prescribed medicines, accurate 
documentation of medicine administration, decision support information 
availability and use of force functions to ensure completion of allergy 
information documentation for every patient. The literature review had 
indicated the creation of a new error type (sociotechnical error) and 
interviewees described instances of this error, although with no reports of 
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actual patient harm which also is in keeping with the study by Abdel-Qader et 
al which indicated that sociotechnical errors were associated with lower patient 
harm (Abdel-Qader et al. 2010). Allergy recording was highlighted as a 
specific difficulty with HEPMA use. A system upgrade on 6th May 2015 
provided an improvement to allergy documentation. Additional areas for 
development were proposed which were fed back to the HEPMA team by the PI 
and were used to formulate a list of requirements for system enhancements.   
Adoption of TDF permitted analysis of behaviour change amongst the various 
professional groups as a consequence of HEPMA implementation. Although 
some different individuals were interviewed before and after implementation 
there was consistency in findings irrespective of previous interview. In the pre-
implementation phase six domains had been relevant; whereas an additional 
two domains (social influences and behavioural regulation) were applicable to 
discussed topics. The beliefs about consequences domain had the greatest 
quantity of applicable subthemes which is unsurprising with a complex IT 
implementation such as HEPMA. The use of TDF highlighted differences in 
professional group interplay and this study provides knowledge about 
behavioural alteration amongst these groups. Consultant medical staff 
behaviour was reported as the most varied of the studied professional groups; 
with some consultants refusing to engage with the electronic system, whilst 
others described sophisticated system use. The implementation of an 
electronic system may have highlighted an existing disparity in hospital 
prescribing. Research by Ross et al indicated that hospital consultants were 
only responsible for 3.4% of inpatient prescribing activity with several possible 
causes postulated including availability and culture (Ross et al. 2012).  The 
majority of staff deemed themselves as skilful system users after resolution of 
initial teething problems. An increase in prescribing confidence with HEPMA 
was articulated especially by ANPs and pharmacists. Interviewees described 
adoption of behaviours to ensure GPs received good quality information in the 
IDLs and resultant process development adopted to achieve this. The 
associated changes in working systems were instigated as a direct 
consequence of HEPMA implementation with some consultant teams moving to 
first and final discharge letters with descriptions of modified processes to 
achieve this outcome which enables compliance with SIGN 128 vision of 
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changing from IDL to CDD (Scottish Intercollegiate Guidelines Network (SIGN) 
2012). Staff described behavioural alteration to overcome the new system 
errors with use of self-checking and adoption of additional actions to prevent 
miscommunication. 
All interviewed staff asserted receiving sufficient training prior to system use 
which is compliant with the recommendation by Black et al (Black et al. 2011). 
Furthermore, several staff described learning new skills or achieving optimal 
system use after “playing around” or advice from other system users. 
Staff provided suggestions for improvement including accessing and pulling 
medicine information from patients’ GP records into HEPMA. This is not 
technically possible currently due to the differences in IT systems and 
prescribing methods in primary and secondary care. Other suggested 
enhancements included greater spread of HEPMA into all departments because 
the use of different IT systems within the organisation leads to problems. This 
issue was particularly problematic in the Emergency Department (ED) which 
doesn’t use the same patient management system (PMS) as the rest of the 
hospital. The hospital PMS is used to create patient files and feeds patient 
demographic information into HEPMA. The hospital e-health team is tasked 
with resolving this issue. Furthermore, integration of HEPMA with other 
hospital systems including blood results is being progressed. Electronic 
transmission of IDLs to GP surgeries has been tested and is under review by 
the hospital e-health team. There are several challenges regarding automatic 
sending of this information both technical and procedural which are currently 
being actioned.  
Governance issues 
Serious issues raised by staff during the interviews required action by the PI 
as they involved staff wellbeing and/or patient safety concerns. 
The PI escalated concerns to the Director of Pharmacy whilst maintaining 
interviewee anonymity. Lack of HEPMA engagement by certain consultant 
doctors perceived as pressurising junior doctors’ prescribing was further 
escalated to the Medical Director and relevant Associate Medical Directors 
(AMD). A new process to evaluate HEPMA use during routine professional 
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development assessments of hospital consultants was adopted as a result of 
this intervention. 
Likewise, concerns about changes to the discharge letter process whereby 
ANPs and junior doctors were completing first and final discharge letters 
without any senior doctor input was escalated. SIGN 128 recommends 
multidisciplinary team input for CDD creation with consultant input essential 
(Scottish Intercollegiate Guidelines Network (SIGN) 2012). Currently, an AMD 
is responsible for review of the hospital discharge letter process. 
Strengths and weaknesses 
The study design adopted a similar robust and rigorous approach with bias 
minimisation as described in Chapter 3. The weaknesses outlined in Chapter 3 
are equally applicable to this study phase.  
Comparison with pre-implementation phase 
Remote prescribing 
Remote prescribing was viewed favourably and none of the interviewees 
identified feeling pressurised to prescribe remotely. This was previously raised 
as a pre-implementation concern. 
Incident reports 
There was a reduction in completion of incident reports as none had been 
completed by the post-implementation interviewees. The general consensus 
was that incidents and adverse events had been reduced. 
Discharge process  
Distinct differences in the discharge letter process had emerged as a 
consequence of HEPMA implementation although this was not universally 
implemented. Certain consultant teams had moved to using the IDL as a first 
and final letter and were no longer sending additional final typed letters which 
was described as an efficiency improvement. 
Further work 
Electronic transmission of discharge letters to GPs and community pharmacies 
is a crucial development that is being progressed by the HEPMA and hospital 
e-health teams. On completion of successful implementation, future work 
should assess staff views and opinions of this development to see whether the 
anticipated benefits have been achieved. 
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CHAPTER SUMMARY 
This chapter described the aim and research questions for the post-
implementation interview phase of the DPP project. A description of the 
methods used was provided with a particular focus on findings and discussion 
of findings. 
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CHAPTER 5 AUDIT PHASE 
CHAPTER INTRODUCTION 
This chapter describes the aim and research questions for the quantitative 
component of the DPP research, conducted before and after HEPMA 
implementation. There is a brief description of methodology prior to detailed 
coverage of study method, results and discussion. 
CONTEXTUALISATION 
Implementation into hospitals of innovative electronic solutions for discharge 
communication has been described in detail in Chapter 1. The literature review 
identified that quantitative methods proliferated; predominately questionnaires 
based studies and retrospective audits. Seven studies comprised retrospective 
case note audits investigating some component of the discharge process 
(Alderton and Callen  2007, Callen J, McIntosh J and Li J  2010, Callen, 
Alderton and McIntosh 2008, Foster, Paterson and Fairfield 2002, McMillan, 
Allan and Black 2006, Scullard et al.  2007, Sexton et al.  2000). Six studies 
employed questionnaire based approaches, either postal or by electronic 
means (Alderton and Callen  2007, Scullard et al.  2007, Sexton et al.  2000, 
Pillai, Thomas and Garg 2004, Chen, Brennan and Magrabi 2010, Yemm et al. 
2014). A variety of outcome measures were utilised with inconsistency in 
approach amongst the studies, as previously described.  A deficiency identified 
in the reviewed literature was the lack of studies involving HEPMA systems. 
AIM 
The aim of this phase of the DPP project was to determine if HEPMA 
implementation impacted discharge information. 
OBJECTIVES 
Pre-implementation objectives 
 To determine  the frequency and nature of prescribing errors on 
immediate discharge letters prepared using traditional handwritten 
processes 
 To determine discharge letter receipt and time of receipt at GP practices  
Post-implementation objectives 
 To determine the frequency, nature and severity of prescribing errors 
on immediate discharge letters post  HEPMA implementation 
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 To determine discharge letter receipt and time of receipt at GP practices  
COMPARISON OBJECTIVES 
Primary Objective 
 To determine if HEPMA implementation impacted  the frequency, nature 
and severity of prescribing errors on immediate discharge letters. 
Secondary Objectives  
 To determine if HEPMA implementation impacted discharge letter receipt 
and time of receipt by GP practices. 
 To determine if HEPMA implementation impacted patient re-admission 
to same specialty at 7, 14, 28 and 90 days after initial discharge date. 
Hypotheses 
 the null hypothesis was that HEPMA implementation did not impact 
discharge letter quality, number and severity of prescribing errors. 
 the alternative hypothesis that HEPMA implementation impacted 
discharge letter quality, number and severity of prescribing errors. 
QUANTITATIVE STUDY DESIGN 
As described in Chapter 2, the philosophical stance of the PI was pragmatism 
and thus the DPP project utilised multiple approaches appropriate to the 
research aims and objectives. As previously outlined, the DPP project 
comprised mixed qualitative and quantitative approaches. This phase of the 
research employed a quantitative methodology, which as described in Chapter 
2 is best at answering “the questions of who, where, how many, how much, 
and what is the relationship between specific variables” (Schimmel  1996).   
Methodology and method 
The study design used an experimental design methodology to test the 
hypothesis that HEPMA implementation impacted the outcome measures 
related to the primary objective (i.e. prescribing error frequency, nature and 
severity). As described in Chapter 2, a quasi experimental before and after 
study based design was adopted. This comprised a retrospective case note 
review, an assessment of discharge letter receipt at GP practices and 
calculation of patient re-admission rates.  
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Retrospective Case Note Review 
A modified version of the Scottish Intercollegiate Guidelines Network (SIGN) 
discharge document template was used as a data collection tool to collate 
information obtained from the patients’ case note review (Scottish 
Intercollegiate Guidelines Network (SIGN) 2012). The data collection tool is 
provided in Appendix 5.1. It includes an explanation and justification for each 
item of information to be collected and a brief description of exclusion criteria. 
Information about the criteria included in SIGN guideline 128 with an 
indication of whether each individual criterion was included in the DPP project 
is provided in Table 5.1. The retrospective review involved assessment of 
patients’ clinical notes, inpatient prescription charts and immediate discharge 
letters (IDLs). The review was completed retrospectively to allow sufficient 
time to elapse after the patient’s hospital discharge to enable full access to the 
patient’s clinical notes. The time period of patient discharge was April to June 
2013 in the pre-implementation phase and February to April 2015 in the post-
implementation phase. The case note review was completed by the PI in 
October to December 2013 for the pilot notes and January to March 2014 for 
the remainder of the pre-implementation notes. The post-implementation 
review was from June to August 2015. The case notes were supplied by the 
medical records department to the dedicated audit room at UHC, where the PI 
undertook all case note reviews. It took approximately 20 to 30 minutes per 
patient to review the documentation and record the required information in 
the data collection tool. The availability of case notes for review was the rate 
limiting step in the completion of the case note review phase.  The data were 
extracted from the patients’ notes by the PI. The documented information of 
primary diagnosis, secondary diagnosis and significant operations/procedures 
was not assessed for accuracy by the PI, merely recorded as present or absent 
in the allocated section on the IDL which is consistent with the approach 
adopted by Callen et al (Callen, Alderton and McIntosh 2008)). Thus, if the 
information was recorded in the incorrect section, it was considered to be 
absent. The communication method of IDL to GP practice was assumed to be 
post. Patients may be requested to deliver the IDL to their GP practice but this 
information is not formally documented.  Normality tests were applied to the 
data to determine data distribution.   
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A pilot of 50 case notes was reviewed to test the suitability of the data 
collection tool and the ability of the PI to extract the required information 
during the review. A random 10% sample was checked for reliability by an 
independent assessor who was a senior pharmacist responsible for prescribing 
development and education. 
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Table 5.1 Criteria included in SIGN Guideline 128 (Scottish Intercollegiate Guidelines 
Network (SIGN) 2012) 
Criteria SIGN Guideline Items Included  
in Study? 
Exclusion 
Reason 
1 Name of Hospital Yes  
2 Patient ID Yes  
3 GP ID Yes  
4 Consultant ID Yes  
5 Ward/Department Yes  
6 Ward/ Dept Telephone Number No Not in either template  
7 Date of admission Yes  
8 Date of discharge Yes  
9 Primary Diagnosis Yes  
10 Secondary Diagnosis Yes  
11 Presenting Complaint No Assessment required 
12 Mode of Admission No Beyond scope 
13 Source of referral No Beyond scope 
14 Significant operations/procedures Yes  
15 Clinical progress No Assessment required 
16 Results awaited? No Assessment required 
17 Investigations pending?                      No Assessment required 
18 Allergies Yes  
19 Stopped medicines Yes  
20 New medicines Yes  
21 Continuing medicine Yes  
22 Follow up arrangements No Assessment required 
23 Copy to community pharmacy No Not in either template 
24 Copy to patient No Not in either template 
25 Copy to carer/relative No Not in either template 
26 Extended discharge to follow Yes  
27 Other information No Beyond scope 
28 Consultant sign-off No Not in either template 
29 Signature, name and position Yes  
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Sampling 
Random sampling (probability) approaches are mainly used in quantitative 
research and details about the different approaches were outlined in Chapter 
2. In random sampling, “each member of the population has an equal 
probability of being selected”, as described by Cresswell (Creswell  2013). 
Furthermore, a simple random sample was defined by Davies as “every 
possible combination of individuals from within the ‘population’ is equally 
likely” and states that you must be able to obtain an exact list of the 
population (Davies  2007). Simple random sampling was selected for the DPP 
project as it was possible to obtain information of the whole population of 
interest from the Business Intelligence Department of NHS Ayrshire and Arran. 
As outlined in Table 2.5, random sampling has the advantage of being easy to 
conduct and was not time consuming as the information was readily available 
within the organisation. 
Eligibility 
Case notes eligible for review were according to the following patient inclusion 
criteria: 
 greater than or equal to sixteen years of age  
 discharged from hospital after an inpatient stay of at least 24 hours  
 discharged from University Hospital Crosshouse  
 discharged during the defined three month period 
 
Patient exclusion criteria consisted of the following: 
 in mental health, maternity and paediatric wards as HEPMA was not 
implemented or previously implemented 
 confirmed prescribed no medicines at discharge  
 inter hospital transfer 
 
Therefore a random sample of patients fulfilling the eligibility criteria was 
required for the project. The PI provided the Business Intelligence department 
of NHS Ayrshire and Arran with the inclusion and exclusion criteria information 
and they e-mailed the sample list of patients to the PI. The patient list was 
forwarded by the PI to the medical records department to obtain the relevant 
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patients’ case notes for review. The case note review patients were also used 
for GP receipt time and re-admission rate assessment. 
Sample Size  
The required sample size was calculated based on the primary objective of 
reducing prescribing errors. Error rates identified from the reviewed literature  
ranged from 12.1% to 66%, dependent on error category. Previous studies 
had used a random 5% sample of summaries produced per defined period 
(Wilson et al. 2001), selected a number of patients (100) without explanation 
(McMillan, Allan and Black 2006), or looked at all patients in a defined time 
period ranging from three months to a year (Callen J, McIntosh J and Li J  
2010, Foster, Paterson and Fairfield 2002). None of these methods are 
statistically robust. Consequently, to enable estimation of sample size the 
following parameters were used: 
 p value of 0.05 
 power of 80% 
 baseline error rate of 15% 
 clinically important difference of 10%  
 
Two different sample size calculators for determining differences in proportions 
were used to determine sample size (Casagrande 2013, Brant). The calculated 
size was 159 case notes before and 159 case notes after i.e. a total of 318 
when using the first calculator (Casagrande 2013). Use of the second 
calculator produced a somewhat smaller 141 case notes before and after i.e. a 
total of 282 (Brant). There is an acceptance that the calculated sample size 
has insufficient power in relation to impact on the secondary objectives. 
Pilot Sample Error Rate 
A pilot sample of 47 case notes was reviewed to calculate the actual error 
rate. This was predicted to enable an accurate calculation of final sample size 
based on actual error rate and minimise the risk of type I and type II errors as 
described in Chapter 2.The pilot audit detected that 76.6% of patients had at 
least one prescribing error if Nil Known Drug Allergies (NKDA) not documented 
on IDL was excluded. If NKDA was included as a prescribing error then 99.4% 
of patients had at least one detected error. 
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The sample size calculation was completed as described previously based on 
an initial error rate of 76%. If the aim was to reduce errors by half to 38% 
then a total of 60 case notes (30 before and after) were required. If the aim 
was to reduce errors from 76% to 60% this would require a total of 120 case 
notes (60 before and after). As the calculated sample size based on the actual 
error rate was much smaller than the initial projected sample size, it was 
decided to proceed with the original sample of 318 patients in total to ensure 
sufficient data were obtained for the DPP project. The pilot data were included 
in the full sample data as no changes were made to the nature of data 
collected. 
DATA COLLECTION 
The PI extracted data from patients’ clinical records and documented 
information in the data collection tool. The PI reviewed a copy of the patients’ 
IDL (either paper or electronic) and noted the documented information, the 
number of medicines prescribed on the IDL and information about who had 
completed the IDL. The medicines prescribed on the IDL were compared to 
those prescribed on the corresponding inpatient chart to identify any 
discrepancies. Medicines not expected to be included in IDLs for example 
intravenous morphine sulphate injection as required would not be considered 
an omission. Medicines that a patient had received either on the day of 
discharge or the preceding day would be considered still to be an active 
current prescription and would therefore be expected to be included in the 
IDL, except if there was an explanatory entry in the patient’s case notes. 
Medication and prescribing errors 
The DPP project involved retrospective case note review of existing 
prescriptions and patients’ clinical records. Therefore, it was appropriate to 
adopt Dean et al’s definition of a prescribing error as “a prescribing error 
occurs, when as a result of a prescribing decision or prescription writing 
process, there is an unintentional reduction in the probability of treatment 
being timely and effective or increase in the risk of harm”(Dean, Barber and 
Schachter 2000). The PI classified prescribing errors in the pre-
implementation group as: 
 omissions 
 commissions 
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 incorrect dose  
 incorrect frequency  
 incorrect duration 
 drug interactions 
 therapeutic duplications 
 missing allergy 
 inaccurate allergy 
An explanation for the error type classification is provided in Table 5.2.
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Table 5.2 Error type classification 
Error type Description Exclusion 
Omission Medicine omitted from IDL currently prescribed on inpatient 
chart. Medicine administered preceding/discharge day. For 
example documentation of “no changes to routine medicines”. 
Medicine not usually required on 
discharge for example antiemetic 
injection. 
Commission Medicine prescribed on IDL not on pre admission list. Medicine 
not administered preceding/discharge day e.g. cyclizine (anti-
emetic) prescribed as a precaution but never administered. 
Explanatory note documented for 
medicine requirement. 
Incorrect dose Discrepancy between dose on inpatient chart and IDL or nil 
documented e.g. carvedilol noted as 19mg instead of 18.75mg 
Explanatory note documented 
regarding dose change. 
Incorrect 
frequency 
Discrepancy between frequency documented on inpatient chart 
and IDL or none documented. For example, as required 
medicines prescribed without specified time interval. 
Explanatory note documented 
regarding frequency change. 
Incorrect 
duration 
Discrepancy between duration documented on inpatient chart 
and IDL or no documented duration provided. 
Explanatory note documented 
regarding duration change. 
Drug 
Interaction 
A drug interaction recorded as a serious interaction in current 
edition of BNF. 
Appropriate to co-prescribe with 
suitable monitoring. 
Therapeutic 
Duplication 
More than one medicine prescribed from same therapeutic 
group. Co-codamol and tramadol co-prescribed. 
Protocol exists to evidence 
prescribing action. 
Missing 
allergy 
Allergy documented on inpatient chart and/or patients’ case 
notes but not on IDL. NKDA missing from IDL. 
Explanatory note documented 
regarding allergy information. 
Inaccurate 
allergy 
Discrepancy between allergy documented on inpatient chart 
and/or patients’ case notes and IDL. 
Explanatory note documented in 
case note regarding allergy 
information change. 
Sociotechnical 
(post HEPMA) 
Error caused by HEPMA system e.g. prednisolone soluble 
tablets instead of plain. 
Error unlikely to be caused by 
HEPMA. 
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This was expanded further to include sociotechnical errors in the post-
implementation group as previously described in Chapter 1 as “occurring at 
the point where the system and the professional intersected and would not 
have occurred in the absence of the system” (Redwood et al. 2011). 
Error severity assessment  
Identified prescribing errors were severity scored using a validated scoring 
system. The NCC MERP medication errors categorisation consists of nine 
severity ratings ranging from potential for error to occur (category A) to error 
occurrence which contributed to or resulted in patient death (category I) 
(MERP  2001). A study using a modified version of this scale assessed errors 
during the medicine reconciliation process with condensed scorings 
categorised to three severity levels (Gleason et al. 2010). A different error 
classification system was used to assess safety of two fully integrated hospital 
electronic prescribing systems in inpatient prescribing with an initial review to 
identify for procedural or clinical errors with further review for applicability of 
sociotechnical error (Westbrook et al. 2013). Sociotechnical errors were 
defined as “errors arising from the use and functionality of the electronic 
prescribing system which would be unlikely or unable to occur in paper-based 
medication ordering systems” (Westbrook et al. 2013).  
Gleason et al’s modified version was selected with severity ratings of: 
(1) no potential harm  
(2) monitoring or intervention potentially required to preclude harm 
(3) potential harm  (Gleason et al. 2010) 
Literature review indicated varying methods to achieve error severity 
consensus. Options included independent practitioner review with meetings to 
agree consensus (Westbrook et al. 2013, Forster et al. 2003), reliability 
testing of error categorisation (Gleason et al. 2010) or alternatively validation 
panels may be used for error severity assessment. The chosen method of 
error severity scoring for the DPP project was a validation panel comprising 
one consultant doctor, one advanced nurse practitioner and one clinical 
pharmacist. This is consistent with the method and staff groups involved in 
local global trigger tool and hospital standardised mortality reviews (Bates et 
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al. 1999). If panel consensus was not achieved, the error was referred to 
another senior doctor for final assessment. Prescribing errors were scrutinised 
independent of patients’ factors as previous studies indicated that focus should 
be on the prescribing systems and not individual patient risk. Reason 
suggested the need to look at the organisational level to prevent errors and 
not at the individual practitioners (Reason  2000). The implementation of 
HEPMA is an organisational level intervention which would be anticipated to 
effect prescribing error causality. After completion of all case note reviews the 
PI convened an error severity scoring panel. The PI personally approached a 
medical consultant, a consultant nurse (ANP) and a principal pharmacist to 
invite them to be part of the panel. All approached staff agreed to be involved. 
The PI followed up with an e-mail communication confirming the date, time 
and venue of the panel. The panel was convened on 11th September 2015. The 
panel discussion was held in a private room in the pharmacy department at 
UHC. The PI provided every panel member with a copy of each unique 
identified error and severity scoring guidance. The panel discussed each error 
in turn and assigned an individual severity score which was documented by 
the PI on a data collection sheet provided in Appendix 5.3. The duration of 
panel discussion was 37 minutes and 18 seconds. The PI collated the totals for 
each individual severity score after the panel had concluded. 
Discharge Letter Receipt at GP practice 
Partially anonymised patient details, including date of discharge recorded on 
the IDL, were collated onto a data collection form provided in Appendix 5.2. 
The patient was identified by Community Hospital Index (CHI) number which 
is a unique patient identification number and with patients’ initials. Thus 
patient confidentiality was maintained as much as possible, whilst permitting 
confirmation of correct patient details by GP practices. The patients were then 
grouped according to their registered GP practice. This information was used 
to obtain the date of receipt of the IDL at the patient’s registered GP practice.  
The information for GP practices within NHS Ayrshire and Arran was obtained 
via the prescribing support pharmacy team who contacted their allocated GP 
practices. The requested information was: did the GP surgery receive the IDL: 
and if so, what was the documented receipt date? There were inconsistent 
approaches to receipt information documentation by the varying GP practices; 
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some recorded the actual receipt date whilst others recorded the date they 
had actioned the information. Therefore, the date the IDL was entered into the 
electronic healthcare data management system was used a proxy for IDL 
receipt. This was compared to the date of patient’s hospital discharge as 
recorded on the hospital patient management system to calculate the number 
of days between patient discharge and GP information receipt. 
The PI obtained GP receipt information for patients with GP practices out with 
NHS Ayrshire and Arran. This was achieved by telephone call to the relevant 
practice and requesting the receptionist to provide the required information. 
The PI confirmed sufficient time was available to respond or offered to phone 
back at a more convenient time. 
Documented GP receipt date of discharge letter was compared against 
recorded date of patient hospital discharge to determine the time interval 
between patient hospital discharge and GP information receipt. 
Patient Readmission  
The patient readmission data was obtained via the Business Intelligence 
department of NHS Ayrshire and Arran. Readmission data were requested for 
seven, 14, 28 and 90 days after the patients’ original hospital discharge date. 
The patient management system used by NHS Ayrshire and Arran provides 
real time data on patient movement through the hospital including admission 
and discharge dates.  
PROMOTION OF VALIDITY AND RELIABILITY 
The case note review used a validated tool from SIGN 128 adapted for local 
use which enhanced external validity as the study results will be applicable to 
other healthcare organisations; face validity as the tool appears to measure 
what it should; and criterion validity as the tool used can be compared to a 
similar validated tool (Scottish Intercollegiate Guidelines Network (SIGN) 
2012). 
A random sample of 10% of case notes was checked by an independent 
assessor for reliability which provided inter-rater and internal consistency 
reliability. Test-retest reliability has been designed into the study by 
undertaking a before and after study design which means that consistency of 
measurement over time will be determined. 
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MINIMISING BIAS 
Biases that have been possible to minimise were: measurement bias by the PI 
applying a consistent approach by using a validated tool; non-response and 
sampling biases by the using a random patient sample obtained from business 
intelligence and by systematic application of the sample by the PI. 
DATA ANALYSIS 
The published literature reviewed in Chapter 1 described different statistical 
analysis ranging from descriptive statistics to inferential statistics using a 
variety of tests including the Mann Whitney U test, Chi-square analysis, 2x2 
tables for odds ratio with Chi-square analysis (Callen J, McIntosh J and Li J  
2010, Callen, Alderton and McIntosh 2008, Chen, Brennan and Magrabi 2010, 
Witherington, Pirzada and Avery 2008). However, some studies did not 
describe statistical analysis (McMillan, Allan and Black 2006, Scullard et al.  
2007). 
The DPP project consisted of two independent (i.e. not paired) samples and 
the choice of appropriate statistical test is dependent on the data type. Data 
types may be categorical or quantitative (Campbell and Swinscow  2011). The 
quantitative data may either be measured or counted whilst the categorical 
data may either be ordered (ordinal) or unordered (nominal) (Campbell and 
Swinscow  2011). For continuous (measured) data, it is important to define if 
the data are parametric or non-parametric which may be determined by 
testing for normality. If the data are normally distributed it is parametric and if 
not it is non-parametric.  
The variables collected in the DPP project included a mixture of data types. 
Categorical, nominal data included sex, discharge diagnosis, number of 
patients with a prescribing error and number of patients with specific types of 
prescribing errors. Quantitative discrete variables included age and number of 
medicines. An appropriate statistical test for categorical variables is the Chi-
square test for data greater than zero and Fisher’s exact test for data including 
a count of zero. Internet programmes were used to calculate Chi- square and 
Fisher exact test (Preacher  2012, QuickCalcs 2015).  
Data were collected using the tool provided in Appendix 5.1, and were then 
input by the PI into Statistical Product and Service Solutions (SPSS©) software 
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version 21.0. This software aided statistical analysis including calculation of 
descriptive statistics, tests of normality and inferential statistics (IBM 2013). A 
mixture of descriptive and inferential statistics was used for data analysis. 
Tests of normality 
Calculation of the mode, the mean and the median allows determination of 
distribution. These will be identical if data are normally distributed 
(Casagrande 2013).  Alternatively, a test for normality can be run using SPSS 
(IBM 2013). Normal data are required for parametric testing. A Shapiro-Wilk 
test of normality was used rather than the Kolmogorov-Smirnov test as 
Shapiro-Wilk is more appropriate for small samples of less than 50 but is also 
appropriate for samples as large as 2000 (Casagrande 2013). If p< 0.05 then 
the data are not normally distributed.  
The patients being studied were different in the before and after study so an 
unpaired t test would be selected as an appropriate statistical test if the data 
were parametric and a Mann Whitney U test if the data were non-parametric 
(Driscoll, Lecky and Crosby 2000a, Driscoll, Lecky and Crosby 2000b). 
Patient re-admission rates were recorded as number of patients re-admitted 
with comparison of pre-and post-implementation groups. 
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RESULTS 
PRE-IMPLEMENTATION RESULTS  
Patient demographic information for the pre-implementation group of patients 
is shown in Table 5.3 
Table 5.3 Pre-implementation patient demographic information 
Variable Result/range Mean  SD 
Gender 57% female 
(n=91) 
  
Age at discharge (years) 18 to 102  60 19.8 
Length of stay (days) 1 to 33  4 4.1 
 
The most frequent length of stay for patients was two days; with Tuesdays 
(20%, n=32) and Thursdays (20%, n=32) the most frequent discharge day; 
Sunday (8%, n=13) was the least frequent. Only 19% (n=30) patients were 
weekend discharges. The majority of patients, 81% (n=129) were discharged 
from medical and surgical wards; 19% (n=30) were discharged from either 
orthopaedic or gynaecology wards. 
Information documented on IDL 
The results of the information documented on the IDL for pre-implementation 
patients are shown in Table 5.4. 
Table 5.4 Results of information documented on IDL (N=159) 
Required information Documented % (n) 
Patient’s GP details 56(89) 
Name only 44(70) 
Name & address 12(19) 
Hospital consultant 97 (154) 
Diagnosis 96 (153) 
Relevant secondary diagnosis 30 (48) 
Procedures/operations 62 (99) 
Allergy information 7 (11) 
Signature 100 (159) 
Full name printed 99 (157) 
Grade of staff 40 (61) 
Contact information 45 (71) 
Further information to follow? 1 (1) 
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The GP full name and address was recorded in only 12% (n=19) patients. 
Hospital consultant information was missing in 3% (n=5) patients with no 
diagnostic information recorded in 4% (n= 6) patients. 
Number of medicines on discharge 
Patients were documented as being discharged home on between zero and 25 
medicines as depicted in Figure 5.1. The mean number of medicines was 5.5 
with a standard deviation of 4.1. (This number excludes medicines identified 
as omitted from the IDL.) The total number of medicines prescribed on IDLs 
pre- implementation was 872.  
 
Figure 5.1 Number of discharge medicines (pre-implementation) 
Two patients were lost to follow up for GP receipt information as they were 
recorded as unknown GP practice. GPs received 71% (n=113) IDL, with 6% 
(n=16) receipt failure as shown in Figure 5.2. A further 22% (n=35) patients 
were lost to follow up for the following reasons: patient left practice (n=10), 
patient deceased (n=14), patient not registered at practice (n=2), and one 
practice declined to provide information (n=9).  
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Figure 5.2 GP receipt information (pre-implementation) 
The time delay between documented date of patient discharge and receipt of 
IDL at GP practice is depicted in Figure 5.3. The mean delay was five days; 
standard deviation of 6.3, with a range varying from zero to 42 days. Patients 
were registered at 34 different GP practices in the NHS Ayrshire and Arran 
Health Board area (n=151) with six patients registered at GPs out with local 
area, all at different practices 
 
Figure 5.3 Days between discharge and GP receipt (pre-implementation) 
The PI detected 726 errors in total in the pre-implementation IDLs. Figure 5.4 
shows the number of patients associated with each specific error types.  
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Figure 5.4 Number of patients with various error types on IDL (pre-implementation) 
Omission of at least one medicine from the IDL was detected in 42% patients 
(n=66) using traditional handwritten systems as shown in Figure 5.5. A total 
of 237 medicines were omitted from IDLs. Types of omitted medicines varied 
considerably: routine medicines were not prescribed at all (for example 
recorded as “no changes to usual medicines”); individual medicines were 
omitted in error which ranged in seriousness from potential patient harm e.g. 
oxycodone to unlikely to cause harm e.g. lactulose. 
 
 
 
Figure 5.5 Frequency of omitted medicines (pre-implementation) 
The number of medicine commissions is shown in Figure 5.6 with a total of 13 
detected in 6% (n=10) patients. An example of a commission was cyclizine 
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(an anti-emetic) prescribed and supplied on the IDL despite not being 
administered during the inpatient stay. 
 
 
 
 Figure 5.6 Number of medicine commissions (pre-implementation) 
Incorrect doses were present in 17 prescribed medicines on the IDL (2% of all 
medicines) and in 14 patients (9% of all patient) pre-implementation. 
Categories of incorrect doses were transcription errors (for example 
trandolapril documented as 20mg instead of 2mg); illegibility (diazepam dose 
indecipherable could have been 20mg or 210mg but should have been 2mg); 
and omission of dosing information (for example no specification of inhaler 
dosages and warfarin documented as charted). 
Incorrect frequencies were present in 49 IDL prescribed medicines (6% of all 
medicines) and in 30 patients (19% of all patient) pre-implementation. 
Incorrect frequencies were categorised as omitted information (for example as 
required medicines with no dose interval information) and incorrect 
transcription (for example ramipril transcribed onto IDL as 1.25mg once daily 
when prescribed twice daily on the inpatient chart). 
 
Figure 5.7 shows that 27% patients (n=43) had at least one medicine 
documented with an incorrect duration, with 225 medicines (26% of all 
prescribed medicines) having incorrect documented duration.  These were 
categorised as incorrect information documented on IDL (for example 
antibiotics marked as to be continued by GP rather than a defined course); 
and no duration information provided, which was a frequent occurrence. 
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Figure 5.7 Number of medicines with incorrect duration (pre-implementation) 
Drug interactions classified as a serious drug interaction in BNF were detected 
in 4% (n=7) patients. Examples included a patient discharged home on both 
clopidogrel and omeprazole which may result in decreased effectiveness of 
clopidogrel; warfarin missed from an IDL, when the patient was also on 
penicillin v which may potentiate the patient’s INR so the patient should have 
more frequent INR checks to prevent harm from warfarin exceeding the 
desired target INR range e.g. bleeding and a patient on amlodipine and 
simvastatin prescribed at a dose of 40mg when the maximum dose should be 
20mg with concomitant use of amlodipine (British Medical Journal and Royal 
Pharmaceutical Society of Great Britain  2015). Therapeutic duplications were 
detected in 3% (n=5) patients. For example a patient discharged home on 
both Laxido ® and lactulose which should be rationalised to either alone (The 
Scottish Government   2012).There were 172 omitted allergies in 97% 
(n=154) patients mainly due to failure to document NKDA. Figure 5.8 
illustrates that 8% (n=13) patients had multiple allergies not documented on 
the IDL.  
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Figure 5.8 Total errors including missing allergies (pre-implementation) 
Patients could have multiple error types or multiple instances of the same 
errors on the IDL. Figure 5.9 shows the wide variation in error percentages in 
pre-implementation patients ranging from one to 25 errors. A frequently 
occurring error was the failure to document NKDA on the IDL (n=105).  
Allergy discrepancies were detected in 1% (n=2) patients. This consisted of 
the allergy being incorrectly documented as uric acid and not uric acid 
metabolites and NKDA documented although the patient was allergic to 
paracetamol.  If the error total is calculated excluding the failure to document 
NKDA the revised totals are illustrated in Figure 5.9.  This demonstrates that 
84% (n=134) of patients had detected errors. 
 
 
Figure 5.9 Error total excluding nil known allergy (pre-implementation) 
The documentation of grade of staff completing the IDL was relatively poor, as 
only 40% IDLs had prescriber grade recorded. None were documented as 
being completed by consultant medical staff in the pre-implementation 
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patients. It would appear that FY1s (26%) and NIPs (9%) were more likely to 
record this information. 
Pre-implementation findings 
The IDL serves as both a prescription and communication about the patients’ 
hospital stay. A fundamental requirement of accurate information 
communication is to document the individual patient’s GP practice information. 
The failure to record essential information necessitates other healthcare staff, 
particularly medical records staff, to retrieve and record this information so 
that the letter may be successfully sent to the patient’s GP. A lack of crucial 
information on the IDL results in information gaps for ongoing care and 
highlights communication issues with the traditional system. Missing allergy 
information was the commonest error type, followed by medicine omission. A 
major cause of omitted medicines was failure to transcribe the medicines and 
document “no changes to regular medicines”. This is not compliant with the 
SIGN guideline requirements (Scottish Intercollegiate Guidelines Network 
(SIGN) 2012). Pharmacists when completing the initial clinical check would be 
unaware of existing medicines and may miss drug interactions and therapeutic 
duplications which may result in patient harm. 
POST-IMPLEMENTATION RESULTS 
Patient demographic information for the post-implementation group of patients 
is shown in Table 5.5 
Table 5.5 Post-implementation patient demographic information 
Variable Result/range Mean  SD 
Gender 57% female   
Age at discharge (years) 17 to 93 55 20.8 
Length of stay (days) 1-25 4 4.2 
 
The most frequent length of stay was two days. Patients were most frequently 
discharged on a Friday (21%, n=33); with Thursday (9%, n=14) the least 
frequent discharge day. Nearly a quarter of patients (24%, n= 38) were 
discharged at the weekend. The majority of patients were discharged from 
medical and surgical wards; 22% (n=35) were discharged from orthopaedic 
and gynaecology wards. 
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Documented information on HEPMA IDL 
The results of information documented on post-implementation IDLs are 
shown in Table 5.6. 
Table 5.6 Results of information documented on HEPMA IDL (N=159) 
Required information Documented HEPMA % (n) 
Patient’s GP details 99 (157) 
unknown GP Scotland 1(2) 
Hospital consultant 100 (159) 
Diagnosis 72 (116) 
Relevant secondary diagnosis 31 (49) 
Procedures/operations 39 (62) 
Allergy information 100 (159) 
Signature* 100 (159) 
Full name printed 100 (159) 
Grade of staff 100 (159) 
Contact information 0 (0) 
Further information to follow? 0 (0) 
*full name considered to be electronic signature  
Table 5.6 provides details of the information completed for the post-
implementation patients. As before, the information was not assessed for 
accuracy by the PI, merely recorded as documented or absent in the relevant 
section of the IDL. The HEPMA IDL has 11 different heading tabs which may be 
completed when creating an IDL as shown in Appendix 5.4. These are namely; 
diagnoses, secondary diagnoses, investigations, operation/procedure, clinical 
progress, results awaited, social/nursing/AHP, GP follow up, hospital follow up, 
subspecialty notes and medicines/pharmacy.  The PI identified that some 
prescribers ignored the individual headings and put all the information in the 
clinical progress section. Thus whilst the diagnosis was not documented in 
diagnosis section, it was often included in the clinical progress segment. 
Number of medicines on discharge 
Patients were documented as being discharged home on between zero and 18 
medicines as shown in Figure 5.10. The mean number of medicines was six 
with a standard deviation of 3.9. (This number excludes medicines identified 
as omitted from the IDL). The total number of medicines prescribed on IDLs 
post-HEPMA implementation was 1018. 
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Figure 5.10 Number of medicines on IDL (post-implementation) 
The grade of prescriber was recorded on all IDLs post-implementation. The 
traditional description of medical staff grade was recorded by HEPMA at this 
time although it is now amended to current terminology of FY1, FY2 etc. JHO 
(FY1s) were responsible for the greatest number of IDLs (45%, n=71) with 
consultants only completing 2% (n=3) of IDLs. HEPMA implementation 
permitted alteration to the conventional process of producing an IDL followed 
by a typed FL. The results show a gradual move to first and final discharge 
letters which were used in 21% of patients (n=34).  
GP receipt information was not obtained for the post-implementation patient 
because the electronic transmission of IDLs to GP practices had not been 
implemented. 
Errors post HEPMA implementation 
The PI detected 75 errors in total in the post-implementation IDLs. Figure 5.11 
shows the number of patients associated with each specific error types. 
Medicine omission was the most frequently detected error type (n=18). 
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Figure 5.11 Number of patients with errors on IDL (post-implementation) 
The PI detected errors in only 23% patients (n=37) post-implementation. 
Figure 5.28 illustrates that the majority of patients with errors had only one 
error (n=26).  
 
Figure 5.12 Percentage of patients with number of errors (post-implementation) 
Examples of specific error types are depicted in Figures 5.13 and 5.14. The 
most frequent error type was omitted medicines which was present in 11% 
patients (n=18) with 51 medicines omitted. Figure 5.13 illustrates that the 
most frequent number of medicine omitted post HEPMA implementation was 
one medicine. 
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Figure 5.13 Number of omitted medicines from IDL (post-implementation) 
Incorrect dosages (1 medicine in 1 patient), incorrect frequencies (3 medicines 
in 2 patients) and drug interactions (1 medicine in 1 patient) accounted for 
less than 1% of errors respectively; with 2% of errors attributable to incorrect 
durations (4 medicines in 3 patients).  Therapeutic duplications were detected 
in 4 patients (2.5%) with two patients prescribed identical duplicate 
medicines. 
Sociotechnical errors which are errors that occur as a result of the technology 
were identified in 5% patients (n=8) for 10 medicines and are shown in Figure 
5.14. Examples of sociotechnical errors include incorrect selection of medicine 
formulation (diclofenac soluble tablets selected instead of tablets as the 
computer lists in alphabetical order and soluble tablets appears prior to 
tablets), eye drops defaulting to choose route and the prescriber failed to 
select the appropriate eye or both eyes as relevant. 
 
Figure 5.14 Sociotechnical errors (post-implementation) 
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Post implementation findings 
Prescribing errors were still detected post-implementation. Medicine omission 
was the most frequent prescribing error type. Socio-technical errors were 
detected as a consequence of the HEPMA system. Information documentation 
was not completely compliant in all sections of the IDL. There was total 
absence of contact information and further information to follow. HEPMA IDLs 
are exempt for the requirement of handwritten signatures as the electronic 
signature will suffice as described in Statutory Instrument 2008 (The 
Secretary of State for Health  2008). Therefore, although the SIGN guideline 
states signature the inclusion of the prescriber’s name documented as an 
electronic signature suffices for both signature and name (Scottish 
Intercollegiate Guidelines Network (SIGN) 2012). 
COMPARISON OF PRE AND POST-IMPLEMENTATION RESULTS 
The pre and post implementation results were compared to assess if HEPMA 
implementation had impacted on the objectives. A normality test was applied 
to the results which demonstrated that the data were non-parametric. 
The results in Table 5.7 show there was no statistically significant difference in 
patient demographics between the two groups. Apparent differences included 
discharge day: in the pre-implementation group the most common discharge 
days were Tuesday and Thursday but this had altered to Friday post-
implementation with more discharges also occurring on a Sunday. This is 
probably reflective of changes in the hospital moving to a seven day discharge 
culture as demonstrated by an increase in weekend discharges from 19% to 
24%. Also more medicines were prescribed on IDLs post HEPMA with 1018 in 
total in contrast to 872 medicines pre-implementation. 
The results in Table 5.8 demonstrate that there was a statistically significant 
improvement in certain aspects of documentation; no impact on others; whilst 
certain sections were associated with reduced information documentation.
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Table 5.7 Comparison of pre and post-implementation results 
Variable Pre-
Implementation 
Post-
Implementation 
Statistical Test 
Mann Whitney U 
Significance 
P value 
Mean patient age 
(years) 
60 55 0.000 0.317 
Mean number of 
discharge medicines 
5.5 4 0.000 0.317 
Most frequent 
discharge day 
Tuesday 20% 
Thursday 20% 
Friday 21% 0.000 0.317 
Gender  57% female 57% female N/A  
Age range (years) 18-102 
Mean 58 
17-93 
Mean 59 
11974.5 0.416 
Length of stay (days) 1 -25 
Mode 2 
1-33 
Mode 2 
11884.0 0.232 
Discharge specialty Medical 47% 
Surgical 33% 
Medical 47% 
Surgical 30% 
12334.5 0.688 
Total number of IDL 
prescribed medicines 
872 1018 10787.5 0.023 
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Table 5.8 Comparison of documented information on IDL 
Comparison of number and percentage  of 
patients with required information 
Pre- HEPMA 
(n=159) 
Post-HEPMA 
(n=159) 
Chi- 
square 
p value 
Patient’s GP details 89 
(56%) 
157 
(98.7%) 
83.019 <0.001 
Hospital consultant 154 
(96.9%) 
159 
(100%) 
Fisher exact 0.0605 
Diagnosis 153 
(96.2%) 
116 
(73%) 
33.028 <0.001 
Relevant secondary diagnosis 48 
(30.2%) 
49 
(30.8%) 
0.015 0.902 
Procedures/ 
operations 
99 
(62.3%) 
62 
(39%) 
17.223 <0.001 
Allergy information 11 
(6.9%) 
159 
(100%) 
Fisher exact <0.0001 
Signature 159 
(100%) 
159 
(100%) 
Fisher exact 1.0000 
Full name printed 157 
(98.7%) 
159 
(100%) 
Fisher exact 0.4984 
Grade of staff 64 
(40.2%) 
159 
(100%) 
Fisher exact <0.0001 
Contact information 72 
(45.3%) 
0 
(0%) 
Fisher exact <0.0001 
Further information to follow? 2 
(1.3%) 
0 
(0%) 
Fisher exact 0.4984 
Fisher exact test used a two tail P value   
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Prescribing errors were compared pre and post HEPMA implementation as 
illustrated in Table 5.9. There was a statistically significant reduction in the 
number of patients with a prescribing error post HEPMA implementation, with 
a reduction from 158 to 37 (p<0.001.) Furthermore, there was a statistically 
significant reduction in all types of prescribing errors post HEPMA 
implementation except for three categories as shown in Table 5.9.   
Therapeutic duplications and incorrect allergies showed no statistical 
difference; although these had small patient numbers in both subsets.  The 
new error type (sociotechnical) showed an increase in occurrence from zero to 
eight patients.  
Multiple error types were detected in 41.5% (n=66) pre-implementation 
patients.  Multiple instances of the same error occurred in 56% (n=89) 
patients in particular multiple omitted medicines or no duration of information. 
Whereas, in the post-implementation cohort, multiple error types were 
detected in only 2% (n=3) patients and multiple instances of the same error in 
7% (n=11). 
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Table 5.9 Comparison of prescribing errors 
Comparison of number and percentage 
of patients with prescribing errors 
Pre- HEPMA 
n=159 
Post-HEPMA 
n=159 
Chi- 
square 
p value 
Patients with errors 158  
(99.4%) 
37 
(23.3%) 
194.115 <0.001 
Patients with errors excluding NKDA 134 
(84.3%) 
37 
(23.3%) 
119.03 <0.001 
Omitted medicines 66  
(41.5%) 
18 
(11.3%) 
37.275 <0.001 
Medicine commissions 10 
(6.3%) 
1 
(0.6%) 
7.627 0.006 
Incorrect Doses 14 
(8.8%) 
1 
(0.6%) 
11.824 <0.001 
Incorrect frequencies 30 
(18.9%) 
2 
(1.3%) 
27.241 <0.001 
Incorrect durations 43 
(27.0%) 
3 
(1.9%) 
40.665 <0.001 
Drug Interactions 7 
(4.40%) 
1 
(0.6%) 
4.616 0.032 
Therapeutic duplications 5 
(3.1%) 
4 
(2.5%) 
0.114 0.736 
Missing allergies 154 
(96.9%) 
2 
(1.3%) 
290.72 <0.001 
Incorrect allergies 2 
(1.3%) 
0 
(0%) 
Fisher exact 0.498 
Sociotechnical error 0 
(0%) 
8 
(5.0%) 
Fisher exact 0.007 
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Error Severity Scoring 
Error severity scoring was arranged with a panel comprising a consultant 
doctor, pharmacist and ANP. The ANP failed to attend the scheduled 
appointment and therefore the panel proceeded with only a consultant doctor 
and pharmacist. The results of the severity scoring are shown in Figure 5.15. 
HEPMA implementation resulted in 22% (n=8) patients with errors assessed 
as likely to cause potential patient harm. It should be noted that patients 
could have errors in more than one severity category. 
There were 40 distinct errors that were assessed for severity. The same error 
may have occurred in multiple patients for example therapeutic duplication of 
lactulose and Laxido© and selection of prednisolone soluble tables instead of 
plain which both occurred in two patients. Table 5.6 provides a description of 
the error with associated score 
The doctor and pharmacist were in agreement with the severity scoring for all 
errors and therefore no errors required further review.  
 
 
Figure 5.15 Percentage of patients with error severity levels 
1= no potential harm; 2= monitoring or intervention potentially required to 
preclude harm; 3=potential harm 
*1+2 Patients could have errors in more than one severity category 
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Hypothesis acceptance or rejection 
The null hypothesis was rejected and therefore HEPMA implementation 
impacted positively the discharge letter quality, number and severity of 
prescribing errors.
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Table 5.10 Post HEPMA error severity scoring 
Error Description Error type Severity 
Score 
Eye drops prescribed on IDL with choose route. Sociotechnical 1 
Both Laxido® and lactulose prescribed on IDL. Therapeutic 
duplication 
2 
Admitted on hyoscine butylbromide 20mg 4x prn, prescribed and administered as inpatient 
but missing from IDL. 
Omission 3 
Zopiclone as required for night sedation missed from IDL. The patient had doses the two 
nights prior to discharge and was admitted on zopiclone. 
Omission 2 
Cilest® suspended on admission due to vaginal bleeding but not transferred to IDL and no 
information documented regarding when to restart.  
Omission 2 
No medicines added to IDL but patient had 18 medicines prescribed and administered as 
inpatient which should be continued on discharge. 
Omission 3 
Esomeprazole 40mg 1x prescribed as inpatient but omitted from IDL. Omission 2 
Wrong formulation of phenoxymethylpenicillin selected; syrup instead of tablets. 
 
Sociotechnical 1 
Bisoprolol 7.5mg prescribed as inpatient but only 5mg on IDL (medicines transferred across 
on 10/03 but dose increased after that and patient discharged on 20/03) Bisoprolol started 
to treat atrial fibrillation. 
Sociotechnical 2 
Senna missed from IDL despite increased dose of co-codamol from 15/500 to 30/500. Omission 2 
Movicol® paediatric plain selected instead of adult. 
 
Sociotechnical 1 
Lantus® and Humulin S® on IDL with no frequency documented. Marked as charted but the 
insulin chart would not be sent to the patient’s GP. 
Incorrect 
frequency 
1 
Glyceryl trinitrate spray omitted from IDL although was prescribed on inpatient prescription. Omission 2 
Prednisolone soluble tablets selected instead of plain. Sociotechnical 1 
Simvastatin withheld during inpatient stay as also prescribed clarithromycin. Information 
documented on IDL to restart simvastatin once antibiotics completed.  Simvastatin and 
clarithromycin both prescribed on IDL and both dispensed. 
Drug 
Interaction 
2 
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Error Description Error type Severity 
Score 
Five day supply of cyclizine requested on IDL but this was not administered during inpatient 
stay. 
Commission 1 
Clomipramine prescribed in morning but should be at night as per admission medicine 
reconciliation. (HEPMA defaults to 10pm time). 
Incorrect 
frequency 
2 
Methocarbomol missing from IDL although prescribed as inpatient. Omission 2 
Amiodarone 200mg tablets selected for 100mg dose (100mg tablets available). Sociotechnical 2 
Diclofenac dispersible tablets selected but all other medicines are solid oral forms and 
patient was taking enteric coated tablets prior to admission. 
Sociotechnical 1 
Commenced on zopiclone for night sedation but developed a skin rash so stopped. 
Information not documented on IDL nor allergy status updated. 
Omitted 
allergy 
3 
Omeprazole started for gastro-intestinal protection whilst on steroids for 14 days. Therefore 
omeprazole should not be long-term but 28 days requested of omeprazole requested on IDL 
and marked as to continue by GP. 
Incorrect 
duration 
3 
Alendronic acid once weekly on a Sunday missing from IDL but prescribed on inpatient 
chart. 
Omission 2 
Palliative care recommended codeine and sevredol for pain as tramadol no longer effective 
but all three on IDL plus dihydrocodeine. 
Therapeutic 
duplication 
3 
Ramipril withheld on admission due to acute kidney injury (AKI) but not restarted on IDL 
despite information stating AKI resolved. 
Omission 2 
NovoRapid® missing from IDL. Only lantus® prescribed on IDL although both prescribed on 
inpatient prescription. 
Omission 2 
Laxido® sachets missing from IDL. The patient is prescribed high dose morphine (Zomorph® 
40mg 2x). 
Omission 2 
Omitted breakthrough morphine (morphine sulphate solution) from IDL. Patient prescribed 
Zomorph® 40mg 2x. 
Omission 2 
Salbutamol metered dose inhaler 2 puffs as required prescribed as inpatient but not 
prescribed on IDL. 
Omission 2 
Prescribed and administered ibuprofen 400mg 3x as inpatient for several days prior to 
discharge but not added to IDL. 
Omission 2 
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Error Description Error type Severity 
Score 
Nicotinell® 30 patch prescribed as inpatient but missing from IDL (Patient started 2 weeks 
prior to admission). 
Omission 2 
Eight routine medicines prescribed as inpatient but not documented on IDL.  Omission 3 
Meloxicam, azathioprine and sulfasalazine should be restarted at normal doses one week 
post discharge but none prescribed on IDL and not mentioned on IDL.  
Omission 3 
Five medicines prescribed on inpatient prescription but not on IDL.  Omission 3 
Tranexamic acid should be continued until clinic appointment but marked as 28 days with 
GP to continue. 
Incorrect 
duration 
2 
Omeprazole prescribed as gastrointestinal cover whilst on diclofenac but this information 
not communicated to GP so potential that this could be continued. 
Incorrect 
duration 
3 
Allergy information recorded as other (see medical notes). There was a note documented in 
inpatient HEPMA as sodium benzoate causes mouth ulcers but this note not added to the 
IDL. 
Missing allergy 2 
Patient prescribed both Fluoxetine and Amitriptyline on IDL (only taking Amitriptyline prior 
to admission). 
Therapeutic 
duplication 
2 
Mometasone cream and Doublebase® gel prescribed as inpatient but missing from IDL. Omission 2 
Doxycycline and prednisolone marked as 28 day supply on IDL but should only be 7 day 
course. 
Incorrect 
duration 
3 
 
1= no potential harm; 2= monitoring or intervention potentially required to preclude harm; 3=potential harm 
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Patient readmission data 
The patient re-admission data is shown in Table 5.7 for seven, 14, 28 and 90 
days to assess whether prescribing errors and the quality of discharge 
communication had an impact on patient readmission episodes. 
 Table 5.11 Patient readmission data 
Comparison of patient 
readmission numbers 
(percentages) 
Pre-
HEPMA 
(n=159) 
Post-
HEPMA 
(n=159) 
Chi-
square 
p value 
7 day  total   3 
(1.9%) 
3 
(1.9%) 
0 1 
14 day total   5 
(3.1%) 
4 
(2.5%) 
0.114 0.736 
28 day total   8 
(5.0%) 
6 
(3.8%) 
0.299 0.585 
90 day total  17 
(10.7%) 
12 
(7.5%) 
0.949 0.330 
7 day same specialty 2 
(1.3%) 
1 
(0.6%) 
0.337 0.562 
14 day same specialty 4 
(2.5%) 
1 
(0.6%) 
1.829 0.176 
28 day same specialty 7 
(4.4%) 
5 
(3.1%) 
0.346 0.556 
90 day same specialty 12 
(7.5%) 
8 
(5.0%) 
0.854 0.355 
 
There were a total of 23 re-admission episodes for 17 patients in the pre-
implementation group in comparison to 16 readmission episodes for 12 patients 
in the post-implementation group.  Table 5.7 shows that there was no 
statistically difference between the pre and post patients. Therefore, there was 
no association between patient readmission and HEPMA implementation.  
DISCUSSION 
This phase of the DPP project quantified the impact of HEPMA implementation in 
relation to information documentation and prescribing errors. While accepting 
the limitations of the pre-post design compared to the ideal randomised 
controlled trial, the findings contribute original knowledge about the alteration in 
number, type and severity of prescribing errors on IDLs as a consequence of 
HEPMA implementation. 
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Information content of IDL 
HEPMA implementation resulted in information content and accuracy 
improvement, although certain information was recorded in incorrect sections of 
the IDL and therefore classified as missing. A similar finding was reported by 
Callen et al (Callen, Alderton and McIntosh 2008). Previous studies had reported 
inconsistent results regarding discharge information content and accuracy when 
moving to electronic systems: either improved, unchanged or worse (Callen J, 
McIntosh J and Li J  2010, Callen, Alderton and McIntosh 2008, Scullard et al.  
2007, Hammad et al. 2014).An unanswered question remains regarding the 
importance of information recorded in incorrect locations on the IDL, for 
example, all diagnostic and stay information typed in the clinical progress 
section. It remains to be established if this is acceptable to GPs, or if the 
information is more accessible when recorded in the designated sections. 
Compliance with SIGN guideline 
An improvement for almost all assessed SIGN guideline criteria was detected as 
a consequence of HEPMA implementation. Notable exceptions were the 
documentation of “extended discharge to follow?” and contact information. 
Currently, there is no defined space to record this information on the HEPMA 
IDL, and therefore a free text entry would be required which may account for 
the low compliance with these criteria. 
Number of prescribing errors 
HEPMA implementation reduced significantly the number of prescribing errors. 
Allergy information documentation especially improved, although noticeably it 
impacted less on therapeutic duplications.  The incidence of this error type 
remained consistent despite the addition of decision support information 
(currently only those conflicts graded as level 4 classified as “do not combine” 
are active. The grading is assessed by a group of First databank pharmacists and 
pharmacologists). The HEPMA system logs every incidence of decision support 
information displayed to prescribers. Conflict information was provided for two of 
the identified errors (simvastatin and clarithromycin drug interaction and 
therapeutic duplication of amitriptyline and fluoxetine). The prescriber may 
override the warning, which accounts for the persistence of error occurrence. 
HEPMA implementation confers automatic import of information from the 
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inpatient chart to the IDL which is consistent with a recommendation by 
Kriplalani et al that “hospitals should use information technology to extract 
information into discharge summaries to ensure accuracy (e.g. medication 
names and doses) and to facilitate rapid completion of summaries” (Kripalani et 
al. 2007). HEPMA implementation eradicates medicine transcription for IDLs 
which was predicted to reduce prescribing errors (Callen J, McIntosh J and Li J  
2010, Callen, Alderton and McIntosh 2008).  Grimes et al reported medicine 
discrepancies in 66% patients (Grimes et al. 2008).  HEPMA implementation 
reduced prescribing errors from 99% to 23% patients. The most frequent 
prescribing error type was omitted medicines which is consistent with published 
studies (Callen J, McIntosh J and Li J  2010, Callen, Alderton and McIntosh 2008, 
Witherington, Pirzada and Avery 2008, Abdel-Qader et al. 2010). Sociotechnical 
errors accounted for 10 (13%) of post-implementation errors and therefore the 
HEPMA system prevented more errors than it created. This is consistent with an 
inpatient error study using an electronic system (Westbrook et al. 2013). Errors 
occurring as a consequence of making changes to inpatient chart after 
preparation of discharge letter had been previously reported (Callen J, McIntosh 
J and Li J  2010). A similar error was detected post HEPMA, despite a system 
alert to indicate that medicines previously added to the IDL. HEPMA 
implementation has not completely eliminated prescribing errors.  The majority 
of detected prescribing errors were classified as execution errors in Reason’s 
model (slips or lapses) which generally occur due to human fallibility (Reason  
2000). Evidence of planning failures remained where practitioners considered 
their actions correct.  Therefore, system design has diminished but not 
eradicated errors. 
Severity of prescribing errors 
HEPMA prescribing errors were categorised as potentially associated with harm 
in 22% (n=8) patients. Comparison with published studies indicates that error 
severity is lower with HEPMA compared to traditional handwritten processes. 
Published error severity varied and a range of severity scoring assessments were 
utilised. Grimes et al reported error severity rates in handwritten IDLs as 47%  
no harm or minor potential harm; with 53% as moderate potential patient harm 
(Grimes et al. 2008). McMillan et al assessed 88% of errors as minor or 
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potentially troublesome (McMillan, Allan and Black 2006).  Abdel-Qader et al 
categorised errors as serious 2.9%; significant 76.3% and minor 20.8% (Abdel-
Qader et al. 2010). Sociotechnical errors (n=10) were rated at either error 
severity level 1 or 2 which is consistent with previous literature which claimed 
this error type was associated with lower levels of harm than other prescribing 
errors (Abdel-Qader et al. 2010).  
GP receipt time 
Lengthy time delays for GP receipt of IDLs were identified in the pre-
implementation patients. This highlighted a potential patient safety issue with a 
mean delay of five days and 6% IDLs not reaching the GP. Thus GPs may not 
have access to essential accurate information after patients’ hospital discharge 
which may result in potential patient harm. Furthermore it highlights 
inefficiencies in the system requiring GP to contact hospital to obtain necessary 
information. The planned electronic transmission of IDLs was not successfully 
implemented prior to completion of post HEPMA evaluation. A previous study 
demonstrated electronic communication methods resulted in improved receipt 
times with 74% or emailed letters received within 7 days (Chen, Brennan and 
Magrabi 2010). 
Patient re-admission rates 
HEPMA implementation was not associated with a statistically significant impact 
on patient readmission rates. The sample size was calculated based on 
prescribing error rate reduction and it is likely that the sample was too small to 
detect this difference. This result is consistent with a systematic review where 
only one study demonstrated patient readmission reduction at 12 months 
(Motamedi et al. 2011). Patient readmissions as a consequence of inaccurate 
medicine information communication were described in the interview phase so it 
was decided to include this assessment because HEPMA implementation may 
have resulted in vastly different patient readmission rates. 
Interplay between technology and humans 
HEPMA significantly reduced errors especially when the system extracted 
information from the hospital patient management system e.g. GP information 
and when data from the inpatient chart was automatically pre-populated onto 
the IDL, for example allergy information. Errors occurred irrespective of HEPMA, 
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when human decision making was required e.g. decisions about which medicines 
to prescribe on discharge. Consideration of human factors would therefore be 
proposed in order to further reduce errors. 
Additional identified communication issues 
Whilst completing the case note review, the PI identified some additional 
communication issues and errors. Failure to accurately complete MR on 
admission was detected which may consist of medicines completely missed from 
the MR document or medicines ticked to be continued but not prescribed on 
HEPMA. Incorrect documentation of medicines on IDL as patients’ own supply 
despite alterations in frequency or dose. Failure to communicate some essential 
information to GPs was noted e.g. specification of the required duration of the 
antiplatelet ticagrelor i.e. three or six months. Reasons selected for discontinuing 
medicines was not always accurate e.g. course complete selected for Ramipril 
when high serum potassium was the rationale. Essential dispensing information 
may be missed especially if the IDL not sent to pharmacy, like requirement for 
Blister Pack omitted. Information documentation was variable, sometimes all 
information included in “Clinical Progress” or “Primary Diagnosis” section and not 
inserted into various sections in IDL and inaccuracies between information 
documented on IDL and FL. 
Governance 
The PI obtained Caldicott guardian approval to access patient confidential 
information as shown in Appendix 5.5. The PI did not detect any prescribing 
errors that necessitated intervention during the case note reviews. None of the 
level 3 errors warranted any intervention at the detected stage as several 
months had passed since patient discharge and review. 
Strengths and weaknesses 
The study strengths include the consistent approach applied by the use of an 
adapted validated tool and appropriate study design to minimise bias. 
Limitations of the study included the study design. The ideal would be to conduct 
a RCT but this was impossible due to the nature of HEPMA implementation which 
required to be implemented per ward and therefore patient randomisation could 
not be completed. The patients included in the two phases were different 
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although the demographic information demonstrated that the populations were 
very similar. Prescribing errors were not attributed to individual practitioners. 
Severity score assessment is subjective and as the ANP failed to attend the 
severity scoring panel the ANP perspective was absent. Therefore a panel 
comprising different members could reach different conclusions. Co-existing 
changes may have occurred during the 20 month time gap between pre and post 
assessment. Staff turnover in all professions occurred during that time period 
which meant that there were different prescribers in the two phases. There was 
a failure to complete GP receipt information post-HEPMA implementation. Finally, 
determination of actual patient harm in relation to detected errors was not 
undertaken. 
Further work 
Implementation of electronic transmission of IDL was delayed due to procedural 
and technical difficulties. Therefore, there was no merit in completing GP receipt 
and time to receipt assessment post- implementation. It is planned to complete 
this assessment once successful electronic transmission of IDLs is achieved. 
Additional work to obtain GP opinion regarding the HEPMA IDL is being 
undertaken by pharmacy colleagues. 
CONCLUSION 
HEPMA implementation was associated with a statistically significant reduction in 
prescribing errors and severity of prescribing errors with a concurrent 
improvement in discharge information content. There was no correlation 
between HEPMA implementation and patient readmission rates. It remains to be 
determined if HEPMA implementation will impact discharge letter receipt and 
time of receipt by GP practices. 
CHAPTER SUMMARY 
This chapter described the aim and research questions for the quantitative 
component of the DPP research, conducted before and after HEPMA 
implementation. There was a brief description of methodology prior to detailed 
coverage of study method, results and discussion. 
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CHAPTER 6 GENERAL DISCUSSION 
CHAPTER INTRODUCTION 
This chapter provides a brief overview of the project aims and description of the 
different project phases. The key findings and results are provided with more 
detailed discussion of the project findings and results especially relating to 
project impact. There is also consideration of future research relating to the 
project. 
AIM 
The overall aims of the project were to assess the impact of HEPMA system 
implementation on medicines related discharge communication and prescribing 
errors, and to gain the perspective of hospital staff involved in the 
communication process. 
A convergent parallel mixed methods design was used consisting of both 
qualitative and quantitative components. The project comprised three separate 
phases. 
Phase 1 Qualitative pre-implementation 
The aim was to describe and understand perspectives of key staff groups (i.e. 
consultant doctors, junior doctors, pharmacists and ANPs) relating to patient 
discharge communication via the traditional paper based system and prior to 
HEPMA implementation.  
Interpretative phenomenology was used to achieve this aim with the key 
findings of: 
 
 challenges described with traditional discharge information 
communication processes, including documentation design 
 patient safety concerns highlighted 
 frequent prescribing errors, associated adverse events and hospital 
readmissions  
 information clarification by GPs common, frequently about medicines  
 HEPMA implementation anticipated to improve patient safety and more 
efficient discharge communication  
 application of TDF to findings to identify potential behavioural change  
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Phase 2 Qualitative post-implementation 
The aim was to describe and understand the perspectives of key staff groups 
(i.e. consultant doctors, junior doctors, pharmacists and ANPs) relating to 
patient discharge communication via the recently implemented HEPMA system.  
Interpretative phenomenology used to achieve this aim and produced the 
following key findings: 
 
 improved IDL quality including complete legibility 
 documentation design facilitated information completeness 
 fewer omitted medicines 
 identification of sociotechnical prescribing errors 
 improved patient safety 
 TDF applied to findings to identify behavioural change due to HEPMA 
implementation 
 process changes to improve prescribing and discharge communication  
 inconsistencies between and among specialties 
 consultant doctor engagement variable 
 GP queries reduced or unchanged  
 staff knowledgeable about HEPMA  
 HEPMA competence and confidence variable amongst professions 
 development of behavioural regulation to prevent errors 
Phase 3 Quantitative  
The aim was to determine if HEPMA implementation impacted discharge 
information. 
An experimental, before and after study design was used to achieve this aim and 
produced the following key results: 
 
 enhanced information content and accuracy 
 improved compliance with SIGN guidelines 
 patients with prescribing errors reduced from 99% to 23% (p<0.001)  
 reduced incorrect doses [8.8% to 0.6% (p<0.001)] 
 reduced  incorrect frequencies [19% to 1% (p<0.001)]  
 reduced incorrect durations [27% to 2% (p<0.001)] 
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 omitted medicines most prevalent error type 
 error severity reduced  
DISCUSSION OF FINDINGS 
Policy documents and government strategies have recommended HEPMA 
implementation into NHS hospitals throughout the UK. Previous studies 
demonstrated that e-prescribing systems reduced inpatient prescribing error 
frequency. This study aimed to fill gaps in existing published literature 
highlighted in Chapter 1, especially the paucity of literature relating to HEPMA 
communication of discharge information to GPs. Previous studies of prescribing 
errors and discharge information communication were restricted to review of 
traditional handwritten systems, comparison of traditional systems with 
electronic interim solutions, or investigated solely electronic interim solutions 
(Sexton et al.  2000, Wilson et al. 2001, Foster, Paterson and Fairfield 2002, 
McMillan, Allan and Black 2006, Grimes et al. 2008, Witherington, Pirzada and 
Avery 2008, Scullard et al.  2007, Callen J, McIntosh J and Li J  2010, Callen, 
Alderton and McIntosh 2008, Hammad et al. 2014, Chen, Brennan and Magrabi 
2010, Pillai, Thomas and Garg 2004, Alderton and Callen  2007, Abdel-Qader et 
al. 2010, Yemm et al. 2014). No previously published study had compared 
HEPMA implementation impact on discharge information communication to the 
traditional paper system it was replacing. Similarly, several of the previously 
published studies had ascertained GP opinion (Wilson et al. 2001, Scullard et al.  
2007, Chen, Brennan and Magrabi 2010, Pillai, Thomas and Garg 2004, Alderton 
and Callen  2007, Yemm et al. 2014), but only one had considered the 
perspectives of hospital doctors (Yemm et al. 2014).Therefore, the findings of 
this project contribute original knowledge concerning the impact of HEPMA 
implementation on discharge information communication and prescribing errors. 
The viewpoints of key staff groups involved in the discharge communication 
process also provide a novel contribution to the HEPMA evidence base. 
The findings of this study confirmed HEPMA implementation achieved the 
Scottish e-health strategy aims of improved working practice efficiencies and 
safety of people taking medicines (The Scottish Government 2012).  The study 
result of 76% reduction in prescribing errors exceeds the 50% reduction 
reported by the Health Foundation (The Health Foundation 2012). HEPMA 
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implementation eliminated information transcription at discharge which reduced 
but did not eradicate prescribing errors. Two error types accounted for the 
majority of errors post-implementation: omissions and sociotechnical errors. The 
most prevalent prescribing error post-implementation was omitted medicines 
(11% patients). When a discharge letter is created, the user is provided with a 
list of the currently prescribed medicines. The prescriber is ultimately 
responsible to transfer each individual clinically appropriate medicine to the IDL. 
Therefore, the incidence of omitted medicines is a direct reflection of failure to 
adequately complete medicine reconciliation on discharge. Sociotechnical errors 
are caused by human interaction with the system and warrant exploration of 
human factors for potential solutions. 
The combined results of the qualitative and quantitative components of the 
project demonstrate that staff aspirations of HEPMA implementation benefit have 
been realised. The primary aspiration prior to implementation was to improve 
patient safety. Staff articulated clearly patient safety improvements including 
complete legibility of prescriptions and IDLs. The statistically significant 
reduction in the quantity of patients with prescribing errors post implementation 
confirms staff beliefs of improved patient safety (p<0.001). Likewise, the 
reduction in error severity post-implementation contributes to increased patient 
safety. The claim of fewer omitted medicines on the IDL, as all relevant 
prescribed medicines are transferred to the IDL, was demonstrated similarly with 
a reduction in the number of patients with omitted medicines after HEPMA 
implementation (p<0.001). 
Staff described more detailed information being included in IDLs and case note 
review data verified statistically significant improvements for certain aspects; GP 
details (p<0.001), allergy information (p<0.0001) and grade of staff completing 
IDL (p<0.0001). Certain information was documented in incorrect sections of the 
IDL, which was classified as missing information in the post-implementation 
study. 
Prior to HEPMA implementation, interviewees expressed concern that 
sociotechnical errors, directly related to the HEPMA system may occur. This 
study confirmed the existence of sociotechnical errors which were identified in 
eight patients. Sociotechnical errors were associated with low error severity, 
which is consistent with previous literature (Abdel-Qader et al. 2010).  
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The DPP results indicate that future process change for discharge information 
communication should concentrate on the application of a consistent approach 
amongst the various clinical teams in the production of discharge letters. In 
addition, improvement activity should focus on senior medical input into 
discharge letter creation. It is anticipated this would reduce the pressure 
described by less experienced team members when feeling responsible for 
compilation of accurate information with associated time restrictions.  
The results indicate the minimum HIS requirement that HEPMA systems should 
be at least as safe as the systems they replace has been exceeded and that 
patient safety improvements have been demonstrated (Healthcare Improvement 
Scotland 2014). 
This study was unable to demonstrate improvement to timeliness of GP 
discharge information receipt because electronic transmission of IDLs had not 
been completed. Furthermore, the study could not correlate the reduction in 
prescribing errors with reduced patient hospital readmissions.  
Theoretical framework application 
Qualitative thematic analysis included application of TDF which enabled 
behavioural change aspects of HEPMA implementation to be explored. Pre-
implementation six TDF domains were pertinent to study findings with an 
additional two domains post implementation. Behavioural alteration amongst the 
different professional groups was evident as a direct consequence of HEPMA 
implementation. Staff described alterations in their prescribing behaviours 
including adoption of self-checking to minimise errors and described improved 
prescribing confidence. Process change also evolved to enable high quality 
discharge communication to be produced with description of multidisciplinary 
and consultant input to increase information accuracy. Variability in behaviours 
was most prevalent within consultant doctor professional group with other 
professions describing greater conformity. TDF may be used in future 
interventions to aid questionnaire design for example when assessing GP and 
community pharmacist satisfaction with HEPMA. 
 
TDF explores individual behaviour changes in response to a clinical intervention. 
NPT permits consideration of the organisational response to HEPMA so there may 
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be merit in consideration of this additional theory to reflect on organisational 
implementation impact. 
HEPMA implementation into a NHS hospital involved the introduction of a 
complex system, for complex process use (prescribing and administration), in a 
complex environment. Normalization process theory (NPT) is a sociological 
model with a specific focus on intervention implementation with an aim of 
achieving sustainable interventions. NPT is pertinent to explain integration of a 
healthcare intervention into an organisation and is particularly relevant to 
organisations like the NHS (May  2006). May defines normalization as “the 
embedding of a technique, technology or organisational change as a routine and 
taken-for-granted element of clinical practice”. NPT concentrates on acceptance 
of interventions into routine practice and is particularly relevant to “imposed 
interventions” such as HEPMA. NPT may be used to consider the” interpretation 
and impact of research findings” and “how new research findings are sustained 
in practice” (May  2006).  
 
The four components of the NPT specifically contextualised to HEPMA are: 
 
 coherence (meaning and sense making of HEPMA by users)  
 cognitive participation (commitment and engagement to HEPMA by users) 
 collective action (the work the users do to make HEPMA function) 
 reflexive monitoring (users reflect or appraise HEPMA) 
 
An advantage of using NPT for analysis of findings is because it “acknowledges 
that healthcare is a collective activity requiring a multitude of interactions 
between professionals, patients, managers and others” and consequently is 
particularly relevant to the appraisal of this practice research concerning 
complex implementation in a NHS hospital. 
NPT analysis of DPP project findings indicates that normalization has occurred for 
this complex intervention according to expressed opinions of different 
professional groups of front line staff engaging with HEPMA. There was 
demonstration of staff acceptance of HEPMA into regular use. Staff described 
routine system use in their professional practice and case note review confirmed 
their assertions. Furthermore, staff articulated clearly perceived advantages and 
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disadvantages according to their specialism. They described adoption of different 
working practices when undertaking their clinical roles as a consequence of 
HEPMA implementation. This indicates sustainability of the implemented HEPMA 
system. Communication of HEPMA impact of immediate benefits to patient and 
practice will enhance sustainability. Longer –term benefits should also be 
communicated to promote continued sustainability. The TDF findings indicate 
certain behavioural enablers and inhibitors contributed to HEPMA implementation 
for example system design aided efficient prescribing but time pressures 
adversely affected prescribers’ perceived abilities. The organisation should 
further explore these to ensure HEPMA implementation sustainability and when 
implementing additional services in the future.  
Potential generalisability 
Although this work was completed in a NHS District General Hospital in Scotland 
the work would be potentially generalisable to similar NHS organisations within 
the UK and also to other countries which have similar healthcare systems for 
example Australia, New Zealand, Canada and Ireland. The generalisability may 
be limited dependant on the implemented HEPMA system functionality. 
Overall strengths and limitations 
The strengths of the DPP project include the adoption of a rigorous study design 
approach to minimise design bias and to ensure trustworthiness for the 
qualitative research component. The quantitative component applied a 
consistent approach by use of an adapted validated tool and appropriate study 
design to minimise bias.  Bias was minimised wherever possible in the 
qualitative research including sampling, interviewer, response and research 
interpreter biases as described previously.  
The limitations of the DPP project include the relatively small sample size of 
interviewed staff which may limit applicability of results to other organisations 
and the variety of experience amongst the different professional groups may 
have impacted their responses relating to discharge communication processes. 
The study design was a limitation of the quantitative research as the ideal would 
be to conduct an RCT which was impossible due to the nature of HEPMA 
implementation. The patients included in the before and after sample were 
different, although the demographic information demonstrated very similar 
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patient populations. Prescribing errors were not attributed to individual 
practitioners. The subjective nature of severity scoring is a limitation further 
exacerbated by failure of ANP to attend the panel therefore a panel comprising 
different members may conclude differently. Furthermore, co-existing changes 
may have occurred during the 20 month time gap between pre and post 
assessment. Staff turnover in all professions occurred therefore there were 
different prescribers in the two phases. Determination of actual patient harm in 
relation to detected errors was not assessed.
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IMPACT  
Impact has been defined as “a marked effect or influence” (Oxford University 
Press 2014).  In terms of research, it is important to ensure that research has 
demonstrable benefits which may be wide ranging, including organisational 
and societal benefits. 
The Research Councils UK diagram for pathways to impact focuses on various 
impact points concentrating on academic and economic significance. A copy of 
the diagram is provided in Figure 6.1 (Research Councils UK 2014).  The DPP 
project mainly impacted the pathways of “enhancing the effectiveness and 
sustainability of organisations including public services and businesses” and 
“improving health and wellbeing”. Post-implementation the discharge 
communication process was more efficient with fewer prescribing errors which 
improved patient safety. 
 
 
 
Figure 6.1 Pathways to impact by Research Councils UK 
Alternatively, impact may be described by consideration of knowledge, people, 
economic and societal factors.  These factors are considered below in relation 
to the DPP project. 
 
 
219 
 
Knowledge 
The advancement of knowledge has been achieved as described: 
Scientific advances 
 New knowledge of HEPMA impact to improve discharge information 
communication and reduce prescribing errors 
 Unique assessment  of hospital staff opinion regarding HEPMA 
Publications 
 Oral and poster presentations and journal article publication as 
described in output section 
Conference attendance 
The PI attended the following conferences which provided networking 
opportunities: 
 RPS annual conference 2013 and 2014 
 European Society of Clinical Pharmacy 2014 and 2015 
 Patient Safety Congress 2014 
Transfer of knowledge 
 Results shared with HEPMA full business case project board 
 Presentations of results to NHS Ayrshire & Arran pharmacy and hospital 
staff 
 Presentation of results to NHS Ayrshire & Arran Safer Medicines Group 
 Presentations and publications as described in output section 
People 
The impact of the DPP on people included skills development by the PI and 
engagement of other people in research activities as outlined below: 
Skills development 
The PI developed the following skills: 
 
 Qualitative research skills including face-to-face interviews and 
interview transcribing 
 Use of electronic analysis software – NVivo© and SPSS 
 Use of electronic reference management system i.e. Refworks© 
 Enhancement of time management skills 
 Development of writing skills including conference abstracts 
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 Development of oral and poster presentation skills 
Outreach 
 Multiple staff exposed to research as a direct consequence of interview 
participation, review of data extraction, or information retrieval 
Economy  
The DPP project impacted on economy by: 
Products and procedures 
 HEPMA system development as a consequence of sharing interview 
participants’  suggestions for improvement to the HEPMA development 
team and national HEPMA full business case project board 
Society 
The societal impacts of the DPP project are described by the following points: 
Quality of life 
 Improved discharge information communication assists with seamless 
transfer of care between secondary and primary care which 
consequently prevents potential patient harm 
 Staff satisfaction with HEPMA is high with described improvements to 
professional confidence and prescribing competence 
Policies  
 HEPMA implementation is recommended by the Scottish government 
and the DPP results support the HEPMA benefits in the e-health strategy 
 HEPMA implementation resulted in improved compliance with SIGN 
guideline 
 HEPMA implementation assessed as being safer than the traditional 
prescribing system it replaced and therefore complies with HIS 
recommendation to be at least as safe as existing system 
Health 
 Improved patient safety as HEPMA implementation resulted in reduced 
prescribing error quantity and severity 
 Improved patient safety as increased quality of IDL communications 
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FURTHER RESEARCH SPECIFIC TO DPP PROJECT 
Three further research areas specific to the DPP project require to be 
completed. 
GP receipt and receipt time 
The planned assessment of IDL GP receipt and receipt time for the DPP project 
was not completed after HEPMA implementation due to technical difficulties 
with electronic IDL transmission. This is a current organisational priority. 
Therefore, the PI will complete the proposed research to establish the 
consequences of electronic transmission.  
Research question 
Did electronic transmission of HEPMA IDLs alter GP IDL receipt and time to 
receipt? 
Methodology 
Quantitative experimental design 
Method 
Quasi experimental before and after study design (before phase already 
completed) 
Key outcome measures 
1. GP receipt 
2. Time difference between GP receipt and patient hospital discharge 
Likely impact pathways 
Changing organisational culture and practice as new process for IDL 
communication will be developed. 
Improving health and well being as GPs should receive IDL information more 
quickly which will facilitate future GP consultations with discharged patients. 
GP opinion 
GP opinion regarding HEPMA IDLs and electronic communication of IDLs to 
patients’ GP should be obtained when successful transmission has been 
achieved. 
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Research question 
What are GP perceptions of HEPMA IDLs and electronic transmission of IDLs 
from UHC? 
Methodology 
Quantitative survey design 
Method 
Questionnaire 
Key outcome measures 
1. GP satisfaction with document design and information completion 
2. Availability of discharge information when required by GP 
Likely impact pathways 
Improving health and well being as GPs should receive IDL information more 
quickly which will facilitate future GP consultations with discharged patients. 
Community pharmacist opinion 
Community pharmacist opinion regarding electronic communication of IDLs to 
patients’ nominated community pharmacy should be obtained when successful 
transmission has been achieved. 
Research question 
What is the perception of community pharmacists about the impact of 
electronic transmission of IDLs on pharmaceutical care provision? 
Methodology 
Quantitative survey design 
Method 
Questionnaire 
Key outcome measures 
1. Pharmacist satisfaction 
2. Pharmaceutical care provision alteration 
Likely impact pathways 
Improving health and well-being as pharmaceutical care provision should be 
better tailored for individual patients. 
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Changing organisational culture and practices as a new process for 
transmission of IDL to patients’ nominated community pharmacist will be  
developed. 
FURTHER HEPMA RESEARCH 
HEPMA implementation is a complex intervention into a complex environment 
and there are multiple future research areas which should be considered by 
NHS Scotland and other areas implementing HEPMA.  Additional research 
could focus on the impact of HEPMA on inpatient prescribing errors; the 
alteration of clinical pharmacist work by use of an electronic screening tool 
which prioritise patients according to predefined criteria including patient 
factors and prescribed medicines; and alteration of staff working as a 
consequence of HEPMA implementation. 
FURTHER PI RESEARCH AMBITIONS 
The PI aims to continue utilising and developing the skills honed during the 
DPP course and plans to conduct further pharmacy practice research. 
Innovation is a core component of the current role of the PI, which creates an 
ideal opportunity to conduct practice research. The PI aims to share research 
findings by conference abstract submissions and publication of completed work 
in peer reviewed journals. Furthermore, the PI aspires to develop research 
capability within the local pharmacy profession and encourage other 
pharmacists, especially junior pharmacists to become involved in research and 
to likewise share research findings either by conference attendances and 
journal publications. The PI would also like to collaborate with other individuals 
or organisations completing comparable research with the ultimate aim of 
enhancing patient care through embedding research in pharmacy practice. 
CONCLUSION 
The key findings of the DPP project indicate that HEPMA implementation 
resulted in statistically significant improvements to the content and quality of 
discharge information with an associated statistically significant reduction in 
prescribing errors. Confirmation of a new error type (sociotechnical), related 
to the system was achieved. A reduction in prescribing error severity was 
demonstrated and sociotechnical errors were associated with low error 
severity. Prescribing errors occur due to multiple causative factors and this 
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study indicates that HEPMA implementation will reduce but not eradicate 
prescribing errors.  
 Hospital staff described perceived benefits of improved patient safety and 
reduced adverse events as a consequence of enhanced discharge information 
communication. The study provided unique insight about behavioural changes 
adopted by staff to facilitate the normalization of this complex intervention 
into routine organisational work. It highlighted differences in professional 
group interplay with consultant medical staff exhibiting the most variable 
behaviour. Staff described process changes adopted as a direct consequence 
of HEPMA implementation to further improve discharge information 
communication. Thus, the advantages ascribed to electronic prescribing 
solutions of improved legibility, information content accuracy and reduced 
errors have been verified in relation to discharge information communication. 
The impact of electronic IDL transmission remains to be ascertained. These 
results will be relevant to other Scottish, UK and national organisations with 
similar healthcare services. The Scottish e-health policy advocates HEPMA 
implementation for all secondary care settings. Significant resource 
investment is required for HEPMA implementation. Thus the demonstrated 
benefits of prescribing error reduction, increased information quality and high 
staff acceptance provides reassurance for organisations in the process of, or 
planning HEPMA implementation.  
 
CHAPTER SUMMARY 
This chapter provided a brief overview of the project aims with description of 
the different project phases. The key findings and results were provided with 
more detailed discussion of the project findings and results especially related 
to project impact. Future research plans were discussed. 
 
 
 
 
 
225 
 
REFERENCES 
 
Mosby's medical dictionary. 2009. [online] Elsevier. Available from: 
http://medical-dictionary.thefreedictionary.com/construct+validity [Accessed 
11/16 2014] 
ABDEL-QADER, D.H. et al., 2010. Pharmacists’ interventions in prescribing 
errors at hospital discharge. Drug Safety, 33(11), pp. 1027-1044 
ACADEMY OF MEDICAL ROYAL COLLEGES, 2008. A clinician's guide to record 
standards- part 2:Standards for the structure and content of medical records 
and communications when patients are admitted to hospital   
[online] Royal College of Physicians. Available from: 
http://www.rcplondon.ac.uk/resources/clinician’s-guide-record-standards-–-
part-2-standards-structure-and-content-medical-record [Accessed 01/16 
2012] 
ALDERTON, M. and CALLEN, J., 2007. Are general practitioners satisfied with 
electronic discharge summaries? Health Information Management Journal, 
36(1), pp. 7-12 
ASHCROFT, D.M. et al., 2015. Prevalence, nature, severity and risk factors for 
prescribing errors in hospital inpatients: prospective study in 20 UK hospitals. 
Drug Safety, 38(9), pp. 833-843 
BAKER, S.E. and EDWARDS, R., 2012. How many qualitative interviews is 
enough. [online]  National Centre for Research Methods Review Paper. 
Available from http://eprints.ncrm.ac.uk/2273/4/how_many_interviews.pdf 
[Accessed 04/30 2013] 
BANDOLIER, 2007. Evidence based thinking about healthcare. [online] Oxford 
University Press. Available from: 
http://www.medicine.ox.ac.uk/bandolier/booth/glossary/RCT.html [Accessed 
01/12 2015] 
BATES, D.W. et al., 1999. Patient risk factors for adverse drug events in 
hospitalized patients. Archives of Internal Medicine, 159(21), pp. 2553 
BENNET, L.W., Research bias. [online] University if Illinois at Chicago. 
Available from: 
http://tigger.uic.edu/~lwbenn/jacswcourses/socw360/week14.htm [Accessed 
12/19 2014] 
BIDDIX, J.,P., Research rundowns. [online] WorldPress.com. Available from: 
http://researchrundowns.wordpress.com/quantitative-methods/instrument-
validity-reliability/ [Accessed 01/12 2015] 
BLACK, A.D. et al., 2011. The impact of eHealth on the quality and safety of 
health care: a systematic overview. PLoS medicine, 8(1), pp. e1000387 
BMJ GROUP AND ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN, 
2015. British National Formulary 69. Royal Pharmaceutical Society. 
 
226 
 
BOWLING, A., 2014. Research methods in health Investigating health and 
health services. 4th ed. Maidenhead, England: McGraw Hill Education Open 
University Press. 
BRANT, R., Inference for proportions: Comparing two independant samples. 
[online] University of British Columbia. Available from: 
http://www.stat.ubc.ca/~rollin/stats/ssize/b2.html [Accessed 05/08 2013] 
CALDICOTT, F., 2013. Information: To share or not to share. Information 
Governance Review. [ online] Available from: 
http://eprints.bucks.ac.uk/1475/2/Information%20Governance%20Review.pdf
.txt [Accessed 08/09 2014] 
CALLEN J, MCINTOSH J and LI J, 2010. Accuracy of medication documentation 
in hospital discharge summaries: A retrospective analysis of medication 
transcription errors in manual and electronic discharge summaries. 
International Journal of Medical Informatics, 79 (1), pp. 58-64 
CALLEN, J.L., ALDERTON, M. and MCINTOSH, J., 2008. Evaluation of electronic 
discharge summaries: a comparison of documentation in electronic and 
handwritten discharge summaries. International Journal of Medical 
Informatics, 77(9), pp. 613-620 
CAMPBELL, M.J. and SWINSCOW, T.D.V., 2011. Statistics at square one. John 
Wiley & Sons. BMJ Books, West Sussex, UK. 
CANE, J., O’CONNOR, D. and MICHIE, S., 2012. Validation of the theoretical 
domains framework for use in behaviour change and implementation research. 
Implementation Science, 7(1), pp. 37 
CASAGRANDE, P.A.S., 2013. Casagrande pike and smith sample size 
calculator: Compare two proportions. [online] Available from: 
http://www.cct.cuhk.edu.hk/stat/proportion/Casagrande.htm [Accessed 05/08 
2013] 
CHEN, Y., BRENNAN, N. and MAGRABI, F., 2010. Is email an effective method 
for hospital discharge communication? A randomized controlled trial to 
examine delivery of computer-generated discharge summaries by email, fax, 
post and patient hand delivery. International Journal of Medical Informatics, 
79(3), pp. 167-172 
CRESSWELL, K. et al., 2013. Investigating and learning lessons from early 
experiences of implementing ePrescribing systems into NHS hospitals: a 
questionnaire study. PloS one, 8(1), pp. e53369 
CRESSWELL, K.M. and SHEIKH, A., 2014. Undertaking sociotechnical 
evaluations of health information technologies. Informatics in Primary Care, 
21(2), pp. 78-83 
CRESWELL, J.W., 2013. Research design: Qualitative, quantitative, and mixed 
methods approaches. Sage. University of Nebraska, Lincoln. USA. 
CORNFORD, T. et al., 2009. Electronic prescribing in hospitals-challenges and 
lessons learned. NHS Connecting for Health. [online] Available from 
eprints.pharmacy.sc.uk [Accessed 05/08 2013] 
227 
 
DAVIES, M.B., 2007. Doing a successful research project: Using qualitative or 
quantitative methods. Palgrave Macmillan New York. 
DEAN, B., BARBER, N. and SCHACHTER, M., 2000. What is a prescribing error? 
Quality in Health Care, 9(4), pp. 232-237 
DEPARTMENT OF HEALTH, 2013. Information to share or not to share? the 
information governance review. [online] Department of Health. Available from: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/fil
e/192572/2900774_InfoGovernance_accv2.pdf [Accessed 04/24 2013] 
DEPARTMENT OF HEALTH, 2013. £260 million invested in patient safety plan. 
[online] Department of Health. Available from: 
https:///www.gov.uk/government/news/260-million-invested-in-patient-
safety-plans [Accessed 05/28 2013] 
DONYAI, P. et al., 2008. The effects of electronic prescribing on the quality of 
prescribing. British Journal of Clinical Pharmacology, 65(2), pp. 230-237 
DORNAN, T. et al., 2009. An in depth investigation into causes of prescribing 
errors by foundation trainees in relation to their medical education—EQUIP 
study. London: General Medical Council,  pp. 1-215 
DRISCOLL, P., LECKY, F. and CROSBY, M., 2000a. An introduction to everyday 
statistics—1. Journal of Accident & Emergency Medicine, 17(3), pp. 205-211 
DRISCOLL, P., LECKY, F. and CROSBY, M., 2000b. An introduction to everyday 
statistics—2. Journal of Accident & Emergency Medicine, 17(4), pp. 274-281 
DUNCAN, E.M. et al., 2012. Learning curves, taking instructions, and patient 
safety: using a theoretical domains framework in an interview study to 
investigate prescribing errors among trainee doctors. Implementation Science, 
7(1), pp. 86 
DURANT-LAW, G., Research paradigms, the philosophical trinity, and 
methodology. [online] Available from: 
http://www.durantlaw.info/sites/durantlaw.info/files/Research%20Paradigms,
%20the%20Philosophical%20Trinity%20and%20Methodology.pdf [Accessed 
04/24 2013] 
EVANS, B.C., COON, D.W. and UME, E., 2011. Use of theoretical frameworks 
as a pragmatic guide for mixed methods studies: A methodological necessity? 
Journal of Mixed Methods Research, 5(4), pp. 276-292 
FERNER, R.E. and ARONSON, J.K., 2006. Clarification of terminology in 
medication errors. Drug Safety, 29(11), pp. 1011-1022 
FLEMING, A. et al., 2014. Antibiotic prescribing in long-term care facilities: a 
qualitative, multidisciplinary investigation. BMJ Open, 4(11), pp. e006442-
2014-006442 
FORSTER, A.J. et al., 2003. The incidence and severity of adverse events 
affecting patients after discharge from the hospital. Annals of Internal 
Medicine, 138(3), pp. 161-167 
228 
 
FOSTER, D., PATERSON, C. and FAIRFIELD, G., 2002. Evaluation of immediate 
discharge documents--room for improvement? Scottish Medical Journal, 47(4), 
pp. 77-79 
FRANCIS, J.J. et al., 2010. What is an adequate sample size? Operationalising 
data saturation for theory-based interview studies. Psychology and Health, 
25(10), pp. 1229-1245 
FRANCIS, J.J., O'CONNOR, D. and CURRAN, J., 2012. Theories of behaviour 
change synthesised into a set of theoretical groupings: introducing a thematic 
series on the theoretical domains framework. Implementation Science, 7(1), 
pp. 35 
FRENCH, S.D. et al., 2012. Developing theory-informed behaviour change 
interventions to implement evidence into practice: a systematic approach 
using the Theoretical Domains Framework. Implementation Science, 7(1), pp. 
38 
GENERAL PHARMACEUTICAL COUNCIL, 2012. Standards of conduct, ethics and 
performance. 2nd ed. London, England: General Pharmaceutical Council. 
GALE, N. et al., 2013. Using the framework method for the analysis of 
qualitative data in multi-disciplinary health research. BMC Medical Research 
Methodology, 13, pp. 117 
GLEASON, K.M. et al., 2010. Results of the Medications at Transitions and 
Clinical Handoffs (MATCH) study: an analysis of medication reconciliation 
errors and risk factors at hospital admission. Journal of General Internal 
Medicine, 25(5), pp. 441-447 
GRIMES, T.C. et al., 2011. Medication details documented on hospital 
discharge: cross‐sectional observational study of factors associated with 
medication non‐reconciliation. British Journal of Clinical Pharmacology, 71(3), 
pp. 449-457 
GRIMES, T. et al., 2008. Survey of medication documentation at hospital 
discharge: implications for patient safety and continuity of care. Irish Journal 
of Medical Science, 177(2), pp. 93-97 
HAMMAD, E.A. et al., 2014. Adherence to UK national guidance for discharge 
information: an audit in primary care. British Journal of Clinical Pharmacology, 
78(6), pp. 1453-1464 
HARRIS, A.D. et al., 2006. The use and interpretation of quasi-experimental 
studies in medical informatics. Journal of the American Medical Informatics 
Association, 13(1), pp. 16-23 
HARTNELL, N. et al., 2012. Identifying, understanding and overcoming 
barriers to medication error reporting in hospitals: a focus group study. BMJ 
Quality & Safety, 21(5), pp. 361-368 
HEALTHCARE IMPROVEMENT SCOTLAND, 2014a. Implementing an electronic 
prescribing and medicines administration system: A good practice guide. 
[online] Edinburgh Scotland: NHS Scotland. Available from: 
http://www.healthcareimprovementscotland.org/our_work/technologies_and_
229 
 
medicines/electronic_prescribing/good_practice_guide.aspx [Accessed 06/10 
2014] 
HEALTHCARE IMPROVEMENT SCOTLAND, 2014b. The Scottish patient safety 
programme. [online] Healthcare Improvement Scotland. Available from: 
http://www.scottishpatientsafetyprogramme.scot.nhs.uk/ [Accessed 09/12 
2014] 
HUIJG, J.M. et al., 2014. Measuring determinants of implementation behavior: 
psychometric properties of a questionnaire based on the theoretical domains 
framework. Implementation Science, 9(33) pp. 9-23 
IBM, 2013. SPSS software version 21. [online] IBM. Available from: 
http://www-01.ibm.com/software/uk/analytics/spss/ [Accessed 09/11 2012] 
JOHNSON, R.B. and ONWUEGBUZIE, A.J., 2004. Mixed methods research: A 
research paradigm whose time has come. Educational Researcher, 33(7), pp. 
14-26 
KERLINGER, F.N., 1979. Behavioral research: A conceptual approach. Holt, 
Rinehart and Winston New York. 
KINASH, S., 2006. Paradigms, Methodology & Methods. Bond University 
Australia,  
KOTZAB, H. et al., 2006. Research methodologies in supply chain 
management. Springer New York 
KRIPALANI, S. et al., 2007. Deficits in communication and information transfer 
between hospital-based and primary care physicians: implications for patient 
safety and continuity of care. Journal of the American Medical Association, 
297(8), pp. 831-841 
KUBLER-ROSS, E., 1970. On death and dying. Scribner. New York 
LEWIN, K., 1947. Frontiers in Group Dynamics II. Channels of group life; 
social planning and action research. Human Relations, 1(2), pp. 143-153 
LEWIS, P.J. et al., 2009. Prevalence, incidence and nature of prescribing errors 
in hospital inpatients. Drug Safety, 32(5), pp. 379-389 
LIPWORTH, W., TAYLOR, N. and BRAITHWAITE, J., 2013. Can the theoretical 
domains framework account for the implementation of clinical quality 
interventions?: a qualitative synthesis and mapping experiment. BMC Health 
Services Research, 13(1), pp. 530 
MAY, C., MURRAY, E., FINCH, T., MAIR, F., TREWEEK, S., BALLINI, L., 
MACFARLANE, A. AND RAPLEY, T., 2010. Normalization process theory on-line 
users' manual and toolkit. [online] Economic and social research council. 
Available from: http://www.normalizationprocess.org [Accessed 06/02 2014] 
MAY, C.R. et al., 2009. Development of a theory of implementation and 
integration: Normalization Process Theory. Implementation Science, 4(29), pp. 
29-37 
230 
 
MAY, C., 2006. A rational model for assessing and evaluating complex 
interventions in health care. BMC Health Services Research, 6(1), pp. 86-96 
MAY, C., 2013. Towards a general theory of implementation. Implementation 
Science 8 (18), pp. 8-21 
MCLEOD, M. et al., 2014. A national survey of inpatient medication systems in 
English NHS hospitals. BMC Health Services Research, 14(1), pp. 93-103 
MCMILLAN, T., ALLAN, W. and BLACK, P., 2006. Accuracy of information on 
medicines in hospital discharge summaries. Internal Medicine Journal, 36(4), 
pp. 221-225 
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY, 2014. What 
we regulate. [online] Medicines and Healthcare Products Regulatory Agency. 
Available from: http://www.mhra.gov.uk/Aboutus/Whatweregulate/ [Accessed 
09/25 2014] 
MERP, N., 2001. National Coordinating Council for Medication Error Reporting 
and Prevention. Taxonomy of Medication Errors [online] Available from: 
http://www. nccmerp. org/pdf/taxo2001-07-31.pdf  [Accessed 03/17 2014] 
MICHIE, S. et al., 2005. Making psychological theory useful for implementing 
evidence based practice: a consensus approach. Quality and Safety in Health 
Care, 14(1), pp. 26-33 
MILES, M.B. and HUBERMAN, A.M., 1994. Qualitative data analysis: An 
expanded sourcebook. Sage. Beverley Hills 
MOTAMEDI, S.M. et al., 2011. The efficacy of computer-enabled discharge 
communication interventions: a systematic review. BMJ Quality & Safety, 
20(5), pp. 403-415 
MOZAFFAR, H. et al., 2014. Product Diversity and Spectrum of Choice in 
Hospital ePrescribing Systems in England. PloS one, 9(4), pp. e92516 
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE AND 
NATIONAL PATIENT SAFETY ASSOCIATION, 2007. Technical patient safety 
solutions for medicines reconciliation on admission of adults to hospital. 
[online] National Institute for Health and Clinical Excellence. Available from: 
http://www.nice.org.uk/guidance/psg001/resources/full-guidance-pdf2 
[Accessed 07/31 2014] 
NHS AYRSHIRE AND ARRAN, NHS Ayrshire and Arran. [online] Available from: 
https://www.nhsaaa.net/ [Accessed 06/10 2013] 
NHS AYRSHIRE AND ARRAN INFORMATION GOVERNANCE TEAM, 2010. 
Information governance and IT guidance for researchers. [online] NHS 
Ayrshire and Arran. Available from: 
http://athena/kmeh/igs/Documents/IGResearch.doc [Accessed 04/10 2013] 
NHS AYRSHIRE AND ARRAN, 2013. Stop press 
significant IT incident at NHS Greater Glasgow and Clyde. [online] Available 
from: http://www.nhsaaa.net/media/231133/sp091013.pdf [Accessed 09/12 
2014] 
231 
 
NHS CONNECTING FOR HEALTH, 2007. ePrescribing baseline functional 
specifications for NHS trusts. [online] Department of Health. Available from: 
http://www.connectingforhealth.nhs.uk/systemsandservices/eprescribing/base
linefunctspec.pdf/view [Accessed 07/13 2014] 
NHS ENGLAND, 2014. Patient safety alert stage one: Warning risks arising 
from breakdown and failure to act on communication during handover at the 
time of discharge from secondary care. [online] NHS England. Available from: 
http://www.england.nhs.uk/2014/08/29/psa-communication/ [Accessed 09/02 
2014] 
NHS RESEARCH ETHICS COMMITTEE, 2006. Differentiating audit, service 
evaluation and research. [online] NHS Health Research Authority. Available 
from: http://www.nres.nhs.uk/applications/guidance/research-
guidance/?entryid62=66988 [Accessed 04/10 2013] 
NIHR PROGRAMME GRANT FOR APPLIED RESEARCH, 2013. e-Prescribing 
Toolkit for NHS Hospitals. [online] Available from: 
http://www.eprescribingtoolkit.com/ [Accessed 09/10 2014] 
OLIVER, D.G., SEROVICH, J.M. and MASON, T.L., 2005. Constraints and 
opportunities with interview transcription: Towards reflection in qualitative 
research. Social Forces, 84(2), pp. 1273-1289 
OXFORD UNIVERSITY PRESS, 2014a. Definition of medicine. [online] Oxford 
University Press. Available from: 
http://www.oxforddictionaries.com/definition/english/medicine [Accessed 
09/10 2014] 
OXFORD UNIVERSITY PRESS, 2014b. Oxford dictionaries. [online] Oxford 
University Press. Available from: 
http://www.oxforddictionaries.com/definition/english/medication [Accessed 
09/10 2014] 
PATEY, A.M. et al., 2012. Anesthesiologists’ and surgeons’ perceptions about 
routine pre-operative testing in low-risk patients: application of the Theoretical 
Domains Framework (TDF) to identify factors that influence physicians’ 
decisions to order pre-operative tests. Implementation Science, 7(1), pp. 52 
PAYNE, J. and  THE NATIONAL HEALTH SERVICE IN SCOTLAND., 2013. SPICe 
briefing 13/10 eHealth in Scotland. [online] Available from: 
http://www.scottish.parliament.uk/ResearchBriefingsAndFactsheets/S4/SB_13
-10.pdf [Accessed 05/06 2013] 
PICTON, C. and WRIGHT, H., 2012. Keeping patients safe when they transfer 
between care providers- getting the medicine right Final Report. London: 
Royal Pharmaceutical Society. 
PILLAI, A., THOMAS, S.S. and GARG, M., 2004. The electronic immediate 
discharge document: experience from the South West of Scotland. Informatics 
in Primary Care, 12(2), pp. 67-73 
POPE, C., ZIEBLAND, S. and MAYS, N., 2000. Qualitative research in health 
care. Analysing qualitative data. British Medical Journal (Clinical research ed.), 
320(7227), pp. 114-116 
232 
 
PREACHER, K., 2012. Calculation for the chi-square test: an interactive 
calculation tool for chi-square tests of goodness of fit and independence 
[computer software].Kristopher J Preacher; 2001 [cited June 23, 2011],  
PRICE, M. and LAU, F., 2014. The clinical adoption meta-model: a temporal 
meta-model describing the clinical adoption of health information systems. 
BMC Medical Informatics and Decision Making, 14(1), pp. 43-52 
QUICKCALCS, G., 2015. [online] GraphPad Software, Inc. Available from: 
http://graphpad.com/quickcalcs/contingency1.cfm [Accessed 09/22 2015] 
QSR INTERNATIONAL, NVivo software. [online] Available from: 
http://www.qsrinternational.com/ [Accessed 09/11 2012] 
REASON, J., 1990. Human error. Cambridge University Press. New York 
REASON, J., 2000. Human error: models and management. British Medical 
Journal (Clinical research ed.), 320(7237), pp. 768-770 
REDWOOD, S. et al., 2011. Does the implementation of an electronic 
prescribing system create unintended medication errors? A study of the 
sociotechnical context through the analysis of reported medication incidents. 
BMC Medical Informatics and Decision Making, 11(1), pp. 29-39 
REEVES, S. et al., 2008. Qualitative Research: Why Use Theories in Qualitative 
Research? BMJ: British Medical Journal, 337, pp. 631-634 
RESEARCH COUNCILS UK, 2014. Pathways to impact. [online] Research 
Councils UK. Available from: http://www.rcuk.ac.uk/innovation/impacts/ 
[Accessed 11/18 2015] 
ROBERTS, P. and PRIEST, H., 2006. Reliability and validity in research. 
Nursing Standard (Royal College of Nursing (Great Britain) : 1987, 20(44), pp. 
41-45 
ROSS, S. et al., 2009. What is the scale of prescribing errors committed by 
junior doctors? A systematic review. British Journal of Clinical Pharmacology, 
67(6), pp. 629-640 
ROSS, S. et al., 2012. Who makes prescribing decisions in hospital inpatients? 
An observational study. Postgraduate Medical Journal, 88(1043), pp. 507-510 
ROSS, S. et al., 2013. Perceived causes of prescribing errors by junior doctors 
in hospital inpatients: a study from the PROTECT programme. British Medical 
Journal Quality & Safety, 22(2), pp. 97-102 
ROUTLEDGE, P.A., 2012. A national in‐patient prescription chart: the 
experience in Wales 2004–2012. British Journal of Clinical Pharmacology, 
74(4), pp. 561-565 
ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN, 2014. Medicines, 
Ethics and Practice: The Professional Guide for Pharmacists. 38th ed. London, 
England: Pharmaceutical Press. 
233 
 
RYAN, C. et al., 2013. Junior doctors' perceptions of their self‐efficacy in 
prescribing, their prescribing errors and the possible causes of errors. British 
Journal of Clinical Pharmacology, 76(6), pp. 980-987 
RYAN, C. et al., 2014. Prevalence and Causes of Prescribing Errors: The 
PRescribing Outcomes for Trainee Doctors Engaged in Clinical Training 
(PROTECT) Study. PloS one, 9(1), pp. e79802 
SANDELOWSKI, M., 1991. Telling stories: Narrative approaches in qualitative 
research. Image: the Journal of Nursing Scholarship, 23(3), pp. 161-166 
SCHIMMEL, D., 1996. Research That Makes a Difference: Complementary 
Methods for Examining Legal Issues in Education. NOLPE Monograph Series 
No. 56. ERIC. SCOTTISH EXECUTIVE AND DEPARTMENT OF HEALTH, 2004. 
Modernising medical careers- the next steps. [online] Department of Health. 
Available from: 
http://www.sehd.scot.nhs.uk/publications/TheNextSteps_Published.pdf 
[Accessed 01/05 2012] 
SCOTTISH INTERCOLLEGIATE GUIDELINES NETWORK (SIGN), 2012. 128 The 
SIGN Discharge Document. [online] Available from: www.sign.ac.uk [Accessed 
04/12 2014] 
SCULLARD, P. et al., 2007. Improved communication between hospital and 
general practice using online patient discharge summaries. Journal of 
Telemedicine and Telecare, 13 (S1), pp. 56-58 
SEIDLING, H. et al., 2013. Medication safety through e‐health technology: can 
we close the gaps? British Journal of Clinical Pharmacology, 76(S1), pp. i-iv 
SEXTON, J. et al., 2000. Ensuring seamless care at hospital discharge: a 
national survey. Journal of Clinical Pharmacy & Therapeutics, 25(5), pp. 385-
93 
SHENTON, A.K., 2004. Strategies for ensuring trustworthiness in qualitative 
research projects. Education for Information, 22(2), pp. 63-75 
SHUTTLEWORTH, M., 2009. Research bias. [online] Explorable.com. Available 
from: https://explorable.com/research-bias [Accessed 12/09 2014] 
THE SECRETARY OF STATE FOR HEALTH., 2008. The Medicines for Human Use 
(Prescribing by EEA Practitioners) Regulations, Statutory Instrument, UK 
SLEE, A., 2014. Benefits realisation guidance for ePrescribing projects. [online] 
NHS England. Available from: http://www.eprescribingtoolkit.com/wp 
content/uploads/2013/11/Benefits-realisation-eP-guidance-v1.0.pdf [Accessed 
12/09 2014] 
SMITH, J. and FIRTH, J., 2011. Qualitative data analysis: the framework 
approach. Nurse Researcher, 18(2), pp. 52-62 
SRIVASTAVA, A. and THOMSON, S.B., 2009. Framework analysis: a qualitative 
methodology for applied policy research. JOAAG, 4(2), pp. 72-79 
234 
 
STARKS, H. and TRINIDAD, S.B., 2007. Choose your method: A comparison of 
phenomenology, discourse analysis, and grounded theory. Qualitative health 
research, 17(10), pp. 1372-1380 
THE DATA PROTECTION ACT, 1998. [online] Available from: 
https://www.gov.uk/data-protection/the-data-protection-act [Accessed 12/30 
2012] 
THE HEALTH FOUNDATION, 2012. Evidence Scan: Reducing prescribing errors. 
[online] Available from: http://www.health.org.uk/publications/reducing-
prescribing-errors/ [Accessed 12/30 2012] 
THE SCOTTISH GOVERNMENT, 2012. eHealth strategy 2011-2017 (revised 
July 2012 to include a sixth strategic aim). [online] Edinburgh: The Scottish 
Government. Available from: 
http://www.scotland.gov.uk/Publications/2012/11/7663/0 [Accessed 12/30 
2012] 
THE SCOTTISH GOVERNMENT, 2012. Polypharmacy guidance. [online] 
Edinburgh: The Scottish Government. Available from: 
http://www.central.knowledge.scot.nhs.uk/upload/Polypharmacy%20full%20g
uidance%20v2.pdf [Accessed 07/30 2015] 
TROCHIM,W,M,K., 2006. Research methods knowledge base. [online] Web 
Center for Social Research Methods. Available from: 
http://www.socialresearchmethods.net/ [Accessed 01/12 2015] 
WAHYUNI, D., 2012. The Research Design Maze: Understanding Paradigms, 
Cases, Methods and Methodologies. Journal of Applied Management 
Accounting Research, 10(1), pp. 69-80 
WESTBROOK, J.I. et al., 2013. The safety of electronic prescribing: 
manifestations, mechanisms, and rates of system-related errors associated 
with two commercial systems in hospitals. Journal of the American Medical 
Informatics Association, 20 (6), pp.1159-1167 
WHITLEY, E. and BALL, J., 2002. Statistics review 4: sample size calculations. 
Critical Care, 6(4), pp. 335 
WILSON, S. et al., 2001. General practitioner–hospital communications: a 
review of discharge summaries. Journal of Quality in Clinical Practice, 21(4), 
pp. 104-108 
WITHERINGTON, E., PIRZADA, O. and AVERY, A., 2008. Communication gaps 
and readmissions to hospital for patients aged 75 years and older: 
observational study. Quality and Safety in Health Care, 17(1), pp. 71-75 
YEMM, R. et al., 2014. What constitutes a high quality discharge summary? A 
comparison between the views of secondary and primary care doctors. 
International Journal of Medical Education, 5, pp. 125-131 
YIN, R.K., 2014. Case study research: Design and methods. Sage publications. 
California 
235 
 
YUSOF, M.M. et al., 2008. An evaluation framework for Health Information 
Systems: human, organization and technology-fit factors (HOT-fit). 
International Journal of Medical Informatics, 77(6), pp. 386-398 
 
 
 
 
 
 
 
 
 
236 
 
APPENDIXES 
APPENDIX 1.1 PRE-IMPLEMENTATION INPATIENT PRESCRIPTION 
CHART 
 
 
 
 
237 
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APPENDIX 1.3 PRE-IMPLEMENTATION IMMEDIATE DISCHARGE 
LETTER 
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APPENDIX 1.4 SCREENSHOT OF HEPMA IMMEDIATE DISCHARGE 
LETTER 
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APPENDIX 1.5 SUMMARY OF KEY POINTS FROM SCOTTISH 
INTERCOLLEGIATE GUIDELINES NETWORK GUIDELINE 128 THE SIGN 
DISCHARGE DOCUMENT 
The template states information requirements for both the CDD and the EDD 
although this is not provided in an actual discharge letter format. The 
information in the table below depicts the different mandatory headings with 
an explanation. 
Information required Explanation 
Hospital name Name of discharging hospital 
Patient Identification Full name, address, date of birth and 
identification number 
GP identification Registered GP 
Consultant identification Consultant at discharge 
Ward/department Ward patient discharged from 
Contact information Phone number  
Date of admission Date admitted to this hospital 
Date of discharge Date of actual discharge 
Primary discharge diagnosis Record if definite or interim 
Secondary discharge diagnosis Record if definite or interim 
Presenting Complaint Reason patient came to hospital 
Admission type Arranged, emergency or transfer 
Referral source GP, self-referral, ambulance etc 
Significant operations/procedures Dates to provided and abbreviations 
avoided 
Clinical progress What happened during stay 
Results awaited Any outstanding results 
Investigations pending Any pending investigations 
Allergies All known allergies 
Medicines stopped Medicines stopped during this episode 
New medicines New medicines started  
Continuing medicines Medicines continuing 
Follow-up arrangements Specify what, when and by whom 
Copy to community pharmacy Was a copy of CDD sent to community 
pharmacy 
Copy to patient Was a copy of CDD given to patient 
Copy to carer/relative Was a copy of CDD given to 
carer/relative 
Extended document to follow? Only required for more complicated 
patients 
Other information Any other relevant information 
Consultant sign-off and comment Consultant responsible for patient at 
discharge 
Signature, name and position Signature, name, job title and contact 
number 
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APPENDIX 1.6 DISCHARGE MEDICINE RECONCILIATION HEPMA 
ASSISTANCE MEDICINE DISCONTINUED 
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APPENDIX 1.7 DISCHARGE MEDICINE RECONCILIATION HEPMA 
ASSISTANCE NEW MEDICINE INFORMATION 
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APPENDIX 1.8 NHS AYRSHIRE AND ARRAN STOP PRESS 
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APPENDIX 3.1 SEMI-STRUCTURED INTERVIEW SCHEDULE (PRE-IMPLEMENTATION) 
 
“Does hospital electronic prescribing impact on discharge communication- staff views and experiences of the traditional system” 
 
Participant Number 
 
Date  
/   / 
Start time  
: 
 
A. Introduction 
Hello, thanks for agreeing to be interviewed for this project.  Please, can I check you have read the participant information sheet. 
If not, here is a copy to read before we begin. 
The main purpose of this interview is to find out your views and experiences about the current prescribing and discharge communication system.  
The organisation is intending to implement a Hospital Electronic Prescribing and Medicines Administration (HEPMA) system in this hospital in the near future. 
I would also like to ask you about how you think this new system might impact on prescribing and discharge communication.  
Your participation is voluntary and you may withdraw at any point.  
If you do not want to answer a specific question, then please let me know.  
There are no right or wrong answers and I am interested in your personal opinion.  
The identities of all participants will remain strictly confidential and it will not be possible to identify individuals from the study results.  
The interview should take approximately 20 to 30 minutes, are you ok to go ahead? 
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IF NO: That’s okay.  When would be more convenient?  
Thanks I’ll see you on day/date/time at ..............location. Bye. 
 
 
Write the new day/date/time here and in diary chart: 
 
IF YES continue:  That’s great, thank you. 
B. Housekeeping 
As you are aware from the information sheet and consent form, this conversation is being audio recorded but I would emphasise that it is confidential.   
Please do not use names of patients or hospital staff during this interview. It is ok to refer to “a patient”, “another doctor”, “ a nurse”, “a GP” etc 
Are you still OK with that?   
 
 
IF NO:  
That’s fine. I’ll need a bit more time to write down notes as we go through the 
sections and I may ask you to repeat some answers so I don’t miss anything. 
 
Reminders 
 Take time to write detailed notes 
 If in doubt, ask the interviewee for clarification before you move on to the 
next section 
 
If you decide after the interview you no longer wish to be a part of the research, please let me know.  The contact details are on the information sheet. 
 
Do you have any questions before we begin? 
 
Technical problem? Keep calm! Explain, apologise and rearrange interview day/date/time   
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C. Background Information 
 
“I would like to ask you some background information” 
 
What is your professional group:  Consultant Medical/Junior Medical/Advanced Nurse Practitioner/ Pharmacist 
 
Sex: Male/Female 
 
How many years have you worked in this hospital?………………years 
 
How many other organisations have you worked in the last 10 years?  ………………… 
 
Have you used electronic systems for prescribing and discharge previously? Y/N 
 
If Yes, please prescribe a description of what this involved e.g. full HEPMA system, stand alone electronic discharge letter………………….. 
If No, go to Section D 
 
 
247 
 
D. Inpatient prescribing 
I would like to ask you about the current inpatient prescription chart- what works well, what doesn’t work well, any experiences you would like to share, any 
thoughts? Please use your experience of patient care as illustrative examples 
Allow free comment and then ask if not covered: 
Comments about prescribing/transcribing daily medicines? 
What about medicines of unusual frequencies e.g. Parkinson’s medicines, 
alternate day, or once weekly? 
What about insulin, warfarin, non-formulary medicines? 
 
Comments about recording/knowing if a patient was admitted on a medicine? 
 
Comments about recording allergy information? 
 
Comments about documenting withheld medicines? 
 
Comments about documenting medicines to be continued on discharge? 
 
Comments about viewing the inpatient chart? 
What about the number of pages per patient? 
What about re-writing prescription charts? 
 
Comments about knowing if a medicine has been administered? 
 
Comments about documenting/knowing if a patient uses a compliance 
device/MAR chart? 
 
How have your experiences of..... impacted on your views? 
What about contribution to patient care and risk? 
Anything you would like to add about why you have made these 
comments.............. 
 
Note answers here for backup and reference 
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E. Discharge prescribing 
I would like to ask you about the current immediate discharge letter (IDL) -what works well, what doesn’t work well, any experiences you would 
like to share, any thoughts? Please use your experience of patient care as illustrative examples 
Allow free comment and then ask if not covered: 
Do you have any comments about recording/knowing diagnosis on IDL? 
What about clinical progress, follow up information? 
 
Do you have any comments about prescribing daily medicines? 
What about medicines of unusual frequencies e.g. Parkinson’s 
medicines or alternate days/ once weekly 
What about insulin, warfarin, non-formulary medicines? 
 
Do you have any comments about recording/knowing if a patient was 
admitted on a medicine? 
What about recording/knowing allergy information, documenting/knowing 
medicine stopped during hospital admission, documenting/knowing if a 
medicine is to be continued by GP on discharge, documenting/knowing 
an indication for newly started medicine? 
 
Comments about the number of pages per patient? 
 
Comments about documenting/knowing that a patient needs a 
compliance device/MAR chart on discharge? 
 
Comments about how often is IDL reviewed and signed off by a 
consultant? 
 
How have your experiences of..... impacted on your views? 
What about contribution to patient care and risk? 
Anything you would like to add about why you have made these 
comments.............. 
Note answers here for backup and reference 
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F. Incident Reports and Significant Adverse Event Reviews 
I would like to ask you about Datix reporting/ reviewing or SAER in relation to current prescribing and discharge communication system? 
Allow free comment and if No go to Section G 
  or then ask if not covered: 
  
- Have you recorded any Datix incidents regarding the current prescribing 
and discharge communication system? 
If Yes, what was the problem, did it result in harm, what would prevent this 
happening again?  
 
- Have you responded to any Datix incidents regarding the current 
prescribing and discharge communication system 
If Yes, what was the problem, did it result in harm, what would prevent this 
happening again?  
 
- Have you been involved in any Significant Adverse Event Reviews 
(SAER) involving the prescribing and discharge communication system? 
If Yes, what was the problem, did it result in harm, what would prevent this 
happening again?  
 
 
Note answers here for backup and reference 
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G. Hospital Electronic Prescribing and Medicines Administration (HEPMA) Implementation 
I would like to ask about your understanding and views about the proposed HEPMA implementation 
Allow free comment and then ask if not covered: 
  
- What, if any, impact do you think this will have on your present role? 
- Why do you think this? 
- What, if any, impact do you think this will have on your profession? 
- Why do you think this? 
- What, if any, impact do you think this will have on inpatient prescribing 
- Why do you think this? 
- What, if any impact do you think this will have on discharge prescribing 
and communication? 
- Why do you think this? 
- What, if any impact do you think this will have on incidents and adverse 
events? 
- Why do you think this? 
- What, if any, impact do you think this will have on patient safety? 
- Why do you think this? 
- What, if any, impact do you think this will have on the hospital service? 
- Why do you think this? 
Note answers here for backup and reference 
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H. Other 
 
Is there anything else you would like to add? Note answers here for backup and reference 
Well that’s all of my questions.  You’ve been very helpful and I appreciate you taking the time to speak to me.  If you think of anything 
else you would like to add, please get in touch.  
If you would like to see a copy of the transcript from the interview, please let me know and I will arrange for this to be supplied to you. 
Thank you very much.   
Transcript Y/N 
 
Interview  
concluded at: 
: 
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APPENDIX 3.2   E-MAIL PARTICIPANT INVITATION 
Dear  
 
I would like to invite you to participate in a short interview to evaluate our current 
prescribing system prior to Hospital Electronic Prescribing and Medicines 
Administration (HEPMA) implementation. 
The study has been approved by Robert Gordon University Ethics Review Panel 
and has been assessed by NHS Ayrshire and Arran Research and Development 
as a service evaluation project and thus does not require NHS Ethics review. 
  
The interviews will be recorded with your agreement. All information will be treated 
confidentially and no names will be used in any analysis or publications. 
  
I hope you will agree to participate and if so I will arrange a date for the interview 
to be held at a mutually convenient time. Ideally I would like the interviews to be in 
January or February 2013. 
The interviews may be held in the pharmacy in a private room or another identified 
room of your choosing that would allow the meeting to remain confidential. 
I enclose a copy of the participant information sheet and consent form for your 
information. 
If you have any queries, please do not hesitate to contact me. 
Thanking you in anticipation. 
  
  
Pamela 
  
Pamela Mills 
Principal Pharmacist- Redesign 
Pharmacy Department 
University Hospital Crosshouse 
Kilmarnock 
KA2 0BE 
  
01563 521133 Bleep 3178 
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APPENDIX 3.3 PARTICIPANT INFORMATION SHEET   
 
 
Title of Project: Does hospital electronic prescribing impact on discharge communication- 
staff views and experiences of the traditional system? 
You are being invited to take part in a research study.  Before you decide if you wish to 
take part it is important for you to understand why the research is being undertaken and 
what it will involve.  Please take time to read the following information carefully. Talk to 
others about the study if you wish.  
Ask me if there is anything that is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part. 
 
What is the purpose of the study? 
The purpose of the study is to investigate if implementing a Hospital Electronic Prescribing 
and Medicines Administration (HEPMA) system has improved discharge communication. 
Currently, there have been problems with inaccurate and incomplete information or 
delayed information being sent to patients’ GPs. These problems may result in either 
potential or actual patient harm especially in relation to information about medicines. 
Study aim 
The aim of this study is to investigate the impact of implementing a HEPMA system into a 
district general hospital (DGH) specifically in relation to discharge information 
communication to patients’ general practitioners after an inpatient hospital stay of adult 
patients (16 years and over).  
The study will be carried out by a pharmacist working within NHS Ayrshire and Arran. This 
work will form part of a submission towards a Doctorate of Professional Practice 
qualification from Robert Gordon University. 
Why have I been chosen? 
You have been chosen because you belong to one of the staff groups involved with 
prescribing medicines and discharge information communication and you are familiar with 
the current hospital prescribing and medicine administration system. 
Do I have to take part? 
No.  It is up to you to decide whether or not to take part.  If you do, you will be given this 
information sheet to keep and be asked to sign an informed consent form. You are still 
free to withdraw at any time and without giving a reason.  A decision to withdraw at any 
time, or a decision not to take part, will not affect any way your employment with NHS 
Ayrshire and Arran. 
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What will happen to me if I take part? 
If you decide to take part in this study, you will be asked to take part in an interview of 
approximately twenty to thirty minutes with the researcher at either a private room in the 
pharmacy department or your office, whichever is more convenient. You will be asked to 
provide your views and opinions relating to the current prescribing and medicine 
administration system. The interview will be audio recorded with your permission. The 
recording will be transcribed into a qualitative data software system to aid analysis. You 
will be provided with a transcript of the audio recording if requested and allowed to make 
any required amendments to the transcript. 
 Any information provided during the interview will be anonymous and confidential. Your 
name will not appear on the transcript or any report of the research. This information may 
be used anonymously in any publication or presentation of the study results.  
Several months after the implementation of the hospital electronic prescribing and 
medicines administration system you will be contacted to participate in another interview 
with the researcher to enable to gain your opinion of the impact of the new system. You 
will be asked for your consent again before participating in the second interview. 
What do I have to do? 
If you decide to take part in the study, you will be asked to sign an informed consent form 
and to take part in the interview as described above. 
What are the possible benefits of taking part? 
There are no direct benefits to you by taking part in the study. There may be benefits to 
the organisation in evaluating any benefits of the newly implemented HEPMA system. 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study will be addressed. 
If you have any complaints or would like further information about the study please 
contact: 
Pamela Mills 
Principal Pharmacist – Redesign 
Pharmacy Department 
University Hospital of Crosshouse  
Kilmarnock 
KA2 0BE 
Telephone: 01563 826066 
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If you remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure. Details can be obtained from Crosshouse or Ayr Hospital. 
 
Will my taking part in the study be kept confidential?  
Yes.  All the information about your participation in this study will be kept confidential.  Any 
data relating to your participation will be stored securely at all times and can only be 
accessed by the researcher. 
You will be given a copy of the information sheet and a signed consent form to keep. 
Thank you for taking time to read the information sheet and for considering taking part in 
this study. 
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APPENDIX 3.4 CONSENT FORM 
 
 
Does hospital electronic prescribing impact on discharge communication- staff 
views and experiences of the traditional system? 
Researcher 
Pamela Mills 
Principal Pharmacist- Redesign 
Pharmacy Department 
University Hospital of Crosshouse 
Ext: 26066 Bleep: 3178 E-mail: pamela.mills@aaaht.scot.nhs.uk 
 
Participant Study Number................. 
 Please INITIAL box 
I confirm that I have read and understand the information sheet for the 
above study and have had the opportunity to ask questions. 
  
 
I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving reason. 
 
I agree to take part in the above study. 
 
I agree to the interview being audio recorded. 
 
I agree to the use of anonymised quotes in publications. 
  
 
 
 
Name of Participant    Date    Signature 
 
 
Name of Interviewer    Date    Signature 
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APPENDIX 3.5 NHS ETHICS (PHASE 1) 
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APPENDIX 3.6 RGU ETHICS REVIEW PANEL (PHASE 1) 
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APPENDIX 4.1 PARTICIPANT INFORMATION SHEET 
 
PARTICIPANT INFORMATION SHEET – Post-implementation  
Title of Project: Does hospital electronic prescribing impact on discharge 
communication- staff views and experiences of the HEPMA system? 
You are being invited to take part in a research study.  Before you decide if you wish to take part it 
is important for you to understand why the research is being undertaken and what it will involve.  
Please take time to read the following information carefully. Talk to others about the study if you 
wish.  
 
Ask me if there is anything that is not clear or if you would like more information.  Take time to 
decide whether or not you wish to take part. 
 
What is the purpose of the study? 
The purpose of the study is to investigate if implementing a Hospital Electronic 
Prescribing and Medicines Administration (HEPMA) system has impacted on 
discharge communication. Traditionally, there have been problems with 
inaccurate and incomplete information or delayed information being sent to 
patients’ GPs. These problems may result in either potential or actual patient 
harm especially in relation to information about medicines. 
Study aim 
The aim of this study is to investigate the impact of implementing a HEPMA 
system into a district general hospital (DGH) specifically in relation to 
discharge information communication to patients’ general practitioners after 
an inpatient hospital stay of adult patients (16 years and over).  
The study will be carried out by a pharmacist working within NHS Ayrshire and 
Arran. This work will form part of a submission towards a Doctorate of 
Professional Practice qualification from Robert Gordon University. 
Why have I been chosen? 
You have been chosen because you belong to one of the staff groups involved 
with prescribing medicines and discharge information communication and you 
are familiar with the newly implemented hospital electronic prescribing and 
medicines administration system. 
Do I have to take part? 
No.  It is up to you to decide whether or not to take part.  If you do, you will be 
given this information sheet to keep and be asked to sign an informed 
consent form. You are still free to withdraw at any time and without giving a 
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reason.  A decision to withdraw at any time, or a decision not to take part, 
will not affect any way your employment with NHS Ayrshire and Arran. 
 
What will happen to me if I take part? 
If you decide to take part in this study, you will be asked to take part in an 
interview of approximately twenty to thirty minutes with the researcher at 
either a private room in the pharmacy department or your office, whichever is 
more convenient. You will be asked to provide your views and opinions 
relating to the newly implemented electronic prescribing and medicine 
administration system. The interview will be audio recorded with your 
permission. The recording will be transcribed into a qualitative data software 
system to aid analysis. You will be provided with a transcript of the audio 
recording if requested and allowed to make any required amendments to the 
transcript. 
 Any information provided during the interview will be anonymous and 
confidential. Your name will not appear on the transcript or any report of the 
research. This information may be used anonymously in any publication or 
presentation of the study results.  
What do I have to do? 
If you decide to take part in the study, you will be asked to sign an informed 
consent form and to take part in the interview as described above. 
What are the possible benefits of taking part? 
There are no direct benefits to you by taking part in the study. There may be 
benefits to the organisation in evaluating any benefits of the newly 
implemented HEPMA system. 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study will 
be addressed. If you have any complaints or would like further information 
about the study please contact: 
Pamela Mills 
Principal Pharmacist – Redesign 
Pharmacy Department 
University Hospital Crosshouse  
Kilmarnock 
KA2 0BE 
Telephone: 01563 826066 
263 
 
 
If you remain unhappy and wish to complain formally, you can do this through 
the NHS Complaints Procedure. Details can be obtained from University 
Hospital Crosshouse or University Hospital Ayr. 
 
Will my taking part in the study be kept confidential?  
Yes.  All the information about your participation in this study will be kept 
confidential.  Any data relating to your participation will be stored securely at 
all times and can only be accessed by the researcher. 
 
You will be given a copy of the information sheet and a signed consent form 
to keep. 
Thank you for taking time to read the information sheet and for considering 
taking part in this study. 
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APPENDIX 4.2 CONSENT FORM 
 
Does hospital electronic prescribing impact on discharge communication- staff 
views and experiences of the newly implemented HEPMA system? 
Researcher 
Pamela Mills 
Principal Pharmacist- Redesign 
Pharmacy Department 
University Hospital of Crosshouse 
Ext: 26066 Bleep: 3178 E-mail: pamela.mills@aaaht.scot.nhs.uk 
Participant Study Number................ 
 Please INITIAL box 
 
I confirm that I have read and understand the information sheet 
for the above study and have had the opportunity to ask 
questions. 
  
 
I understand that my participation is voluntary and that I am 
free to withdraw at any time, without giving reason. 
 
I agree to take part in the above study. 
I agree to the interview being audio recorded. 
I agree to the use of anonymised quotes in publications. 
 
  
 
 
Name of Participant    Date   
 Signature 
 
Name of Interviewer    Date   
 Signature 
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APPENDIX 4.3 SEMI-STRUCTURED INTERVIEW SCHEDULE 
 
Participant Number 
 
Date  
/   / 
Start time  
: 
 
A. Introduction 
 
Hello, thanks for agreeing to be interviewed for this project.  Please, can I check you have read the participant information 
sheet. 
If not, here is a copy to read before we begin. 
The main purpose of this interview is to find out your views and experiences about the electronic prescribing and discharge 
communication system.  The focus is specifically on the systems and how people interact with the systems. 
The organisation recently implemented a Hospital Electronic Prescribing and Medicines Administration (HEPMA) system in 
this hospital. Whilst the intervention was electronic, it is people that will use the system so I am interested in your 
experience and opinions. 
  
The interview will be divided into 5 different sections and this will cover some background information, 1) inpatient 
prescribing looking at the electronic system, 2) discharge prescribing looking at the electronic version, 3) the discharge 
process  4) incident reports and significant adverse event reviews and 5) opinion about HEPMA implementation 
Your participation is voluntary and you may withdraw at any point.  
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If you do not want to answer a specific question, then please let me know.  
There are no right or wrong answers and I am interested in your personal opinion.  
The identities of all participants will remain strictly confidential and it will not be possible to identify individuals from the 
study results.  
The interview should take approximately 20 to 30 minutes, are you ok to go ahead? 
 
 
 
IF NO: That’s okay.  When would be more convenient?  
 
Thanks I’ll see you on day/date/time at ..............location. Bye. 
 
 
Write the new day/date/time here and in diary chart: 
 
IF YES continue:  That’s great, thank you. 
 
B. Housekeeping 
As you are aware from the information sheet and consent form, this conversation is being audio recorded but I would 
emphasise that it is confidential.   
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Please do not use names of patients or hospital staff during this interview. It is ok to refer to “a patient”, “another doctor”, 
“ a nurse”, “a GP” etc 
Are you still OK with that?   
 
 
IF NO:  
That’s fine. I’ll need a bit more time to write down notes as we 
go through the sections and I may ask you to repeat some 
answers so I don’t miss anything. 
 
Reminders 
Take time to write detailed notes 
If in doubt, ask the interviewee for clarification before you 
move on to the next section 
 
If you decide after the interview you no longer wish to be a part of the evaluation, please let me know.  The contact details 
are on the information sheet. 
 
Do you have any questions before we begin? 
 
Technical problem? Keep calm! Explain, apologise and rearrange interview day/date/time   
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C. Background Information 
“I would like to ask you some background information” 
 
What is your professional group:  Consultant Medical/Junior Medical/Advanced Nurse Practitioner/ Pharmacist 
 
Sex: Male/Female 
 
How would you describe your ethnic origin: White/ Mixed Race/ Asian/ African, Caribbean, Black/Arab/Other 
 
How many years have you worked in this hospital?………………years 
 
How many other organisations have you worked in the last 10 years?  ………………… 
 
Have you used electronic systems for prescribing and discharge in previous organisations? Y/N 
 
If Yes, please prescribe a description of what this involved e.g. full HEPMA system, stand alone electronic discharge 
letter………………….. 
If No, go to Section D 
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D. Inpatient prescribing 
1. I would like to ask you about the electronic inpatient prescription chart- what works well, what doesn’t work well, any 
experience Allow free comment and then ask if not covered: 
Comments about prescribing/transcribing daily medicines?  
– What about medicines that are of unusual frequencies e.g. Parkinson’s medicines, alternate day, or once weekly? 
What about insulin, warfarin, non-formulary medicines? 
 
Comments about recording/knowing if a patient was admitted on a medicine? 
 
Comments about recording allergy information? 
 
Comments about documenting withheld medicines? 
 
Comments about documenting medicine to be continued on discharge? 
 
Comments about viewing the inpatient chart? 
-What about the number of pages per patients? 
Comments about knowing if a medicine has been administered? 
 
Comments about documenting/knowing if a patient uses a compliance device/MAR chart? 
 
Comments about prescribing/transcribing daily 
medicines?  
– What about medicines that are of unusual frequencies e.g. 
Parkinson’s medicines, alternate day, or once weekly? 
Comments about recording/knowing if a patient was admitted 
on a medicine? 
Comments about recording allergy information? 
Comments about documenting withheld medicines? 
Comments about documenting continuing medicines on 
discharge? 
viewing the inpatient chart? 
Comments about knowing if a medicine has been 
administered? 
Comments about documenting/knowing if a patient uses a 
compliance device/MAR chart? 
How have your experiences of…………impacted on your views? 
What about contribution to patient care and risk? 
Anything you would like to add about why you have made 
these comment…………….. 
Note answers here for backup and reference 
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E. Discharge prescribing  I would like to ask you about the electronic discharge letter -what works well, what doesn’t work 
well, any experiences you would like to share, any thoughts? Allow free comment and then ask if not covered: 
Do you have any comments about recording/knowing 
diagnosis on DL? 
What about clinical progress, follow up information? 
Do you have any comments about prescribing daily medicines?  
What about medicines that are of unusual frequencies e.g. 
Parkinson’s medicines or alternate days/ once weekly 
Do you have any comments about recording/knowing if a 
patient was admitted on a medicine? 
What about recording/knowing allergy information, 
documenting/knowing medicine stopped during hospital 
admission, documenting/knowing if a medicine is to be 
continued by GP on discharge, documenting/knowing an 
indication for newly started medicine? 
Comments about the number of pages per patient? 
Comments about documenting/knowing that a patient needs a 
compliance device/MAR chart on discharge? 
Comments about consultant IDL reviewed and sign off  
 
How have your experiences of…………impacted on your views? 
What about contribution to patient care and risk? 
Anything you would like to add....... 
Note answers here for backup and reference 
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3. I would like to ask you about the electronic discharge letter process- what works well, what doesn’t work well, any 
experiences you would like to share, any thoughts? Please use your experience of patient care as illustrative examples 
Allow free comment and then ask if not covered: 
Has HEPMA implementation altered this process? 
If Yes, please explain 
Comments about the completion of this process? 
What do you think facilitates this process? 
 
What barriers do you think impede this process? 
 
Comments about the time taken to complete this process? 
What are the main problems, if any you experience with this 
process 
Have you had any queries from GPs regarding the content of the 
electronic discharge letters? 
If Yes, what and why 
Do you have any comments about the ability to resolve these 
queries 
How have your experiences of…………impacted on your views? 
What about contribution to patient care and risk? 
Anything you would like to add about why you have made these 
comment…………….. 
 
Note answers here for backup and reference 
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F. Incident Reports and Significant Adverse Event Reviews 
4. I would like to ask you about Datix reporting/ reviewing or SAER in relation to newly implemented HEPMA system? 
Allow free comment and if No go to Section 5 
  or then ask if not covered: 
Have you recorded any Datix incidents regarding the HEPMA 
system? 
If Yes, what was the problem, did it result in harm, what 
would prevent this happening again?  
 
Have you responded to any Datix incidents regarding the 
HEPMA system? 
If Yes, what was the problem, did it result in harm, what 
would prevent this happening again?  
 
Have you been involved in any Significant Adverse Event 
Reviews (SAER) after HEPMA implementation? 
If Yes, what was the problem, did it result in harm, what 
would prevent this happening again?  
 
How have your experiences of…………impacted on your views? 
What about contribution to patient care and risk? 
Anything you would like to add about why you have 
made these comment…………….. 
 
Note answers here for backup and reference 
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G. Hospital Electronic Prescribing and Medicines Administration (HEPMA) Implementation 
5. I would like to ask about your personal thoughts and opinions about HEPMA implementation 
Allow free comment and then ask if not covered: 
What, if any, impact has this had on your present role? 
Why do you think this? 
What, if any, impact has this had on your profession? 
Why do you think this? 
What, if any impact has this had on incidents and adverse 
events? 
Why do you think this? 
What, if any, impact has this had on patient safety? 
Why do you think this? 
What, if any, impact has this had on the hospital service? 
Why do you think this? 
Note answers here for backup and reference 
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H. Other 
 
6. Is there anything else you would like to add? Note answers here for backup and reference 
Well that’s all of my questions.  You’ve been very helpful and I appreciate you taking the time to speak to 
me.  If you think of anything else you would like to add, please get in touch.  
If you would like to see a copy of the transcript from the interview, please let me know and I will arrange 
for this to be supplied to you. 
Thank you very much.   
Transcript Y/N 
 
Interview  
concluded at: 
: 
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APPENDIX 4.4 NHS ETHICS (PHASES 2&3) 
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APPENDIX 4.5 RGU ETHICS REVIEW PANEL (PHASES 2&3) 
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APPENDIX 4.6 CALDICOTT GUARDIAN APPROVAL  
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APPENDIX 5.1 QUANTITATIVE DATA COLLECTION TOOL 
Data  Explanation Exclusion Criteria Data Collection 
Reason 
Name of Hospital Hospital discharged from Not Crosshouse Ensure only study hospital 
Patient Name Name as documented on 
case notes 
Nil Required to contact GP for 
information 
Patient CHI number Unique identifier Outside Scotland Required to contact GP for 
information 
Patient’s age Age at discharge Nil Demographic comparison 
 
Patient’s sex Male or Female Nil Demographic comparison 
 
General Practitioner 
(GP) ID 
What is documented n/a if patient has no GP Required to contact GP for 
information 
Consultant ID What is documented Nil To determine discharge 
speciality/ demographic 
comparison 
Ward/ Department What is documented Nil Demographic comparison 
 
Discharge specialty Specialty of consultant at 
discharge 
Nil Demographic comparison 
Date and time of 
admission 
Data from patient 
management system 
Nil To enable calculation of 
length of stay  
Date and time of 
discharge 
Data from patient 
management system 
Nil To enable calculation of 
stay length and time to 
receipt 
Patient – length of 
stay 
Days as inpatient Nil Longer stay more potential 
for errors and discrepancies 
Discharge day of week Monday, Tuesday, 
Wednesday, Thursday, 
Friday, Saturday, Sunday 
Nil Do errors rates differ 
depending on discharge day 
Primary Diagnosis What is documented Accuracy not assessed Completeness of 
information 
Secondary Diagnosis What is documented Accuracy not assessed Completeness of 
information 
Significant 
operations/procedures 
What is documented Accuracy not assessed Completeness of 
information 
Allergies What is documented on IDL 
versus what is documented 
on inpatient prescription 
Nil- if nothing 
documented this should 
be recorded 
To assess completeness 
and accuracy of information 
communicated 
Number of admission 
medicines 
Number recorded on 
medicine reconciliation, GP 
referral letter or clerk-in. 
Also check pharmacist care 
plan for discrepancies 
More than one dose e.g. 
warfarin 
The greater the number of 
medicines the greater 
potential for errors 
Number of medicines 
on discharge 
Number recorded on 
discharge letter 
More than one dose e.g. 
warfarin 
The greater the number of 
medicines the greater 
potential for error 
Number of medication 
changes during stay 
Number changed from 
admission to discharge 
Nil The greater the number of 
medication changes the 
greater potential for error 
Stopped medicines Number of admission 
medicines stopped during 
stay 
Temporary 
discontinuations 
The greater the number of 
medication changes the 
greater potential for error 
New medicines Number of new medicines 
discharged home  
Temporary 
administrations 
The greater the number of 
medication changes the 
greater potential for error 
Continuing medicine Number of medicines 
unchanged from admission 
to discharge 
Dose changes The greater the number of 
medicines the greater 
potential for error 
Signature, name and 
position 
What has been documented Nil Required legal information 
for prescribing and to 
enable person completing 
document to be contacted 
Grade of staff  NIP, FY1, FY2 etc Nil Is there a difference in 
error rate between different 
staff groups  
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Data Explanation Exclusion Criteria Data Collection 
Reason 
Extended discharge to 
follow 
What has been documented Nil The more communication 
the greater potential for 
discrepancies and delay in  
information receipt 
Has HEPMA implementation 
changed practice to first 
and final discharge letter 
Method discharge 
communication 
Post or e-mail Nil Is there a difference in 
receipt or receipt time by 
different communication 
methods 
Has HEPMA implementation 
changed practice of 
discharge communication 
method 
Receipt ? Did GP surgery receive- 
Yes/no/n/a 
n/a if patient has no GP  Is there a difference in 
receipt or receipt time by 
different communication 
methods 
Date and time of 
receipt at GP 
Date and time as recorded 
on GP system 
n/a if patient has no GP Is there a difference in 
receipt or receipt time by 
different communication 
methods 
Number of additional 
discharge 
communication(s) to 
GP 
Typed final letters, 
additional results etc 
Telephone or verbal 
communication 
The more communication 
the greater potential for 
discrepancies and delay in 
receipt of information Has 
HEPMA implementation 
changed practice to first 
and final discharge 
communication 
Error – omission 
(from inpatient to 
discharge 
prescription) 
Number of medicines 
omitted  
Nil To quantify different types 
of prescribing errors 
Error- commission 
(from inpatient to 
discharge 
prescription) 
Number of medicines 
unintentionally started  
Nil To quantify different types 
of prescribing errors 
Error-incorrect dose  
(from inpatient to 
discharge 
prescription) 
Number of medicines with 
wrong dose  
Nil To quantify different types 
of prescribing errors 
Error- incorrect 
frequency 
(from inpatient to 
discharge 
prescription) 
Number of medicines with 
incorrect frequency  
Nil To quantify different types 
of prescribing errors 
Error-incorrect 
duration 
 
Number of medicines with 
incorrect duration  
Nil To quantify different types 
of prescribing errors 
Error- drug interaction Number of detected drug 
interactions 
Nil To quantify different types 
of prescribing errors 
Error-therapeutic 
duplication 
Number of detected 
therapeutic duplications 
Nil To quantify different types 
of prescribing errors 
Error-omitted allergy 
(from inpatient to 
discharge 
prescription) 
Number of omitted allergies  Nil To quantify different types 
of prescribing errors 
Error- incorrect allergy 
(from inpatient to 
discharge 
prescription) 
Number of allergy 
discrepancies  
Nil To quantify different types 
of prescribing errors 
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APPENDIX 5.2 GP RECEIPT INFORMATION DATA COLLECTION TOOL 
Patient 
CHI 
Patient 
Initials 
Discharge Date GP Name GP Surgery Date of Receipt 
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APPENDIX 5.3 ERROR SEVERITY DATA COLLECTION TOOL 
Error Description Error type Severity 
Score 
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APPENDIX 5.4 HEADING TABS IN HEPMA IDL 
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APPENDIX 5.5 CALDICOTT GUARDIAN APPROVAL 
 
 
